trial_id,AE_label_raw,event_category,is_any_ae,is_serious_ae,is_fatal,is_ae_leading_to_discontinuation,is_aesi,arm_label,arm_role,arm_total_n,n_with_event,percent_with_event,label_raw,ae_canonical,ae_family,is_summary,summary_type,drug_name,is_clinical_dose,include_in_plot,dose_mg,route,frequency
NCT01272219,Adverse events in ≥5% of patients,Adverse events in ≥5% of patients,True,False,False,False,False,Liraglutide,treatment,2481,1992.0,80.3,Adverse events in ≥5% of patients,Adverse events (≥5% of patients),Adverse events (≥5% of patients),True,other_summary,Liraglutide,True,True,,SC,QD
NCT01272219,Adverse events in ≥5% of patients,Adverse events in ≥5% of patients,True,False,False,False,False,Placebo,control,1242,786.0,63.3,Adverse events in ≥5% of patients,Adverse events (≥5% of patients),Adverse events (≥5% of patients),True,other_summary,Liraglutide,False,False,,,
NCT01272219,Nausea,Adverse events in ≥5% of patients,True,False,False,False,False,Liraglutide,treatment,2481,997.0,40.2,Nausea,Nausea,Nausea,False,,Liraglutide,True,True,,SC,QD
NCT01272219,Nausea,Adverse events in ≥5% of patients,True,False,False,False,False,Placebo,control,1242,183.0,14.7,Nausea,Nausea,Nausea,False,,Liraglutide,False,False,,,
NCT01272219,Diarrhea,Adverse events in ≥5% of patients,True,False,False,False,False,Liraglutide,treatment,2481,518.0,20.9,Diarrhea,Diarrhea,Diarrhea,False,,Liraglutide,True,True,,SC,QD
NCT01272219,Diarrhea,Adverse events in ≥5% of patients,True,False,False,False,False,Placebo,control,1242,115.0,9.3,Diarrhea,Diarrhea,Diarrhea,False,,Liraglutide,False,False,,,
NCT01272219,Constipation,Adverse events in ≥5% of patients,True,False,False,False,False,Liraglutide,treatment,2481,495.0,20.0,Constipation,Constipation,Constipation,False,,Liraglutide,True,True,,SC,QD
NCT01272219,Constipation,Adverse events in ≥5% of patients,True,False,False,False,False,Placebo,control,1242,108.0,8.7,Constipation,Constipation,Constipation,False,,Liraglutide,False,False,,,
NCT01272219,Vomiting,Adverse events in ≥5% of patients,True,False,False,False,False,Liraglutide,treatment,2481,404.0,16.3,Vomiting,Vomiting,Vomiting,False,,Liraglutide,True,True,,SC,QD
NCT01272219,Vomiting,Adverse events in ≥5% of patients,True,False,False,False,False,Placebo,control,1242,51.0,4.1,Vomiting,Vomiting,Vomiting,False,,Liraglutide,False,False,,,
NCT01272219,Dyspepsia,Adverse events in ≥5% of patients,True,False,False,False,False,Liraglutide,treatment,2481,236.0,9.5,Dyspepsia,Dyspepsia,Dyspepsia,False,,Liraglutide,True,True,,SC,QD
NCT01272219,Dyspepsia,Adverse events in ≥5% of patients,True,False,False,False,False,Placebo,control,1242,39.0,3.1,Dyspepsia,Dyspepsia,Dyspepsia,False,,Liraglutide,False,False,,,
NCT01272219,Upper abdominal pain,Adverse events in ≥5% of patients,True,False,False,False,False,Liraglutide,treatment,2481,141.0,5.7,Upper abdominal pain,Upper abdominal pain,Abdominal pain,False,,Liraglutide,True,True,,SC,QD
NCT01272219,Upper abdominal pain,Adverse events in ≥5% of patients,True,False,False,False,False,Placebo,control,1242,43.0,3.5,Upper abdominal pain,Upper abdominal pain,Abdominal pain,False,,Liraglutide,False,False,,,
NCT01272219,Abdominal pain,Adverse events in ≥5% of patients,True,False,False,False,False,Liraglutide,treatment,2481,130.0,5.2,Abdominal pain,Abdominal pain,Abdominal pain,False,,Liraglutide,True,True,,SC,QD
NCT01272219,Abdominal pain,Adverse events in ≥5% of patients,True,False,False,False,False,Placebo,control,1242,43.0,3.5,Abdominal pain,Abdominal pain,Abdominal pain,False,,Liraglutide,False,False,,,
NCT01272219,Nasopharyngitis,Adverse events in ≥5% of patients,True,False,False,False,False,Liraglutide,treatment,2481,427.0,17.2,Nasopharyngitis,Nasopharyngitis,Nasopharyngitis,False,,Liraglutide,True,True,,SC,QD
NCT01272219,Nasopharyngitis,Adverse events in ≥5% of patients,True,False,False,False,False,Placebo,control,1242,234.0,18.8,Nasopharyngitis,Nasopharyngitis,Nasopharyngitis,False,,Liraglutide,False,False,,,
NCT01272219,Upper respiratory tract infection,Adverse events in ≥5% of patients,True,False,False,False,False,Liraglutide,treatment,2481,213.0,8.6,Upper respiratory tract infection,Upper respiratory tract infection,Upper respiratory tract infection,False,,Liraglutide,True,True,,SC,QD
NCT01272219,Upper respiratory tract infection,Adverse events in ≥5% of patients,True,False,False,False,False,Placebo,control,1242,122.0,9.8,Upper respiratory tract infection,Upper respiratory tract infection,Upper respiratory tract infection,False,,Liraglutide,False,False,,,
NCT01272219,Sinusitis,Adverse events in ≥5% of patients,True,False,False,False,False,Liraglutide,treatment,2481,128.0,5.2,Sinusitis,Sinusitis,Sinusitis,False,,Liraglutide,True,True,,SC,QD
NCT01272219,Sinusitis,Adverse events in ≥5% of patients,True,False,False,False,False,Placebo,control,1242,73.0,5.9,Sinusitis,Sinusitis,Sinusitis,False,,Liraglutide,False,False,,,
NCT01272219,Influenza,Adverse events in ≥5% of patients,True,False,False,False,False,Liraglutide,treatment,2481,144.0,5.8,Influenza,Influenza,Influenza,False,,Liraglutide,True,True,,SC,QD
NCT01272219,Influenza,Adverse events in ≥5% of patients,True,False,False,False,False,Placebo,control,1242,66.0,5.3,Influenza,Influenza,Influenza,False,,Liraglutide,False,False,,,
NCT01272219,Headache,Adverse events in ≥5% of patients,True,False,False,False,False,Liraglutide,treatment,2481,327.0,13.2,Headache,Headache,Headache,False,,Liraglutide,True,True,,SC,QD
NCT01272219,Headache,Adverse events in ≥5% of patients,True,False,False,False,False,Placebo,control,1242,154.0,12.4,Headache,Headache,Headache,False,,Liraglutide,False,False,,,
NCT01272219,Dizziness,Adverse events in ≥5% of patients,True,False,False,False,False,Liraglutide,treatment,2481,167.0,6.7,Dizziness,Dizziness,Dizziness,False,,Liraglutide,True,True,,SC,QD
NCT01272219,Dizziness,Adverse events in ≥5% of patients,True,False,False,False,False,Placebo,control,1242,60.0,4.8,Dizziness,Dizziness,Dizziness,False,,Liraglutide,False,False,,,
NCT01272219,Decreased appetite,Adverse events in ≥5% of patients,True,False,False,False,False,Liraglutide,treatment,2481,267.0,10.8,Decreased appetite,Decreased appetite,Decreased appetite,False,,Liraglutide,True,True,,SC,QD
NCT01272219,Decreased appetite,Adverse events in ≥5% of patients,True,False,False,False,False,Placebo,control,1242,38.0,3.1,Decreased appetite,Decreased appetite,Decreased appetite,False,,Liraglutide,False,False,,,
NCT01272219,Back pain,Adverse events in ≥5% of patients,True,False,False,False,False,Liraglutide,treatment,2481,171.0,6.9,Back pain,Back pain,Musculoskeletal pain,False,,Liraglutide,True,True,,SC,QD
NCT01272219,Back pain,Adverse events in ≥5% of patients,True,False,False,False,False,Placebo,control,1242,105.0,8.5,Back pain,Back pain,Musculoskeletal pain,False,,Liraglutide,False,False,,,
NCT01272219,Arthralgia,Adverse events in ≥5% of patients,True,False,False,False,False,Liraglutide,treatment,2481,125.0,5.0,Arthralgia,Arthralgia,Joint disorders,False,,Liraglutide,True,True,,SC,QD
NCT01272219,Arthralgia,Adverse events in ≥5% of patients,True,False,False,False,False,Placebo,control,1242,71.0,5.7,Arthralgia,Arthralgia,Joint disorders,False,,Liraglutide,False,False,,,
NCT01272219,Fatigue,Adverse events in ≥5% of patients,True,False,False,False,False,Liraglutide,treatment,2481,185.0,7.5,Fatigue,Fatigue,Fatigue,False,,Liraglutide,True,True,,SC,QD
NCT01272219,Fatigue,Adverse events in ≥5% of patients,True,False,False,False,False,Placebo,control,1242,65.0,5.2,Fatigue,Fatigue,Fatigue,False,,Liraglutide,False,False,,,
NCT01272219,Injection-site hematoma,Adverse events in ≥5% of patients,True,False,False,False,False,Liraglutide,treatment,2481,142.0,5.7,Injection-site hematoma,Injection-site hematoma,Injection-site reactions,False,,Liraglutide,True,True,,SC,QD
NCT01272219,Injection-site hematoma,Adverse events in ≥5% of patients,True,False,False,False,False,Placebo,control,1242,93.0,7.5,Injection-site hematoma,Injection-site hematoma,Injection-site reactions,False,,Liraglutide,False,False,,,
NCT01272219,Serious adverse events in ≥0.2% of patients,Serious adverse events in ≥0.2% of patients,False,True,False,False,False,Liraglutide,treatment,2481,154.0,6.2,Serious adverse events in ≥0.2% of patients,Serious adverse events (≥0.2% of patients),Serious adverse events,True,serious_ae,Liraglutide,True,True,,SC,QD
NCT01272219,Serious adverse events in ≥0.2% of patients,Serious adverse events in ≥0.2% of patients,False,True,False,False,False,Placebo,control,1242,62.0,5.0,Serious adverse events in ≥0.2% of patients,Serious adverse events (≥0.2% of patients),Serious adverse events,True,serious_ae,Liraglutide,False,False,,,
NCT01272219,Cholelithiasis,Serious adverse events in ≥0.2% of patients,False,True,False,False,False,Liraglutide,treatment,2481,20.0,0.8,Cholelithiasis,Cholelithiasis,Gallbladder disease,False,,Liraglutide,True,True,,SC,QD
NCT01272219,Cholelithiasis,Serious adverse events in ≥0.2% of patients,False,True,False,False,False,Placebo,control,1242,5.0,0.4,Cholelithiasis,Cholelithiasis,Gallbladder disease,False,,Liraglutide,False,False,,,
NCT01272219,Cholecystitis acute,Serious adverse events in ≥0.2% of patients,False,True,False,False,False,Liraglutide,treatment,2481,12.0,0.5,Cholecystitis acute,Acute cholecystitis,Gallbladder disease,False,,Liraglutide,True,True,,SC,QD
NCT01272219,Cholecystitis acute,Serious adverse events in ≥0.2% of patients,False,True,False,False,False,Placebo,control,1242,0.0,0.0,Cholecystitis acute,Acute cholecystitis,Gallbladder disease,False,,Liraglutide,False,False,,,
NCT01272219,Osteoarthritis,Serious adverse events in ≥0.2% of patients,False,True,False,False,False,Liraglutide,treatment,2481,6.0,0.2,Osteoarthritis,Osteoarthritis,Osteoarthritis,False,,Liraglutide,True,True,,SC,QD
NCT01272219,Osteoarthritis,Serious adverse events in ≥0.2% of patients,False,True,False,False,False,Placebo,control,1242,0.0,0.0,Osteoarthritis,Osteoarthritis,Osteoarthritis,False,,Liraglutide,False,False,,,
NCT01272219,Intervertebral disc protrusion,Serious adverse events in ≥0.2% of patients,False,True,False,False,False,Liraglutide,treatment,2481,5.0,0.2,Intervertebral disc protrusion,Intervertebral disc protrusion,Spinal disorders,False,,Liraglutide,True,True,,SC,QD
NCT01272219,Intervertebral disc protrusion,Serious adverse events in ≥0.2% of patients,False,True,False,False,False,Placebo,control,1242,1.0,0.1,Intervertebral disc protrusion,Intervertebral disc protrusion,Spinal disorders,False,,Liraglutide,False,False,,,
NCT01272219,Pancreatitis acute,Serious adverse events in ≥0.2% of patients,False,True,False,False,False,Liraglutide,treatment,2481,4.0,0.2,Pancreatitis acute,Acute pancreatitis,Pancreatitis,False,,Liraglutide,True,True,,SC,QD
NCT01272219,Pancreatitis acute,Serious adverse events in ≥0.2% of patients,False,True,False,False,False,Placebo,control,1242,0.0,0.0,Pancreatitis acute,Acute pancreatitis,Pancreatitis,False,,Liraglutide,False,False,,,
NCT01272219,Cholecystitis,Serious adverse events in ≥0.2% of patients,False,True,False,False,False,Liraglutide,treatment,2481,4.0,0.2,Cholecystitis,Cholecystitis,Gallbladder disease,False,,Liraglutide,True,True,,SC,QD
NCT01272219,Cholecystitis,Serious adverse events in ≥0.2% of patients,False,True,False,False,False,Placebo,control,1242,0.0,0.0,Cholecystitis,Cholecystitis,Gallbladder disease,False,,Liraglutide,False,False,,,
NCT01272219,Breast cancer,Serious adverse events in ≥0.2% of patients,False,True,False,False,False,Liraglutide,treatment,2481,4.0,0.2,Breast cancer,Breast cancer,Breast cancer,False,,Liraglutide,True,True,,SC,QD
NCT01272219,Breast cancer,Serious adverse events in ≥0.2% of patients,False,True,False,False,False,Placebo,control,1242,1.0,0.1,Breast cancer,Breast cancer,Breast cancer,False,,Liraglutide,False,False,,,
NCT01272219,Back pain,Serious adverse events in ≥0.2% of patients,False,True,False,False,False,Liraglutide,treatment,2481,2.0,0.1,Back pain,Back pain,Musculoskeletal pain,False,,Liraglutide,True,True,,SC,QD
NCT01272219,Back pain,Serious adverse events in ≥0.2% of patients,False,True,False,False,False,Placebo,control,1242,2.0,0.2,Back pain,Back pain,Musculoskeletal pain,False,,Liraglutide,False,False,,,
NCT01272219,Uterine leiomyoma,Serious adverse events in ≥0.2% of patients,False,True,False,False,False,Liraglutide,treatment,2481,1.0,0.0,Uterine leiomyoma,Uterine leiomyoma,Uterine fibroid,False,,Liraglutide,True,True,,SC,QD
NCT01272219,Uterine leiomyoma,Serious adverse events in ≥0.2% of patients,False,True,False,False,False,Placebo,control,1242,2.0,0.2,Uterine leiomyoma,Uterine leiomyoma,Uterine fibroid,False,,Liraglutide,False,False,,,
NCT01272219,Cellulitis,Serious adverse events in ≥0.2% of patients,False,True,False,False,False,Liraglutide,treatment,2481,1.0,0.0,Cellulitis,Cellulitis,Cellulitis,False,,Liraglutide,True,True,,SC,QD
NCT01272219,Cellulitis,Serious adverse events in ≥0.2% of patients,False,True,False,False,False,Placebo,control,1242,3.0,0.2,Cellulitis,Cellulitis,Cellulitis,False,,Liraglutide,False,False,,,
NCT01272219,Gastroesophageal reflux disease,Serious adverse events in ≥0.2% of patients,False,True,False,False,False,Liraglutide,treatment,2481,0.0,0.0,Gastroesophageal reflux disease,Gastroesophageal reflux disease,Gastroesophageal reflux disease,False,,Liraglutide,True,True,,SC,QD
NCT01272219,Gastroesophageal reflux disease,Serious adverse events in ≥0.2% of patients,False,True,False,False,False,Placebo,control,1242,2.0,0.2,Gastroesophageal reflux disease,Gastroesophageal reflux disease,Gastroesophageal reflux disease,False,,Liraglutide,False,False,,,
NCT01272219,Bronchitis,Serious adverse events in ≥0.2% of patients,False,True,False,False,False,Liraglutide,treatment,2481,0.0,0.0,Bronchitis,Bronchitis,Bronchitis,False,,Liraglutide,True,True,,SC,QD
NCT01272219,Bronchitis,Serious adverse events in ≥0.2% of patients,False,True,False,False,False,Placebo,control,1242,2.0,0.2,Bronchitis,Bronchitis,Bronchitis,False,,Liraglutide,False,False,,,
NCT01272219,Bladder prolapse,Serious adverse events in ≥0.2% of patients,False,True,False,False,False,Liraglutide,treatment,2481,0.0,0.0,Bladder prolapse,Bladder prolapse,Pelvic organ prolapse,False,,Liraglutide,True,True,,SC,QD
NCT01272219,Bladder prolapse,Serious adverse events in ≥0.2% of patients,False,True,False,False,False,Placebo,control,1242,2.0,0.2,Bladder prolapse,Bladder prolapse,Pelvic organ prolapse,False,,Liraglutide,False,False,,,
NCT01272219,Chest pain,Serious adverse events in ≥0.2% of patients,False,True,False,False,False,Liraglutide,treatment,2481,0.0,0.0,Chest pain,Chest pain,Chest pain,False,,Liraglutide,True,True,,SC,QD
NCT01272219,Chest pain,Serious adverse events in ≥0.2% of patients,False,True,False,False,False,Placebo,control,1242,3.0,0.2,Chest pain,Chest pain,Chest pain,False,,Liraglutide,False,False,,,
NCT03495102,Nausea,TEAEs occurring in ≥5% patients in any group,True,False,False,True,False,DU 1.5 mg,treatment,612,87.0,14.2,Nausea,Nausea,Nausea,False,,Dulaglutide,True,True,1.5,SC,QW
NCT03495102,Nausea,TEAEs occurring in ≥5% patients in any group,True,False,False,True,False,DU 3.0 mg,treatment,616,99.0,16.1,Nausea,Nausea,Nausea,False,,Dulaglutide,True,True,3.0,SC,QW
NCT03495102,Nausea,TEAEs occurring in ≥5% patients in any group,True,False,False,True,False,DU 4.5 mg,treatment,614,106.0,17.3,Nausea,Nausea,Nausea,False,,Dulaglutide,True,True,4.5,SC,QW
NCT03495102,Diarrhea,TEAEs occurring in ≥5% patients in any group,True,False,False,True,False,DU 1.5 mg,treatment,612,47.0,7.7,Diarrhea,Diarrhea,Diarrhea,False,,Dulaglutide,True,True,1.5,SC,QW
NCT03495102,Diarrhea,TEAEs occurring in ≥5% patients in any group,True,False,False,True,False,DU 3.0 mg,treatment,616,74.0,12.0,Diarrhea,Diarrhea,Diarrhea,False,,Dulaglutide,True,True,3.0,SC,QW
NCT03495102,Diarrhea,TEAEs occurring in ≥5% patients in any group,True,False,False,True,False,DU 4.5 mg,treatment,614,71.0,11.6,Diarrhea,Diarrhea,Diarrhea,False,,Dulaglutide,True,True,4.5,SC,QW
NCT03495102,Vomiting,TEAEs occurring in ≥5% patients in any group,True,False,False,True,False,DU 1.5 mg,treatment,612,39.0,6.4,Vomiting,Vomiting,Vomiting,False,,Dulaglutide,True,True,1.5,SC,QW
NCT03495102,Vomiting,TEAEs occurring in ≥5% patients in any group,True,False,False,True,False,DU 3.0 mg,treatment,616,56.0,9.1,Vomiting,Vomiting,Vomiting,False,,Dulaglutide,True,True,3.0,SC,QW
NCT03495102,Vomiting,TEAEs occurring in ≥5% patients in any group,True,False,False,True,False,DU 4.5 mg,treatment,614,62.0,10.1,Vomiting,Vomiting,Vomiting,False,,Dulaglutide,True,True,4.5,SC,QW
NCT03495102,Nasopharyngitis,TEAEs occurring in ≥5% patients in any group,True,False,False,False,False,DU 1.5 mg,treatment,612,28.0,4.6,Nasopharyngitis,Nasopharyngitis,Nasopharyngitis,False,,Dulaglutide,True,True,1.5,SC,QW
NCT03495102,Nasopharyngitis,TEAEs occurring in ≥5% patients in any group,True,False,False,False,False,DU 3.0 mg,treatment,616,32.0,5.2,Nasopharyngitis,Nasopharyngitis,Nasopharyngitis,False,,Dulaglutide,True,True,3.0,SC,QW
NCT03495102,Nasopharyngitis,TEAEs occurring in ≥5% patients in any group,True,False,False,False,False,DU 4.5 mg,treatment,614,38.0,6.2,Nasopharyngitis,Nasopharyngitis,Nasopharyngitis,False,,Dulaglutide,True,True,4.5,SC,QW
NCT03495102,Dyspepsia,TEAEs occurring in ≥5% patients in any group,True,False,False,True,False,DU 1.5 mg,treatment,612,17.0,2.8,Dyspepsia,Dyspepsia,Dyspepsia,False,,Dulaglutide,True,True,1.5,SC,QW
NCT03495102,Dyspepsia,TEAEs occurring in ≥5% patients in any group,True,False,False,True,False,DU 3.0 mg,treatment,616,31.0,5.0,Dyspepsia,Dyspepsia,Dyspepsia,False,,Dulaglutide,True,True,3.0,SC,QW
NCT03495102,Dyspepsia,TEAEs occurring in ≥5% patients in any group,True,False,False,True,False,DU 4.5 mg,treatment,614,17.0,2.8,Dyspepsia,Dyspepsia,Dyspepsia,False,,Dulaglutide,True,True,4.5,SC,QW
NCT03495102,Acute pancreatitis,Adjudication confirmed,True,True,False,False,True,DU 1.5 mg,treatment,612,1.0,0.2,Acute pancreatitis,Acute pancreatitis,Pancreatitis,False,,Dulaglutide,True,True,1.5,SC,QW
NCT03495102,Acute pancreatitis,Adjudication confirmed,True,True,False,False,True,DU 3.0 mg,treatment,616,2.0,0.3,Acute pancreatitis,Acute pancreatitis,Pancreatitis,False,,Dulaglutide,True,True,3.0,SC,QW
NCT03495102,Acute pancreatitis,Adjudication confirmed,True,True,False,False,True,DU 4.5 mg,treatment,614,3.0,0.5,Acute pancreatitis,Acute pancreatitis,Pancreatitis,False,,Dulaglutide,True,True,4.5,SC,QW
NCT03495102,CV events,Adjudication confirmed,True,True,False,False,True,DU 1.5 mg,treatment,612,2.0,0.3,CV events,Cardiovascular events,Cardiovascular events,True,other_summary,Dulaglutide,True,True,1.5,SC,QW
NCT03495102,CV events,Adjudication confirmed,True,True,False,False,True,DU 3.0 mg,treatment,616,8.0,1.3,CV events,Cardiovascular events,Cardiovascular events,True,other_summary,Dulaglutide,True,True,3.0,SC,QW
NCT03495102,CV events,Adjudication confirmed,True,True,False,False,True,DU 4.5 mg,treatment,614,5.0,0.8,CV events,Cardiovascular events,Cardiovascular events,True,other_summary,Dulaglutide,True,True,4.5,SC,QW
NCT03495102,Gallbladder-related events,Gallbladder-related events,True,False,False,False,True,DU 1.5 mg,treatment,612,9.0,1.5,Gallbladder-related events,Gallbladder-related events,Gallbladder-related events,True,other_summary,Dulaglutide,True,True,1.5,SC,QW
NCT03495102,Gallbladder-related events,Gallbladder-related events,True,False,False,False,True,DU 3.0 mg,treatment,616,11.0,1.8,Gallbladder-related events,Gallbladder-related events,Gallbladder-related events,True,other_summary,Dulaglutide,True,True,3.0,SC,QW
NCT03495102,Gallbladder-related events,Gallbladder-related events,True,False,False,False,True,DU 4.5 mg,treatment,614,10.0,1.6,Gallbladder-related events,Gallbladder-related events,Gallbladder-related events,True,other_summary,Dulaglutide,True,True,4.5,SC,QW
NCT03495102,Acute renal events,Acute renal events,True,False,False,False,True,DU 1.5 mg,treatment,612,6.0,1.0,Acute renal events,Acute kidney injury,Renal impairment,False,,Dulaglutide,True,True,1.5,SC,QW
NCT03495102,Acute renal events,Acute renal events,True,False,False,False,True,DU 3.0 mg,treatment,616,6.0,1.0,Acute renal events,Acute kidney injury,Renal impairment,False,,Dulaglutide,True,True,3.0,SC,QW
NCT03495102,Acute renal events,Acute renal events,True,False,False,False,True,DU 4.5 mg,treatment,614,5.0,0.8,Acute renal events,Acute kidney injury,Renal impairment,False,,Dulaglutide,True,True,4.5,SC,QW
NCT03495102,Documented hypoglycemia (<54 mg/dL),Hypoglycemia,True,False,False,False,True,DU 1.5 mg,treatment,612,8.0,1.3,Documented hypoglycemia (<54 mg/dL),Hypoglycemia (<54 mg/dL),Hypoglycemia,False,,Dulaglutide,True,True,1.5,SC,QW
NCT03495102,Documented hypoglycemia (<54 mg/dL),Hypoglycemia,True,False,False,False,True,DU 3.0 mg,treatment,616,2.0,0.3,Documented hypoglycemia (<54 mg/dL),Hypoglycemia (<54 mg/dL),Hypoglycemia,False,,Dulaglutide,True,True,3.0,SC,QW
NCT03495102,Documented hypoglycemia (<54 mg/dL),Hypoglycemia,True,False,False,False,True,DU 4.5 mg,treatment,614,7.0,1.1,Documented hypoglycemia (<54 mg/dL),Hypoglycemia (<54 mg/dL),Hypoglycemia,False,,Dulaglutide,True,True,4.5,SC,QW
NCT03495102,Severe hypoglycemia,Hypoglycemia,True,True,False,False,True,DU 1.5 mg,treatment,612,1.0,0.2,Severe hypoglycemia,Severe hypoglycemia,Hypoglycemia,False,,Dulaglutide,True,True,1.5,SC,QW
NCT03495102,Severe hypoglycemia,Hypoglycemia,True,True,False,False,True,DU 3.0 mg,treatment,616,0.0,0.0,Severe hypoglycemia,Severe hypoglycemia,Hypoglycemia,False,,Dulaglutide,True,True,3.0,SC,QW
NCT03495102,Severe hypoglycemia,Hypoglycemia,True,True,False,False,True,DU 4.5 mg,treatment,614,1.0,0.2,Severe hypoglycemia,Severe hypoglycemia,Hypoglycemia,False,,Dulaglutide,True,True,4.5,SC,QW
NCT03548935,Any adverse event,Adverse events reported in ≥10% of participants,True,False,False,False,False,Semaglutide,treatment,1306,1171.0,89.7,Any adverse event,Any adverse event,Any adverse event,True,any_ae,Semaglutide,True,True,,SC,QW
NCT03548935,Any adverse event,Adverse events reported in ≥10% of participants,True,False,False,False,False,Placebo,control,655,566.0,86.4,Any adverse event,Any adverse event,Any adverse event,True,any_ae,Semaglutide,False,False,,,
NCT03548935,Serious adverse events,Adverse events reported in ≥10% of participants,False,True,False,False,False,Semaglutide,treatment,1306,128.0,9.8,Serious adverse events,Serious adverse events,Serious adverse events,True,serious_ae,Semaglutide,True,True,,SC,QW
NCT03548935,Serious adverse events,Adverse events reported in ≥10% of participants,False,True,False,False,False,Placebo,control,655,42.0,6.4,Serious adverse events,Serious adverse events,Serious adverse events,True,serious_ae,Semaglutide,False,False,,,
NCT03548935,Adverse events leading to discontinuation of drug or placebo,Adverse events reported in ≥10% of participants,False,False,False,True,False,Semaglutide,treatment,1306,92.0,7.0,Adverse events leading to discontinuation of drug or placebo,Adverse events leading to discontinuation,Adverse event leading to discontinuation,True,ae_leading_to_discontinuation,Semaglutide,True,True,,SC,QW
NCT03548935,Adverse events leading to discontinuation of drug or placebo,Adverse events reported in ≥10% of participants,False,False,False,True,False,Placebo,control,655,20.0,3.1,Adverse events leading to discontinuation of drug or placebo,Adverse events leading to discontinuation,Adverse event leading to discontinuation,True,ae_leading_to_discontinuation,Semaglutide,False,False,,,
NCT03548935,Gastrointestinal disorders,Adverse events reported in ≥10% of participants,False,False,False,True,False,Semaglutide,treatment,1306,59.0,4.5,Gastrointestinal disorders,Gastrointestinal disorders,Gastrointestinal disorders,True,other_summary,Semaglutide,True,True,,SC,QW
NCT03548935,Gastrointestinal disorders,Adverse events reported in ≥10% of participants,False,False,False,True,False,Placebo,control,655,5.0,0.8,Gastrointestinal disorders,Gastrointestinal disorders,Gastrointestinal disorders,True,other_summary,Semaglutide,False,False,,,
NCT03548935,Fatal events,Adverse events reported in ≥10% of participants,False,False,True,False,False,Semaglutide,treatment,1306,1.0,0.1,Fatal events,Fatal adverse events,Fatal adverse events,True,fatal_ae,Semaglutide,True,True,,SC,QW
NCT03548935,Fatal events,Adverse events reported in ≥10% of participants,False,False,True,False,False,Placebo,control,655,1.0,0.2,Fatal events,Fatal adverse events,Fatal adverse events,True,fatal_ae,Semaglutide,False,False,,,
NCT03548935,Nausea,Adverse events reported in ≥10% of participants,True,False,False,False,False,Semaglutide,treatment,1306,577.0,44.2,Nausea,Nausea,Nausea,False,,Semaglutide,True,True,,SC,QW
NCT03548935,Nausea,Adverse events reported in ≥10% of participants,True,False,False,False,False,Placebo,control,655,114.0,17.4,Nausea,Nausea,Nausea,False,,Semaglutide,False,False,,,
NCT03548935,Diarrhea,Adverse events reported in ≥10% of participants,True,False,False,False,False,Semaglutide,treatment,1306,412.0,31.5,Diarrhea,Diarrhea,Diarrhea,False,,Semaglutide,True,True,,SC,QW
NCT03548935,Diarrhea,Adverse events reported in ≥10% of participants,True,False,False,False,False,Placebo,control,655,104.0,15.9,Diarrhea,Diarrhea,Diarrhea,False,,Semaglutide,False,False,,,
NCT03548935,Vomiting,Adverse events reported in ≥10% of participants,True,False,False,False,False,Semaglutide,treatment,1306,324.0,24.8,Vomiting,Vomiting,Vomiting,False,,Semaglutide,True,True,,SC,QW
NCT03548935,Vomiting,Adverse events reported in ≥10% of participants,True,False,False,False,False,Placebo,control,655,43.0,6.6,Vomiting,Vomiting,Vomiting,False,,Semaglutide,False,False,,,
NCT03548935,Constipation,Adverse events reported in ≥10% of participants,True,False,False,False,False,Semaglutide,treatment,1306,306.0,23.4,Constipation,Constipation,Constipation,False,,Semaglutide,True,True,,SC,QW
NCT03548935,Constipation,Adverse events reported in ≥10% of participants,True,False,False,False,False,Placebo,control,655,62.0,9.5,Constipation,Constipation,Constipation,False,,Semaglutide,False,False,,,
NCT03548935,Nasopharyngitis,Adverse events reported in ≥10% of participants,True,False,False,False,False,Semaglutide,treatment,1306,281.0,21.5,Nasopharyngitis,Nasopharyngitis,Nasopharyngitis,False,,Semaglutide,True,True,,SC,QW
NCT03548935,Nasopharyngitis,Adverse events reported in ≥10% of participants,True,False,False,False,False,Placebo,control,655,133.0,20.3,Nasopharyngitis,Nasopharyngitis,Nasopharyngitis,False,,Semaglutide,False,False,,,
NCT03548935,Headache,Adverse events reported in ≥10% of participants,True,False,False,False,False,Semaglutide,treatment,1306,198.0,15.2,Headache,Headache,Headache,False,,Semaglutide,True,True,,SC,QW
NCT03548935,Headache,Adverse events reported in ≥10% of participants,True,False,False,False,False,Placebo,control,655,80.0,12.2,Headache,Headache,Headache,False,,Semaglutide,False,False,,,
NCT03548935,Dyspepsia,Adverse events reported in ≥10% of participants,True,False,False,False,False,Semaglutide,treatment,1306,135.0,10.3,Dyspepsia,Dyspepsia,Dyspepsia,False,,Semaglutide,True,True,,SC,QW
NCT03548935,Dyspepsia,Adverse events reported in ≥10% of participants,True,False,False,False,False,Placebo,control,655,23.0,3.5,Dyspepsia,Dyspepsia,Dyspepsia,False,,Semaglutide,False,False,,,
NCT03548935,Abdominal pain,Adverse events reported in ≥10% of participants,True,False,False,False,False,Semaglutide,treatment,1306,130.0,10.0,Abdominal pain,Abdominal pain,Abdominal pain,False,,Semaglutide,True,True,,SC,QW
NCT03548935,Abdominal pain,Adverse events reported in ≥10% of participants,True,False,False,False,False,Placebo,control,655,36.0,5.5,Abdominal pain,Abdominal pain,Abdominal pain,False,,Semaglutide,False,False,,,
NCT03548935,Upper respiratory tract infection,Adverse events reported in ≥10% of participants,True,False,False,False,False,Semaglutide,treatment,1306,114.0,8.7,Upper respiratory tract infection,Upper respiratory tract infection,Upper respiratory tract infection,False,,Semaglutide,True,True,,SC,QW
NCT03548935,Upper respiratory tract infection,Adverse events reported in ≥10% of participants,True,False,False,False,False,Placebo,control,655,80.0,12.2,Upper respiratory tract infection,Upper respiratory tract infection,Upper respiratory tract infection,False,,Semaglutide,False,False,,,
NCT03548935,Gastrointestinal disorders,Safety focus areas,True,False,False,False,True,Semaglutide,treatment,1306,969.0,74.2,Gastrointestinal disorders,Gastrointestinal disorders,Gastrointestinal disorders,True,other_summary,Semaglutide,True,True,,SC,QW
NCT03548935,Gastrointestinal disorders,Safety focus areas,True,False,False,False,True,Placebo,control,655,314.0,47.9,Gastrointestinal disorders,Gastrointestinal disorders,Gastrointestinal disorders,True,other_summary,Semaglutide,False,False,,,
NCT03548935,Gallbladder-related disorders,Safety focus areas,True,False,False,False,True,Semaglutide,treatment,1306,34.0,2.6,Gallbladder-related disorders,Gallbladder-related disorders,Gallbladder-related disorders,True,other_summary,Semaglutide,True,True,,SC,QW
NCT03548935,Gallbladder-related disorders,Safety focus areas,True,False,False,False,True,Placebo,control,655,8.0,1.2,Gallbladder-related disorders,Gallbladder-related disorders,Gallbladder-related disorders,True,other_summary,Semaglutide,False,False,,,
NCT03548935,Hepatobiliary disorders,Safety focus areas,True,False,False,False,True,Semaglutide,treatment,1306,33.0,2.5,Hepatobiliary disorders,Hepatobiliary disorders,Hepatobiliary disorders,True,other_summary,Semaglutide,True,True,,SC,QW
NCT03548935,Hepatobiliary disorders,Safety focus areas,True,False,False,False,True,Placebo,control,655,5.0,0.8,Hepatobiliary disorders,Hepatobiliary disorders,Hepatobiliary disorders,True,other_summary,Semaglutide,False,False,,,
NCT03548935,Cholelithiasis,Safety focus areas,True,False,False,False,True,Semaglutide,treatment,1306,23.0,1.8,Cholelithiasis,Cholelithiasis,Gallbladder disease,False,,Semaglutide,True,True,,SC,QW
NCT03548935,Cholelithiasis,Safety focus areas,True,False,False,False,True,Placebo,control,655,4.0,0.6,Cholelithiasis,Cholelithiasis,Gallbladder disease,False,,Semaglutide,False,False,,,
NCT03548935,Hepatic disorders,Safety focus areas,True,False,False,False,True,Semaglutide,treatment,1306,31.0,2.4,Hepatic disorders,Hepatic disorders,Hepatic disorders,True,other_summary,Semaglutide,True,True,,SC,QW
NCT03548935,Hepatic disorders,Safety focus areas,True,False,False,False,True,Placebo,control,655,20.0,3.1,Hepatic disorders,Hepatic disorders,Hepatic disorders,True,other_summary,Semaglutide,False,False,,,
NCT03548935,Acute pancreatitis,Safety focus areas,True,True,False,False,True,Semaglutide,treatment,1306,3.0,0.2,Acute pancreatitis,Acute pancreatitis,Pancreatitis,False,,Semaglutide,True,True,,SC,QW
NCT03548935,Acute pancreatitis,Safety focus areas,True,True,False,False,True,Placebo,control,655,0.0,0.0,Acute pancreatitis,Acute pancreatitis,Pancreatitis,False,,Semaglutide,False,False,,,
NCT03548935,Cardiovascular disorders,Safety focus areas,True,True,False,False,True,Semaglutide,treatment,1306,107.0,8.2,Cardiovascular disorders,Cardiovascular disorders,Cardiovascular disorders,True,other_summary,Semaglutide,True,True,,SC,QW
NCT03548935,Cardiovascular disorders,Safety focus areas,True,True,False,False,True,Placebo,control,655,75.0,11.5,Cardiovascular disorders,Cardiovascular disorders,Cardiovascular disorders,True,other_summary,Semaglutide,False,False,,,
NCT03548935,Allergic reactions,Safety focus areas,True,False,False,False,True,Semaglutide,treatment,1306,96.0,7.4,Allergic reactions,Hypersensitivity,Hypersensitivity,False,,Semaglutide,True,True,,SC,QW
NCT03548935,Allergic reactions,Safety focus areas,True,False,False,False,True,Placebo,control,655,54.0,8.2,Allergic reactions,Hypersensitivity,Hypersensitivity,False,,Semaglutide,False,False,,,
NCT03548935,Injection-site reactions,Safety focus areas,True,False,False,False,True,Semaglutide,treatment,1306,65.0,5.0,Injection-site reactions,Injection-site reaction,Injection-site reactions,False,,Semaglutide,True,True,,SC,QW
NCT03548935,Injection-site reactions,Safety focus areas,True,False,False,False,True,Placebo,control,655,44.0,6.7,Injection-site reactions,Injection-site reaction,Injection-site reactions,False,,Semaglutide,False,False,,,
NCT03548935,Malignant neoplasms,Safety focus areas,True,True,False,False,True,Semaglutide,treatment,1306,14.0,1.1,Malignant neoplasms,Malignant neoplasm,Cancer,False,,Semaglutide,True,True,,SC,QW
NCT03548935,Malignant neoplasms,Safety focus areas,True,True,False,False,True,Placebo,control,655,7.0,1.1,Malignant neoplasms,Malignant neoplasm,Cancer,False,,Semaglutide,False,False,,,
NCT03548935,Psychiatric disorders,Safety focus areas,True,False,False,False,True,Semaglutide,treatment,1306,124.0,9.5,Psychiatric disorders,Psychiatric disorders,Psychiatric disorders,True,other_summary,Semaglutide,True,True,,SC,QW
NCT03548935,Psychiatric disorders,Safety focus areas,True,False,False,False,True,Placebo,control,655,83.0,12.7,Psychiatric disorders,Psychiatric disorders,Psychiatric disorders,True,other_summary,Semaglutide,False,False,,,
NCT03548935,Acute renal failure,Safety focus areas,True,True,False,False,True,Semaglutide,treatment,1306,3.0,0.2,Acute renal failure,Acute kidney injury,Renal impairment,False,,Semaglutide,True,True,,SC,QW
NCT03548935,Acute renal failure,Safety focus areas,True,True,False,False,True,Placebo,control,655,2.0,0.3,Acute renal failure,Acute kidney injury,Renal impairment,False,,Semaglutide,False,False,,,
NCT03548935,Hypoglycemia,Safety focus areas,True,False,False,False,True,Semaglutide,treatment,1306,8.0,0.6,Hypoglycemia,Hypoglycemia,Hypoglycemia,False,,Semaglutide,True,True,,SC,QW
NCT03548935,Hypoglycemia,Safety focus areas,True,False,False,False,True,Placebo,control,655,5.0,0.8,Hypoglycemia,Hypoglycemia,Hypoglycemia,False,,Semaglutide,False,False,,,
NCT00849017,Any adverse event,Overall,True,False,False,False,False,Placebo,control,101,77.0,76.2,Any adverse event,Any adverse event,Any adverse event,True,any_ae,albiglutide,False,False,,,
NCT00849017,Any adverse event,Overall,True,False,False,False,False,Albiglutide 30 mg weekly,treatment,101,79.0,78.2,Any adverse event,Any adverse event,Any adverse event,True,any_ae,albiglutide,True,True,30.0,SC,QW
NCT00849017,Any adverse event,Overall,True,False,False,False,False,Albiglutide 50 mg weekly,treatment,99,81.0,81.8,Any adverse event,Any adverse event,Any adverse event,True,any_ae,albiglutide,True,True,50.0,SC,QW
NCT00849017,Serious adverse event,Overall,False,True,False,False,False,Placebo,control,101,8.0,7.9,Serious adverse event,Serious adverse events,Serious adverse events,True,serious_ae,albiglutide,False,False,,,
NCT00849017,Serious adverse event,Overall,False,True,False,False,False,Albiglutide 30 mg weekly,treatment,101,11.0,10.9,Serious adverse event,Serious adverse events,Serious adverse events,True,serious_ae,albiglutide,True,True,30.0,SC,QW
NCT00849017,Serious adverse event,Overall,False,True,False,False,False,Albiglutide 50 mg weekly,treatment,99,10.0,10.1,Serious adverse event,Serious adverse events,Serious adverse events,True,serious_ae,albiglutide,True,True,50.0,SC,QW
NCT00849017,Related adverse event,Overall,True,False,False,False,False,Placebo,control,101,21.0,20.8,Related adverse event,Drug-related adverse events,Drug-related adverse events,True,other_summary,albiglutide,False,False,,,
NCT00849017,Related adverse event,Overall,True,False,False,False,False,Albiglutide 30 mg weekly,treatment,101,35.0,34.7,Related adverse event,Drug-related adverse events,Drug-related adverse events,True,other_summary,albiglutide,True,True,30.0,SC,QW
NCT00849017,Related adverse event,Overall,True,False,False,False,False,Albiglutide 50 mg weekly,treatment,99,36.0,36.4,Related adverse event,Drug-related adverse events,Drug-related adverse events,True,other_summary,albiglutide,True,True,50.0,SC,QW
NCT00849017,Adverse event leading to withdrawal,Overall,False,False,False,True,False,Placebo,control,101,2.0,2.0,Adverse event leading to withdrawal,Adverse event leading to discontinuation,Adverse event leading to discontinuation,True,ae_leading_to_discontinuation,albiglutide,False,False,,,
NCT00849017,Adverse event leading to withdrawal,Overall,False,False,False,True,False,Albiglutide 30 mg weekly,treatment,101,5.0,5.0,Adverse event leading to withdrawal,Adverse event leading to discontinuation,Adverse event leading to discontinuation,True,ae_leading_to_discontinuation,albiglutide,True,True,30.0,SC,QW
NCT00849017,Adverse event leading to withdrawal,Overall,False,False,False,True,False,Albiglutide 50 mg weekly,treatment,99,13.0,13.1,Adverse event leading to withdrawal,Adverse event leading to discontinuation,Adverse event leading to discontinuation,True,ae_leading_to_discontinuation,albiglutide,True,True,50.0,SC,QW
NCT00849017,Injection-site reaction,"Most common adverse event (≥6.0% in either albiglutide group), by preferred term",True,False,False,False,True,Placebo,control,101,2.0,2.0,Injection-site reaction,Injection-site reaction,Injection-site reactions,False,,albiglutide,False,False,,,
NCT00849017,Injection-site reaction,"Most common adverse event (≥6.0% in either albiglutide group), by preferred term",True,False,False,False,True,Albiglutide 30 mg weekly,treatment,101,9.0,8.9,Injection-site reaction,Injection-site reaction,Injection-site reactions,False,,albiglutide,True,True,30.0,SC,QW
NCT00849017,Injection-site reaction,"Most common adverse event (≥6.0% in either albiglutide group), by preferred term",True,False,False,False,True,Albiglutide 50 mg weekly,treatment,99,14.0,14.1,Injection-site reaction,Injection-site reaction,Injection-site reactions,False,,albiglutide,True,True,50.0,SC,QW
NCT00849017,Diarrhoea,"Most common adverse event (≥6.0% in either albiglutide group), by preferred term",True,False,False,False,True,Placebo,control,101,12.0,11.9,Diarrhoea,Diarrhea,Diarrhea,False,,albiglutide,False,False,,,
NCT00849017,Diarrhoea,"Most common adverse event (≥6.0% in either albiglutide group), by preferred term",True,False,False,False,True,Albiglutide 30 mg weekly,treatment,101,10.0,9.9,Diarrhoea,Diarrhea,Diarrhea,False,,albiglutide,True,True,30.0,SC,QW
NCT00849017,Diarrhoea,"Most common adverse event (≥6.0% in either albiglutide group), by preferred term",True,False,False,False,True,Albiglutide 50 mg weekly,treatment,99,13.0,13.1,Diarrhoea,Diarrhea,Diarrhea,False,,albiglutide,True,True,50.0,SC,QW
NCT00849017,Nausea,"Most common adverse event (≥6.0% in either albiglutide group), by preferred term",True,False,False,False,True,Placebo,control,101,8.0,7.9,Nausea,Nausea,Nausea,False,,albiglutide,False,False,,,
NCT00849017,Nausea,"Most common adverse event (≥6.0% in either albiglutide group), by preferred term",True,False,False,False,True,Albiglutide 30 mg weekly,treatment,101,10.0,9.9,Nausea,Nausea,Nausea,False,,albiglutide,True,True,30.0,SC,QW
NCT00849017,Nausea,"Most common adverse event (≥6.0% in either albiglutide group), by preferred term",True,False,False,False,True,Albiglutide 50 mg weekly,treatment,99,9.0,9.1,Nausea,Nausea,Nausea,False,,albiglutide,True,True,50.0,SC,QW
NCT00849017,Upper respiratory tract infection,"Most common adverse event (≥6.0% in either albiglutide group), by preferred term",True,False,False,False,False,Placebo,control,101,10.0,9.9,Upper respiratory tract infection,Upper respiratory tract infection,Upper respiratory tract infection,False,,albiglutide,False,False,,,
NCT00849017,Upper respiratory tract infection,"Most common adverse event (≥6.0% in either albiglutide group), by preferred term",True,False,False,False,False,Albiglutide 30 mg weekly,treatment,101,6.0,5.9,Upper respiratory tract infection,Upper respiratory tract infection,Upper respiratory tract infection,False,,albiglutide,True,True,30.0,SC,QW
NCT00849017,Upper respiratory tract infection,"Most common adverse event (≥6.0% in either albiglutide group), by preferred term",True,False,False,False,False,Albiglutide 50 mg weekly,treatment,99,9.0,9.1,Upper respiratory tract infection,Upper respiratory tract infection,Upper respiratory tract infection,False,,albiglutide,True,True,50.0,SC,QW
NCT00849017,Nasopharyngitis,"Most common adverse event (≥6.0% in either albiglutide group), by preferred term",True,False,False,False,False,Placebo,control,101,6.0,5.9,Nasopharyngitis,Nasopharyngitis,Nasopharyngitis,False,,albiglutide,False,False,,,
NCT00849017,Nasopharyngitis,"Most common adverse event (≥6.0% in either albiglutide group), by preferred term",True,False,False,False,False,Albiglutide 30 mg weekly,treatment,101,6.0,5.9,Nasopharyngitis,Nasopharyngitis,Nasopharyngitis,False,,albiglutide,True,True,30.0,SC,QW
NCT00849017,Nasopharyngitis,"Most common adverse event (≥6.0% in either albiglutide group), by preferred term",True,False,False,False,False,Albiglutide 50 mg weekly,treatment,99,7.0,7.1,Nasopharyngitis,Nasopharyngitis,Nasopharyngitis,False,,albiglutide,True,True,50.0,SC,QW
NCT00849017,Sinusitis,"Most common adverse event (≥6.0% in either albiglutide group), by preferred term",True,False,False,False,False,Placebo,control,101,2.0,2.0,Sinusitis,Sinusitis,Sinusitis,False,,albiglutide,False,False,,,
NCT00849017,Sinusitis,"Most common adverse event (≥6.0% in either albiglutide group), by preferred term",True,False,False,False,False,Albiglutide 30 mg weekly,treatment,101,3.0,3.0,Sinusitis,Sinusitis,Sinusitis,False,,albiglutide,True,True,30.0,SC,QW
NCT00849017,Sinusitis,"Most common adverse event (≥6.0% in either albiglutide group), by preferred term",True,False,False,False,False,Albiglutide 50 mg weekly,treatment,99,7.0,7.1,Sinusitis,Sinusitis,Sinusitis,False,,albiglutide,True,True,50.0,SC,QW
NCT00849017,Urinary-tract infection,"Most common adverse event (≥6.0% in either albiglutide group), by preferred term",True,False,False,False,False,Placebo,control,101,3.0,3.0,Urinary-tract infection,Urinary tract infection,Urinary tract infection,False,,albiglutide,False,False,,,
NCT00849017,Urinary-tract infection,"Most common adverse event (≥6.0% in either albiglutide group), by preferred term",True,False,False,False,False,Albiglutide 30 mg weekly,treatment,101,1.0,1.0,Urinary-tract infection,Urinary tract infection,Urinary tract infection,False,,albiglutide,True,True,30.0,SC,QW
NCT00849017,Urinary-tract infection,"Most common adverse event (≥6.0% in either albiglutide group), by preferred term",True,False,False,False,False,Albiglutide 50 mg weekly,treatment,99,6.0,6.1,Urinary-tract infection,Urinary tract infection,Urinary tract infection,False,,albiglutide,True,True,50.0,SC,QW
NCT00849017,Headache,"Most common adverse event (≥6.0% in either albiglutide group), by preferred term",True,False,False,False,False,Placebo,control,101,14.0,13.9,Headache,Headache,Headache,False,,albiglutide,False,False,,,
NCT00849017,Headache,"Most common adverse event (≥6.0% in either albiglutide group), by preferred term",True,False,False,False,False,Albiglutide 30 mg weekly,treatment,101,10.0,9.9,Headache,Headache,Headache,False,,albiglutide,True,True,30.0,SC,QW
NCT00849017,Headache,"Most common adverse event (≥6.0% in either albiglutide group), by preferred term",True,False,False,False,False,Albiglutide 50 mg weekly,treatment,99,6.0,6.1,Headache,Headache,Headache,False,,albiglutide,True,True,50.0,SC,QW
NCT00849017,Any GI adverse event,GI adverse event,True,False,False,False,True,Placebo,control,101,27.0,26.7,Any GI adverse event,Gastrointestinal adverse events (any),Gastrointestinal adverse events (any),True,other_summary,albiglutide,False,False,,,
NCT00849017,Any GI adverse event,GI adverse event,True,False,False,False,True,Albiglutide 30 mg weekly,treatment,101,32.0,31.7,Any GI adverse event,Gastrointestinal adverse events (any),Gastrointestinal adverse events (any),True,other_summary,albiglutide,True,True,30.0,SC,QW
NCT00849017,Any GI adverse event,GI adverse event,True,False,False,False,True,Albiglutide 50 mg weekly,treatment,99,30.0,30.3,Any GI adverse event,Gastrointestinal adverse events (any),Gastrointestinal adverse events (any),True,other_summary,albiglutide,True,True,50.0,SC,QW
NCT00849017,Gastro-oesophageal reflux disease,GI adverse event,True,False,False,False,True,Placebo,control,101,2.0,2.0,Gastro-oesophageal reflux disease,Gastroesophageal reflux disease,Gastroesophageal reflux disease,False,,albiglutide,False,False,,,
NCT00849017,Gastro-oesophageal reflux disease,GI adverse event,True,False,False,False,True,Albiglutide 30 mg weekly,treatment,101,1.0,1.0,Gastro-oesophageal reflux disease,Gastroesophageal reflux disease,Gastroesophageal reflux disease,False,,albiglutide,True,True,30.0,SC,QW
NCT00849017,Gastro-oesophageal reflux disease,GI adverse event,True,False,False,False,True,Albiglutide 50 mg weekly,treatment,99,4.0,4.0,Gastro-oesophageal reflux disease,Gastroesophageal reflux disease,Gastroesophageal reflux disease,False,,albiglutide,True,True,50.0,SC,QW
NCT00849017,Constipation,GI adverse event,True,False,False,False,True,Placebo,control,101,3.0,3.0,Constipation,Constipation,Constipation,False,,albiglutide,False,False,,,
NCT00849017,Constipation,GI adverse event,True,False,False,False,True,Albiglutide 30 mg weekly,treatment,101,2.0,2.0,Constipation,Constipation,Constipation,False,,albiglutide,True,True,30.0,SC,QW
NCT00849017,Constipation,GI adverse event,True,False,False,False,True,Albiglutide 50 mg weekly,treatment,99,3.0,3.0,Constipation,Constipation,Constipation,False,,albiglutide,True,True,50.0,SC,QW
NCT00849017,Vomiting,GI adverse event,True,False,False,False,True,Placebo,control,101,1.0,1.0,Vomiting,Vomiting,Vomiting,False,,albiglutide,False,False,,,
NCT00849017,Vomiting,GI adverse event,True,False,False,False,True,Albiglutide 30 mg weekly,treatment,101,3.0,3.0,Vomiting,Vomiting,Vomiting,False,,albiglutide,True,True,30.0,SC,QW
NCT00849017,Vomiting,GI adverse event,True,False,False,False,True,Albiglutide 50 mg weekly,treatment,99,3.0,3.0,Vomiting,Vomiting,Vomiting,False,,albiglutide,True,True,50.0,SC,QW
NCT00849017,Dyspepsia,GI adverse event,True,False,False,False,True,Placebo,control,101,3.0,3.0,Dyspepsia,Dyspepsia,Dyspepsia,False,,albiglutide,False,False,,,
NCT00849017,Dyspepsia,GI adverse event,True,False,False,False,True,Albiglutide 30 mg weekly,treatment,101,2.0,2.0,Dyspepsia,Dyspepsia,Dyspepsia,False,,albiglutide,True,True,30.0,SC,QW
NCT00849017,Dyspepsia,GI adverse event,True,False,False,False,True,Albiglutide 50 mg weekly,treatment,99,1.0,1.0,Dyspepsia,Dyspepsia,Dyspepsia,False,,albiglutide,True,True,50.0,SC,QW
NCT00849017,Any hypoglycaemic event,Pre-rescue hypoglycaemic event,True,False,False,False,True,Placebo,control,101,4.0,4.0,Any hypoglycaemic event,Hypoglycemia (any),Hypoglycemia,True,other_summary,albiglutide,False,False,,,
NCT00849017,Any hypoglycaemic event,Pre-rescue hypoglycaemic event,True,False,False,False,True,Albiglutide 30 mg weekly,treatment,101,6.0,5.9,Any hypoglycaemic event,Hypoglycemia (any),Hypoglycemia,True,other_summary,albiglutide,True,True,30.0,SC,QW
NCT00849017,Any hypoglycaemic event,Pre-rescue hypoglycaemic event,True,False,False,False,True,Albiglutide 50 mg weekly,treatment,99,6.0,6.1,Any hypoglycaemic event,Hypoglycemia (any),Hypoglycemia,True,other_summary,albiglutide,True,True,50.0,SC,QW
NCT00849017,Severe hypoglycaemic event,Pre-rescue hypoglycaemic event,False,True,False,False,True,Placebo,control,101,0.0,0.0,Severe hypoglycaemic event,Severe hypoglycemia,Hypoglycemia,False,,albiglutide,False,False,,,
NCT00849017,Severe hypoglycaemic event,Pre-rescue hypoglycaemic event,False,True,False,False,True,Albiglutide 30 mg weekly,treatment,101,0.0,0.0,Severe hypoglycaemic event,Severe hypoglycemia,Hypoglycemia,False,,albiglutide,True,True,30.0,SC,QW
NCT00849017,Severe hypoglycaemic event,Pre-rescue hypoglycaemic event,False,True,False,False,True,Albiglutide 50 mg weekly,treatment,99,0.0,0.0,Severe hypoglycaemic event,Severe hypoglycemia,Hypoglycemia,False,,albiglutide,True,True,50.0,SC,QW
NCT00849017,Documented symptomatic hypoglycaemic event,Pre-rescue hypoglycaemic event,True,False,False,False,True,Placebo,control,101,2.0,2.0,Documented symptomatic hypoglycaemic event,Symptomatic hypoglycemia,Hypoglycemia,False,,albiglutide,False,False,,,
NCT00849017,Documented symptomatic hypoglycaemic event,Pre-rescue hypoglycaemic event,True,False,False,False,True,Albiglutide 30 mg weekly,treatment,101,1.0,1.0,Documented symptomatic hypoglycaemic event,Symptomatic hypoglycemia,Hypoglycemia,False,,albiglutide,True,True,30.0,SC,QW
NCT00849017,Documented symptomatic hypoglycaemic event,Pre-rescue hypoglycaemic event,True,False,False,False,True,Albiglutide 50 mg weekly,treatment,99,0.0,0.0,Documented symptomatic hypoglycaemic event,Symptomatic hypoglycemia,Hypoglycemia,False,,albiglutide,True,True,50.0,SC,QW
NCT00849017,Any ISR,ISR,True,False,False,False,True,Placebo,control,101,10.0,9.9,Any ISR,Injection-site reactions (any),Injection-site reactions (any),True,other_summary,albiglutide,False,False,,,
NCT00849017,Any ISR,ISR,True,False,False,False,True,Albiglutide 30 mg weekly,treatment,101,18.0,17.8,Any ISR,Injection-site reactions (any),Injection-site reactions (any),True,other_summary,albiglutide,True,True,30.0,SC,QW
NCT00849017,Any ISR,ISR,True,False,False,False,True,Albiglutide 50 mg weekly,treatment,99,22.0,22.2,Any ISR,Injection-site reactions (any),Injection-site reactions (any),True,other_summary,albiglutide,True,True,50.0,SC,QW
NCT00849017,Mild ISR event,ISR,True,False,False,False,True,Placebo,control,44,44.0,100.0,Mild ISR event,Mild injection-site reaction,Injection-site reactions,False,,albiglutide,False,False,,,
NCT00849017,Mild ISR event,ISR,True,False,False,False,True,Albiglutide 30 mg weekly,treatment,82,82.0,90.0,Mild ISR event,Mild injection-site reaction,Injection-site reactions,False,,albiglutide,True,True,30.0,SC,QW
NCT00849017,Mild ISR event,ISR,True,False,False,False,True,Albiglutide 50 mg weekly,treatment,49,49.0,89.0,Mild ISR event,Mild injection-site reaction,Injection-site reactions,False,,albiglutide,True,True,50.0,SC,QW
NCT00849017,Withdrawal due to an ISR,ISR,False,False,False,True,True,Placebo,control,0,0.0,0.0,Withdrawal due to an ISR,Withdrawal due to injection-site reaction,Adverse event leading to discontinuation,True,ae_leading_to_discontinuation,albiglutide,False,False,,,
NCT00849017,Withdrawal due to an ISR,ISR,False,False,False,True,True,Albiglutide 30 mg weekly,treatment,4,4.0,4.0,Withdrawal due to an ISR,Withdrawal due to injection-site reaction,Adverse event leading to discontinuation,True,ae_leading_to_discontinuation,albiglutide,True,True,30.0,SC,QW
NCT00849017,Withdrawal due to an ISR,ISR,False,False,False,True,True,Albiglutide 50 mg weekly,treatment,4,4.0,4.0,Withdrawal due to an ISR,Withdrawal due to injection-site reaction,Adverse event leading to discontinuation,True,ae_leading_to_discontinuation,albiglutide,True,True,50.0,SC,QW
NCT00849017,No. of patients with one or two ISR events among patients with an ISR,ISR,True,False,False,False,True,Placebo,control,8,8.0,80.0,No. of patients with one or two ISR events among patients with an ISR,Injection-site reactions (patients with 1–2 events),Injection-site reactions (patients with 1–2 events),True,other_summary,albiglutide,False,False,,,
NCT00849017,No. of patients with one or two ISR events among patients with an ISR,ISR,True,False,False,False,True,Albiglutide 30 mg weekly,treatment,9,9.0,50.0,No. of patients with one or two ISR events among patients with an ISR,Injection-site reactions (patients with 1–2 events),Injection-site reactions (patients with 1–2 events),True,other_summary,albiglutide,True,True,30.0,SC,QW
NCT00849017,No. of patients with one or two ISR events among patients with an ISR,ISR,True,False,False,False,True,Albiglutide 50 mg weekly,treatment,15,15.0,68.0,No. of patients with one or two ISR events among patients with an ISR,Injection-site reactions (patients with 1–2 events),Injection-site reactions (patients with 1–2 events),True,other_summary,albiglutide,True,True,50.0,SC,QW
NCT05567796,Any adverse event,Adverse Events,True,False,False,False,False,Cagrilintide-Semaglutide,treatment,2106,1943.0,92.3,Any adverse event,Any adverse event,Any adverse event,True,any_ae,Cagrilintide-Semaglutide,True,True,,SC,QW
NCT05567796,Any adverse event,Adverse Events,True,False,False,False,False,Semaglutide,treatment,302,271.0,89.7,Any adverse event,Any adverse event,Any adverse event,True,any_ae,Cagrilintide-Semaglutide,True,True,,SC,QW
NCT05567796,Any adverse event,Adverse Events,True,False,False,False,False,Cagrilintide,treatment,302,254.0,84.1,Any adverse event,Any adverse event,Any adverse event,True,any_ae,Cagrilintide-Semaglutide,True,True,,SC,QW
NCT05567796,Any adverse event,Adverse Events,True,False,False,False,False,Placebo,control,705,580.0,82.3,Any adverse event,Any adverse event,Any adverse event,True,any_ae,Cagrilintide-Semaglutide,False,False,,,
NCT05567796,Serious adverse event,Serious Adverse Events,False,True,False,False,False,Cagrilintide-Semaglutide,treatment,2106,206.0,9.8,Serious adverse event,Serious adverse events,Serious adverse events,True,serious_ae,Cagrilintide-Semaglutide,True,True,,SC,QW
NCT05567796,Serious adverse event,Serious Adverse Events,False,True,False,False,False,Semaglutide,treatment,302,15.0,5.0,Serious adverse event,Serious adverse events,Serious adverse events,True,serious_ae,Cagrilintide-Semaglutide,True,True,,SC,QW
NCT05567796,Serious adverse event,Serious Adverse Events,False,True,False,False,False,Cagrilintide,treatment,302,27.0,8.9,Serious adverse event,Serious adverse events,Serious adverse events,True,serious_ae,Cagrilintide-Semaglutide,True,True,,SC,QW
NCT05567796,Serious adverse event,Serious Adverse Events,False,True,False,False,False,Placebo,control,705,43.0,6.1,Serious adverse event,Serious adverse events,Serious adverse events,True,serious_ae,Cagrilintide-Semaglutide,False,False,,,
NCT05567796,Adverse event leading to permanent trial-product discontinuation,Adverse Events Leading to Discontinuation,False,False,False,True,False,Cagrilintide-Semaglutide,treatment,2106,125.0,5.9,Adverse event leading to permanent trial-product discontinuation,Adverse event leading to discontinuation,Adverse event leading to discontinuation,True,ae_leading_to_discontinuation,Cagrilintide-Semaglutide,True,True,,SC,QW
NCT05567796,Adverse event leading to permanent trial-product discontinuation,Adverse Events Leading to Discontinuation,False,False,False,True,False,Semaglutide,treatment,302,11.0,3.6,Adverse event leading to permanent trial-product discontinuation,Adverse event leading to discontinuation,Adverse event leading to discontinuation,True,ae_leading_to_discontinuation,Cagrilintide-Semaglutide,True,True,,SC,QW
NCT05567796,Adverse event leading to permanent trial-product discontinuation,Adverse Events Leading to Discontinuation,False,False,False,True,False,Cagrilintide,treatment,302,8.0,2.6,Adverse event leading to permanent trial-product discontinuation,Adverse event leading to discontinuation,Adverse event leading to discontinuation,True,ae_leading_to_discontinuation,Cagrilintide-Semaglutide,True,True,,SC,QW
NCT05567796,Adverse event leading to permanent trial-product discontinuation,Adverse Events Leading to Discontinuation,False,False,False,True,False,Placebo,control,705,25.0,3.5,Adverse event leading to permanent trial-product discontinuation,Adverse event leading to discontinuation,Adverse event leading to discontinuation,True,ae_leading_to_discontinuation,Cagrilintide-Semaglutide,False,False,,,
NCT05567796,Gastrointestinal leading adverse events to permanent trial-product discontinuation,Gastrointestinal Adverse Events Leading to Discontinuation,False,False,False,True,False,Cagrilintide-Semaglutide,treatment,2106,76.0,3.6,Gastrointestinal leading adverse events to permanent trial-product discontinuation,Gastrointestinal AE leading to discontinuation,Adverse event leading to discontinuation,True,ae_leading_to_discontinuation,Cagrilintide-Semaglutide,True,True,,SC,QW
NCT05567796,Gastrointestinal leading adverse events to permanent trial-product discontinuation,Gastrointestinal Adverse Events Leading to Discontinuation,False,False,False,True,False,Semaglutide,treatment,302,4.0,1.3,Gastrointestinal leading adverse events to permanent trial-product discontinuation,Gastrointestinal AE leading to discontinuation,Adverse event leading to discontinuation,True,ae_leading_to_discontinuation,Cagrilintide-Semaglutide,True,True,,SC,QW
NCT05567796,Gastrointestinal leading adverse events to permanent trial-product discontinuation,Gastrointestinal Adverse Events Leading to Discontinuation,False,False,False,True,False,Cagrilintide,treatment,302,4.0,1.3,Gastrointestinal leading adverse events to permanent trial-product discontinuation,Gastrointestinal AE leading to discontinuation,Adverse event leading to discontinuation,True,ae_leading_to_discontinuation,Cagrilintide-Semaglutide,True,True,,SC,QW
NCT05567796,Gastrointestinal leading adverse events to permanent trial-product discontinuation,Gastrointestinal Adverse Events Leading to Discontinuation,False,False,False,True,False,Placebo,control,705,4.0,0.6,Gastrointestinal leading adverse events to permanent trial-product discontinuation,Gastrointestinal AE leading to discontinuation,Adverse event leading to discontinuation,True,ae_leading_to_discontinuation,Cagrilintide-Semaglutide,False,False,,,
NCT05567796,Fatal event,Fatal Events,False,False,True,False,False,Cagrilintide-Semaglutide,treatment,2106,2.0,0.1,Fatal event,Fatal adverse events,Fatal adverse events,True,fatal_ae,Cagrilintide-Semaglutide,True,True,,SC,QW
NCT05567796,Fatal event,Fatal Events,False,False,True,False,False,Semaglutide,treatment,302,0.0,0.0,Fatal event,Fatal adverse events,Fatal adverse events,True,fatal_ae,Cagrilintide-Semaglutide,True,True,,SC,QW
NCT05567796,Fatal event,Fatal Events,False,False,True,False,False,Cagrilintide,treatment,302,0.0,0.0,Fatal event,Fatal adverse events,Fatal adverse events,True,fatal_ae,Cagrilintide-Semaglutide,True,True,,SC,QW
NCT05567796,Fatal event,Fatal Events,False,False,True,False,False,Placebo,control,705,0.0,0.0,Fatal event,Fatal adverse events,Fatal adverse events,True,fatal_ae,Cagrilintide-Semaglutide,False,False,,,
NCT05567796,Gastrointestinal adverse events,Gastrointestinal Adverse Events,False,False,False,False,True,Cagrilintide-Semaglutide,treatment,2106,1676.0,79.6,Gastrointestinal adverse events,Gastrointestinal adverse events,Gastrointestinal adverse events,True,other_summary,Cagrilintide-Semaglutide,True,True,,SC,QW
NCT05567796,Gastrointestinal adverse events,Gastrointestinal Adverse Events,False,False,False,False,True,Semaglutide,treatment,302,223.0,73.8,Gastrointestinal adverse events,Gastrointestinal adverse events,Gastrointestinal adverse events,True,other_summary,Cagrilintide-Semaglutide,True,True,,SC,QW
NCT05567796,Gastrointestinal adverse events,Gastrointestinal Adverse Events,False,False,False,False,True,Cagrilintide,treatment,302,163.0,54.0,Gastrointestinal adverse events,Gastrointestinal adverse events,Gastrointestinal adverse events,True,other_summary,Cagrilintide-Semaglutide,True,True,,SC,QW
NCT05567796,Gastrointestinal adverse events,Gastrointestinal Adverse Events,False,False,False,False,True,Placebo,control,705,281.0,39.9,Gastrointestinal adverse events,Gastrointestinal adverse events,Gastrointestinal adverse events,True,other_summary,Cagrilintide-Semaglutide,False,False,,,
NCT05567796,Injection-site reactions,Injection-Site Reactions,False,False,False,False,True,Cagrilintide-Semaglutide,treatment,2106,256.0,12.2,Injection-site reactions,Injection-site reaction,Injection-site reactions,False,,Cagrilintide-Semaglutide,True,True,,SC,QW
NCT05567796,Injection-site reactions,Injection-Site Reactions,False,False,False,False,True,Semaglutide,treatment,302,8.0,2.6,Injection-site reactions,Injection-site reaction,Injection-site reactions,False,,Cagrilintide-Semaglutide,True,True,,SC,QW
NCT05567796,Injection-site reactions,Injection-Site Reactions,False,False,False,False,True,Cagrilintide,treatment,302,51.0,16.9,Injection-site reactions,Injection-site reaction,Injection-site reactions,False,,Cagrilintide-Semaglutide,True,True,,SC,QW
NCT05567796,Injection-site reactions,Injection-Site Reactions,False,False,False,False,True,Placebo,control,705,21.0,3.0,Injection-site reactions,Injection-site reaction,Injection-site reactions,False,,Cagrilintide-Semaglutide,False,False,,,
NCT05567796,Allergic reactions,Allergic Reactions,False,False,False,False,True,Cagrilintide-Semaglutide,treatment,2106,110.0,5.2,Allergic reactions,Hypersensitivity,Hypersensitivity,False,,Cagrilintide-Semaglutide,True,True,,SC,QW
NCT05567796,Allergic reactions,Allergic Reactions,False,False,False,False,True,Semaglutide,treatment,302,17.0,5.6,Allergic reactions,Hypersensitivity,Hypersensitivity,False,,Cagrilintide-Semaglutide,True,True,,SC,QW
NCT05567796,Allergic reactions,Allergic Reactions,False,False,False,False,True,Cagrilintide,treatment,302,23.0,7.6,Allergic reactions,Hypersensitivity,Hypersensitivity,False,,Cagrilintide-Semaglutide,True,True,,SC,QW
NCT05567796,Allergic reactions,Allergic Reactions,False,False,False,False,True,Placebo,control,705,39.0,5.5,Allergic reactions,Hypersensitivity,Hypersensitivity,False,,Cagrilintide-Semaglutide,False,False,,,
NCT05567796,Neoplasms,Neoplasms,False,False,False,False,True,Cagrilintide-Semaglutide,treatment,2106,134.0,6.4,Neoplasms,Neoplasms,Neoplasms,True,other_summary,Cagrilintide-Semaglutide,True,True,,SC,QW
NCT05567796,Neoplasms,Neoplasms,False,False,False,False,True,Semaglutide,treatment,302,20.0,6.6,Neoplasms,Neoplasms,Neoplasms,True,other_summary,Cagrilintide-Semaglutide,True,True,,SC,QW
NCT05567796,Neoplasms,Neoplasms,False,False,False,False,True,Cagrilintide,treatment,302,5.0,1.7,Neoplasms,Neoplasms,Neoplasms,True,other_summary,Cagrilintide-Semaglutide,True,True,,SC,QW
NCT05567796,Neoplasms,Neoplasms,False,False,False,False,True,Placebo,control,705,31.0,4.4,Neoplasms,Neoplasms,Neoplasms,True,other_summary,Cagrilintide-Semaglutide,False,False,,,
NCT05567796,Gallbladder-related disorders,Gallbladder-Related Disorders,False,False,False,False,True,Cagrilintide-Semaglutide,treatment,2106,87.0,4.1,Gallbladder-related disorders,Gallbladder-related disorders,Gallbladder-related disorders,True,other_summary,Cagrilintide-Semaglutide,True,True,,SC,QW
NCT05567796,Gallbladder-related disorders,Gallbladder-Related Disorders,False,False,False,False,True,Semaglutide,treatment,302,9.0,3.0,Gallbladder-related disorders,Gallbladder-related disorders,Gallbladder-related disorders,True,other_summary,Cagrilintide-Semaglutide,True,True,,SC,QW
NCT05567796,Gallbladder-related disorders,Gallbladder-Related Disorders,False,False,False,False,True,Cagrilintide,treatment,302,7.0,2.3,Gallbladder-related disorders,Gallbladder-related disorders,Gallbladder-related disorders,True,other_summary,Cagrilintide-Semaglutide,True,True,,SC,QW
NCT05567796,Gallbladder-related disorders,Gallbladder-Related Disorders,False,False,False,False,True,Placebo,control,705,7.0,1.0,Gallbladder-related disorders,Gallbladder-related disorders,Gallbladder-related disorders,True,other_summary,Cagrilintide-Semaglutide,False,False,,,
NCT05567796,Malignant neoplasms,Malignant Neoplasms,False,True,False,False,True,Cagrilintide-Semaglutide,treatment,2106,14.0,0.7,Malignant neoplasms,Malignant neoplasm,Cancer,False,,Cagrilintide-Semaglutide,True,True,,SC,QW
NCT05567796,Malignant neoplasms,Malignant Neoplasms,False,True,False,False,True,Semaglutide,treatment,302,2.0,0.7,Malignant neoplasms,Malignant neoplasm,Cancer,False,,Cagrilintide-Semaglutide,True,True,,SC,QW
NCT05567796,Malignant neoplasms,Malignant Neoplasms,False,True,False,False,True,Cagrilintide,treatment,302,2.0,0.7,Malignant neoplasms,Malignant neoplasm,Cancer,False,,Cagrilintide-Semaglutide,True,True,,SC,QW
NCT05567796,Malignant neoplasms,Malignant Neoplasms,False,True,False,False,True,Placebo,control,705,4.0,0.6,Malignant neoplasms,Malignant neoplasm,Cancer,False,,Cagrilintide-Semaglutide,False,False,,,
NCT05567796,Pancreatitis,Pancreatitis,False,True,False,False,True,Cagrilintide-Semaglutide,treatment,2106,4.0,0.2,Pancreatitis,Pancreatitis,Pancreatitis,False,,Cagrilintide-Semaglutide,True,True,,SC,QW
NCT05567796,Pancreatitis,Pancreatitis,False,True,False,False,True,Semaglutide,treatment,302,1.0,0.3,Pancreatitis,Pancreatitis,Pancreatitis,False,,Cagrilintide-Semaglutide,True,True,,SC,QW
NCT05567796,Pancreatitis,Pancreatitis,False,True,False,False,True,Cagrilintide,treatment,302,0.0,0.0,Pancreatitis,Pancreatitis,Pancreatitis,False,,Cagrilintide-Semaglutide,True,True,,SC,QW
NCT05567796,Pancreatitis,Pancreatitis,False,True,False,False,True,Placebo,control,705,0.0,0.0,Pancreatitis,Pancreatitis,Pancreatitis,False,,Cagrilintide-Semaglutide,False,False,,,
NCT05567796,Fatigue,Adverse Events >5%,False,False,False,False,False,Cagrilintide-Semaglutide,treatment,2106,,,Fatigue,Fatigue,Fatigue,False,,Cagrilintide-Semaglutide,True,True,,SC,QW
NCT05567796,Dizziness,Adverse Events >5%,False,False,False,False,False,Cagrilintide-Semaglutide,treatment,2106,,,Dizziness,Dizziness,Dizziness,False,,Cagrilintide-Semaglutide,True,True,,SC,QW
NCT05567796,Alopecia,Adverse Events >5%,False,False,False,False,False,Cagrilintide-Semaglutide,treatment,2106,,,Alopecia,Alopecia,Alopecia,False,,Cagrilintide-Semaglutide,True,True,,SC,QW
NCT04707469,Total adverse events,Total adverse events,True,False,False,False,False,Oral semaglutide 14 mg group,treatment,534,404.0,76.0,Total adverse events,Any adverse event,Any adverse event,True,any_ae,oral semaglutide,True,True,14.0,oral,QD
NCT04707469,Total adverse events,Total adverse events,True,False,False,False,False,Oral semaglutide 25 mg group,treatment,534,422.0,79.0,Total adverse events,Any adverse event,Any adverse event,True,any_ae,oral semaglutide,False,False,25.0,oral,QD
NCT04707469,Total adverse events,Total adverse events,True,False,False,False,False,Oral semaglutide 50 mg group,treatment,534,428.0,80.0,Total adverse events,Any adverse event,Any adverse event,True,any_ae,oral semaglutide,False,False,50.0,oral,QD
NCT04707469,Total serious adverse events,Total serious adverse events,False,True,False,False,False,Oral semaglutide 14 mg group,treatment,534,53.0,10.0,Total serious adverse events,Serious adverse events,Serious adverse events,True,serious_ae,oral semaglutide,True,True,14.0,oral,QD
NCT04707469,Total serious adverse events,Total serious adverse events,False,True,False,False,False,Oral semaglutide 25 mg group,treatment,534,57.0,11.0,Total serious adverse events,Serious adverse events,Serious adverse events,True,serious_ae,oral semaglutide,False,False,25.0,oral,QD
NCT04707469,Total serious adverse events,Total serious adverse events,False,True,False,False,False,Oral semaglutide 50 mg group,treatment,534,44.0,8.0,Total serious adverse events,Serious adverse events,Serious adverse events,True,serious_ae,oral semaglutide,False,False,50.0,oral,QD
NCT04707469,Adverse events leading to discontinuation of trial product,Adverse events leading to discontinuation of trial product,False,False,False,True,False,Oral semaglutide 14 mg group,treatment,534,54.0,10.0,Adverse events leading to discontinuation of trial product,Adverse events leading to discontinuation,Adverse event leading to discontinuation,True,ae_leading_to_discontinuation,oral semaglutide,True,True,14.0,oral,QD
NCT04707469,Adverse events leading to discontinuation of trial product,Adverse events leading to discontinuation of trial product,False,False,False,True,False,Oral semaglutide 25 mg group,treatment,534,66.0,12.0,Adverse events leading to discontinuation of trial product,Adverse events leading to discontinuation,Adverse event leading to discontinuation,True,ae_leading_to_discontinuation,oral semaglutide,False,False,25.0,oral,QD
NCT04707469,Adverse events leading to discontinuation of trial product,Adverse events leading to discontinuation of trial product,False,False,False,True,False,Oral semaglutide 50 mg group,treatment,534,68.0,13.0,Adverse events leading to discontinuation of trial product,Adverse events leading to discontinuation,Adverse event leading to discontinuation,True,ae_leading_to_discontinuation,oral semaglutide,False,False,50.0,oral,QD
NCT04707469,Fatal events,Fatal events,False,False,True,False,False,Oral semaglutide 14 mg group,treatment,534,2.0,0.0,Fatal events,Fatal adverse events,Fatal adverse events,True,fatal_ae,oral semaglutide,True,True,14.0,oral,QD
NCT04707469,Fatal events,Fatal events,False,False,True,False,False,Oral semaglutide 25 mg group,treatment,534,5.0,0.0,Fatal events,Fatal adverse events,Fatal adverse events,True,fatal_ae,oral semaglutide,False,False,25.0,oral,QD
NCT04707469,Fatal events,Fatal events,False,False,True,False,False,Oral semaglutide 50 mg group,treatment,534,2.0,0.0,Fatal events,Fatal adverse events,Fatal adverse events,True,fatal_ae,oral semaglutide,False,False,50.0,oral,QD
NCT04707469,Hypoglycaemic episodes,Hypoglycaemic episodes,False,False,False,False,True,Oral semaglutide 14 mg group,treatment,534,70.0,13.0,Hypoglycaemic episodes,Hypoglycemia,Hypoglycemia,False,,oral semaglutide,True,True,14.0,oral,QD
NCT04707469,Hypoglycaemic episodes,Hypoglycaemic episodes,False,False,False,False,True,Oral semaglutide 25 mg group,treatment,534,74.0,14.0,Hypoglycaemic episodes,Hypoglycemia,Hypoglycemia,False,,oral semaglutide,False,False,25.0,oral,QD
NCT04707469,Hypoglycaemic episodes,Hypoglycaemic episodes,False,False,False,False,True,Oral semaglutide 50 mg group,treatment,534,90.0,17.0,Hypoglycaemic episodes,Hypoglycemia,Hypoglycemia,False,,oral semaglutide,False,False,50.0,oral,QD
NCT04707469,Nausea,Most frequent adverse events,True,False,False,False,False,Oral semaglutide 14 mg group,treatment,534,97.0,18.0,Nausea,Nausea,Nausea,False,,oral semaglutide,True,True,14.0,oral,QD
NCT04707469,Nausea,Most frequent adverse events,True,False,False,False,False,Oral semaglutide 25 mg group,treatment,534,145.0,27.0,Nausea,Nausea,Nausea,False,,oral semaglutide,False,False,25.0,oral,QD
NCT04707469,Nausea,Most frequent adverse events,True,False,False,False,False,Oral semaglutide 50 mg group,treatment,534,146.0,27.0,Nausea,Nausea,Nausea,False,,oral semaglutide,False,False,50.0,oral,QD
NCT04707469,Vomiting,Most frequent adverse events,True,False,False,False,False,Oral semaglutide 14 mg group,treatment,534,54.0,10.0,Vomiting,Vomiting,Vomiting,False,,oral semaglutide,True,True,14.0,oral,QD
NCT04707469,Vomiting,Most frequent adverse events,True,False,False,False,False,Oral semaglutide 25 mg group,treatment,534,91.0,17.0,Vomiting,Vomiting,Vomiting,False,,oral semaglutide,False,False,25.0,oral,QD
NCT04707469,Vomiting,Most frequent adverse events,True,False,False,False,False,Oral semaglutide 50 mg group,treatment,534,97.0,18.0,Vomiting,Vomiting,Vomiting,False,,oral semaglutide,False,False,50.0,oral,QD
NCT04707469,Diarrhoea,Most frequent adverse events,True,False,False,False,False,Oral semaglutide 14 mg group,treatment,534,66.0,12.0,Diarrhoea,Diarrhea,Diarrhea,False,,oral semaglutide,True,True,14.0,oral,QD
NCT04707469,Diarrhoea,Most frequent adverse events,True,False,False,False,False,Oral semaglutide 25 mg group,treatment,534,69.0,13.0,Diarrhoea,Diarrhea,Diarrhea,False,,oral semaglutide,False,False,25.0,oral,QD
NCT04707469,Diarrhoea,Most frequent adverse events,True,False,False,False,False,Oral semaglutide 50 mg group,treatment,534,76.0,14.0,Diarrhoea,Diarrhea,Diarrhea,False,,oral semaglutide,False,False,50.0,oral,QD
NCT04707469,COVID-19,Most frequent adverse events,True,False,False,False,False,Oral semaglutide 14 mg group,treatment,534,66.0,12.0,COVID-19,COVID-19,COVID-19,False,,oral semaglutide,True,True,14.0,oral,QD
NCT04707469,COVID-19,Most frequent adverse events,True,False,False,False,False,Oral semaglutide 25 mg group,treatment,534,64.0,12.0,COVID-19,COVID-19,COVID-19,False,,oral semaglutide,False,False,25.0,oral,QD
NCT04707469,COVID-19,Most frequent adverse events,True,False,False,False,False,Oral semaglutide 50 mg group,treatment,534,69.0,13.0,COVID-19,COVID-19,COVID-19,False,,oral semaglutide,False,False,50.0,oral,QD
NCT04707469,Decreased appetite,Most frequent adverse events,True,False,False,False,False,Oral semaglutide 14 mg group,treatment,534,38.0,7.0,Decreased appetite,Decreased appetite,Decreased appetite,False,,oral semaglutide,True,True,14.0,oral,QD
NCT04707469,Decreased appetite,Most frequent adverse events,True,False,False,False,False,Oral semaglutide 25 mg group,treatment,534,39.0,7.0,Decreased appetite,Decreased appetite,Decreased appetite,False,,oral semaglutide,False,False,25.0,oral,QD
NCT04707469,Decreased appetite,Most frequent adverse events,True,False,False,False,False,Oral semaglutide 50 mg group,treatment,534,58.0,11.0,Decreased appetite,Decreased appetite,Decreased appetite,False,,oral semaglutide,False,False,50.0,oral,QD
NCT04707469,Constipation,Most frequent adverse events,True,False,False,False,False,Oral semaglutide 14 mg group,treatment,534,40.0,7.0,Constipation,Constipation,Constipation,False,,oral semaglutide,True,True,14.0,oral,QD
NCT04707469,Constipation,Most frequent adverse events,True,False,False,False,False,Oral semaglutide 25 mg group,treatment,534,35.0,7.0,Constipation,Constipation,Constipation,False,,oral semaglutide,False,False,25.0,oral,QD
NCT04707469,Constipation,Most frequent adverse events,True,False,False,False,False,Oral semaglutide 50 mg group,treatment,534,33.0,6.0,Constipation,Constipation,Constipation,False,,oral semaglutide,False,False,50.0,oral,QD
NCT04707469,Diabetic retinopathy,Most frequent adverse events,True,False,False,False,True,Oral semaglutide 14 mg group,treatment,534,41.0,8.0,Diabetic retinopathy,Diabetic retinopathy,Diabetic retinopathy,False,,oral semaglutide,True,True,14.0,oral,QD
NCT04707469,Diabetic retinopathy,Most frequent adverse events,True,False,False,False,True,Oral semaglutide 25 mg group,treatment,534,26.0,5.0,Diabetic retinopathy,Diabetic retinopathy,Diabetic retinopathy,False,,oral semaglutide,False,False,25.0,oral,QD
NCT04707469,Diabetic retinopathy,Most frequent adverse events,True,False,False,False,True,Oral semaglutide 50 mg group,treatment,534,35.0,7.0,Diabetic retinopathy,Diabetic retinopathy,Diabetic retinopathy,False,,oral semaglutide,False,False,50.0,oral,QD
NCT04707469,Headache,Most frequent adverse events,True,False,False,False,False,Oral semaglutide 14 mg group,treatment,534,34.0,6.0,Headache,Headache,Headache,False,,oral semaglutide,True,True,14.0,oral,QD
NCT04707469,Headache,Most frequent adverse events,True,False,False,False,False,Oral semaglutide 25 mg group,treatment,534,28.0,5.0,Headache,Headache,Headache,False,,oral semaglutide,False,False,25.0,oral,QD
NCT04707469,Headache,Most frequent adverse events,True,False,False,False,False,Oral semaglutide 50 mg group,treatment,534,38.0,7.0,Headache,Headache,Headache,False,,oral semaglutide,False,False,50.0,oral,QD
NCT04707469,Dyspepsia,Most frequent adverse events,True,False,False,False,False,Oral semaglutide 14 mg group,treatment,534,28.0,5.0,Dyspepsia,Dyspepsia,Dyspepsia,False,,oral semaglutide,True,True,14.0,oral,QD
NCT04707469,Dyspepsia,Most frequent adverse events,True,False,False,False,False,Oral semaglutide 25 mg group,treatment,534,30.0,6.0,Dyspepsia,Dyspepsia,Dyspepsia,False,,oral semaglutide,False,False,25.0,oral,QD
NCT04707469,Dyspepsia,Most frequent adverse events,True,False,False,False,False,Oral semaglutide 50 mg group,treatment,534,30.0,6.0,Dyspepsia,Dyspepsia,Dyspepsia,False,,oral semaglutide,False,False,50.0,oral,QD
NCT04707469,Nasopharyngitis,Most frequent adverse events,True,False,False,False,False,Oral semaglutide 14 mg group,treatment,534,24.0,4.0,Nasopharyngitis,Nasopharyngitis,Nasopharyngitis,False,,oral semaglutide,True,True,14.0,oral,QD
NCT04707469,Nasopharyngitis,Most frequent adverse events,True,False,False,False,False,Oral semaglutide 25 mg group,treatment,534,22.0,4.0,Nasopharyngitis,Nasopharyngitis,Nasopharyngitis,False,,oral semaglutide,False,False,25.0,oral,QD
NCT04707469,Nasopharyngitis,Most frequent adverse events,True,False,False,False,False,Oral semaglutide 50 mg group,treatment,534,27.0,5.0,Nasopharyngitis,Nasopharyngitis,Nasopharyngitis,False,,oral semaglutide,False,False,50.0,oral,QD
NCT04707469,Abdominal pain upper,Most frequent adverse events,True,False,False,False,False,Oral semaglutide 14 mg group,treatment,534,14.0,3.0,Abdominal pain upper,Upper abdominal pain,Abdominal pain,False,,oral semaglutide,True,True,14.0,oral,QD
NCT04707469,Abdominal pain upper,Most frequent adverse events,True,False,False,False,False,Oral semaglutide 25 mg group,treatment,534,32.0,6.0,Abdominal pain upper,Upper abdominal pain,Abdominal pain,False,,oral semaglutide,False,False,25.0,oral,QD
NCT04707469,Abdominal pain upper,Most frequent adverse events,True,False,False,False,False,Oral semaglutide 50 mg group,treatment,534,22.0,4.0,Abdominal pain upper,Upper abdominal pain,Abdominal pain,False,,oral semaglutide,False,False,50.0,oral,QD
NCT04707469,Abdominal pain,Most frequent adverse events,True,False,False,False,False,Oral semaglutide 14 mg group,treatment,534,15.0,3.0,Abdominal pain,Abdominal pain,Abdominal pain,False,,oral semaglutide,True,True,14.0,oral,QD
NCT04707469,Abdominal pain,Most frequent adverse events,True,False,False,False,False,Oral semaglutide 25 mg group,treatment,534,28.0,5.0,Abdominal pain,Abdominal pain,Abdominal pain,False,,oral semaglutide,False,False,25.0,oral,QD
NCT04707469,Abdominal pain,Most frequent adverse events,True,False,False,False,False,Oral semaglutide 50 mg group,treatment,534,21.0,4.0,Abdominal pain,Abdominal pain,Abdominal pain,False,,oral semaglutide,False,False,50.0,oral,QD
NCT04707469,Gastrointestinal disorders,Safety focus areas,True,False,False,False,True,Oral semaglutide 14 mg group,treatment,534,225.0,42.0,Gastrointestinal disorders,Gastrointestinal disorders,Gastrointestinal disorders,True,other_summary,oral semaglutide,True,True,14.0,oral,QD
NCT04707469,Gastrointestinal disorders,Safety focus areas,True,False,False,False,True,Oral semaglutide 25 mg group,treatment,534,282.0,53.0,Gastrointestinal disorders,Gastrointestinal disorders,Gastrointestinal disorders,True,other_summary,oral semaglutide,False,False,25.0,oral,QD
NCT04707469,Gastrointestinal disorders,Safety focus areas,True,False,False,False,True,Oral semaglutide 50 mg group,treatment,534,286.0,54.0,Gastrointestinal disorders,Gastrointestinal disorders,Gastrointestinal disorders,True,other_summary,oral semaglutide,False,False,50.0,oral,QD
NCT04707469,Renal disorders,Safety focus areas,True,False,False,False,True,Oral semaglutide 14 mg group,treatment,534,2.0,0.0,Renal disorders,Renal disorders,Renal disorders,True,other_summary,oral semaglutide,True,True,14.0,oral,QD
NCT04707469,Renal disorders,Safety focus areas,True,False,False,False,True,Oral semaglutide 25 mg group,treatment,534,6.0,1.0,Renal disorders,Renal disorders,Renal disorders,True,other_summary,oral semaglutide,False,False,25.0,oral,QD
NCT04707469,Renal disorders,Safety focus areas,True,False,False,False,True,Oral semaglutide 50 mg group,treatment,534,2.0,0.0,Renal disorders,Renal disorders,Renal disorders,True,other_summary,oral semaglutide,False,False,50.0,oral,QD
NCT04707469,Acute kidney injury,Safety focus areas,True,False,False,False,True,Oral semaglutide 14 mg group,treatment,534,2.0,0.0,Acute kidney injury,Acute kidney injury,Renal impairment,False,,oral semaglutide,True,True,14.0,oral,QD
NCT04707469,Acute kidney injury,Safety focus areas,True,False,False,False,True,Oral semaglutide 25 mg group,treatment,534,3.0,0.0,Acute kidney injury,Acute kidney injury,Renal impairment,False,,oral semaglutide,False,False,25.0,oral,QD
NCT04707469,Acute kidney injury,Safety focus areas,True,False,False,False,True,Oral semaglutide 50 mg group,treatment,534,2.0,0.0,Acute kidney injury,Acute kidney injury,Renal impairment,False,,oral semaglutide,False,False,50.0,oral,QD
NCT04707469,Renal impairment,Safety focus areas,True,False,False,False,True,Oral semaglutide 14 mg group,treatment,534,0.0,0.0,Renal impairment,Renal impairment,Renal impairment,False,,oral semaglutide,True,True,14.0,oral,QD
NCT04707469,Renal impairment,Safety focus areas,True,False,False,False,True,Oral semaglutide 25 mg group,treatment,534,3.0,0.0,Renal impairment,Renal impairment,Renal impairment,False,,oral semaglutide,False,False,25.0,oral,QD
NCT04707469,Renal impairment,Safety focus areas,True,False,False,False,True,Oral semaglutide 50 mg group,treatment,534,0.0,0.0,Renal impairment,Renal impairment,Renal impairment,False,,oral semaglutide,False,False,50.0,oral,QD
NCT04707469,Drug-related hepatic disorders,Safety focus areas,True,False,False,False,True,Oral semaglutide 14 mg group,treatment,534,14.0,3.0,Drug-related hepatic disorders,Drug-related hepatic disorders,Drug-related hepatic disorders,True,other_summary,oral semaglutide,True,True,14.0,oral,QD
NCT04707469,Drug-related hepatic disorders,Safety focus areas,True,False,False,False,True,Oral semaglutide 25 mg group,treatment,534,10.0,2.0,Drug-related hepatic disorders,Drug-related hepatic disorders,Drug-related hepatic disorders,True,other_summary,oral semaglutide,False,False,25.0,oral,QD
NCT04707469,Drug-related hepatic disorders,Safety focus areas,True,False,False,False,True,Oral semaglutide 50 mg group,treatment,534,11.0,2.0,Drug-related hepatic disorders,Drug-related hepatic disorders,Drug-related hepatic disorders,True,other_summary,oral semaglutide,False,False,50.0,oral,QD
NCT04707469,Gallbladder-related disorders,Safety focus areas,True,False,False,False,True,Oral semaglutide 14 mg group,treatment,534,4.0,0.0,Gallbladder-related disorders,Gallbladder-related disorders,Gallbladder-related disorders,True,other_summary,oral semaglutide,True,True,14.0,oral,QD
NCT04707469,Gallbladder-related disorders,Safety focus areas,True,False,False,False,True,Oral semaglutide 25 mg group,treatment,534,8.0,1.0,Gallbladder-related disorders,Gallbladder-related disorders,Gallbladder-related disorders,True,other_summary,oral semaglutide,False,False,25.0,oral,QD
NCT04707469,Gallbladder-related disorders,Safety focus areas,True,False,False,False,True,Oral semaglutide 50 mg group,treatment,534,4.0,0.0,Gallbladder-related disorders,Gallbladder-related disorders,Gallbladder-related disorders,True,other_summary,oral semaglutide,False,False,50.0,oral,QD
NCT04707469,Hepatobiliary disorders,Safety focus areas,True,False,False,False,True,Oral semaglutide 14 mg group,treatment,534,4.0,0.0,Hepatobiliary disorders,Hepatobiliary disorders,Hepatobiliary disorders,True,other_summary,oral semaglutide,True,True,14.0,oral,QD
NCT04707469,Hepatobiliary disorders,Safety focus areas,True,False,False,False,True,Oral semaglutide 25 mg group,treatment,534,7.0,1.0,Hepatobiliary disorders,Hepatobiliary disorders,Hepatobiliary disorders,True,other_summary,oral semaglutide,False,False,25.0,oral,QD
NCT04707469,Hepatobiliary disorders,Safety focus areas,True,False,False,False,True,Oral semaglutide 50 mg group,treatment,534,3.0,0.0,Hepatobiliary disorders,Hepatobiliary disorders,Hepatobiliary disorders,True,other_summary,oral semaglutide,False,False,50.0,oral,QD
NCT04707469,Cholelithiasis,Safety focus areas,True,False,False,False,True,Oral semaglutide 14 mg group,treatment,534,2.0,0.0,Cholelithiasis,Cholelithiasis,Gallbladder disease,False,,oral semaglutide,True,True,14.0,oral,QD
NCT04707469,Cholelithiasis,Safety focus areas,True,False,False,False,True,Oral semaglutide 25 mg group,treatment,534,3.0,0.0,Cholelithiasis,Cholelithiasis,Gallbladder disease,False,,oral semaglutide,False,False,25.0,oral,QD
NCT04707469,Cholelithiasis,Safety focus areas,True,False,False,False,True,Oral semaglutide 50 mg group,treatment,534,3.0,0.0,Cholelithiasis,Cholelithiasis,Gallbladder disease,False,,oral semaglutide,False,False,50.0,oral,QD
NCT04707469,Pancreatitis,Safety focus areas,True,False,False,False,True,Oral semaglutide 14 mg group,treatment,534,2.0,0.0,Pancreatitis,Pancreatitis,Pancreatitis,False,,oral semaglutide,True,True,14.0,oral,QD
NCT04707469,Pancreatitis,Safety focus areas,True,False,False,False,True,Oral semaglutide 25 mg group,treatment,534,1.0,0.0,Pancreatitis,Pancreatitis,Pancreatitis,False,,oral semaglutide,False,False,25.0,oral,QD
NCT04707469,Pancreatitis,Safety focus areas,True,False,False,False,True,Oral semaglutide 50 mg group,treatment,534,1.0,0.0,Pancreatitis,Pancreatitis,Pancreatitis,False,,oral semaglutide,False,False,50.0,oral,QD
NCT04707469,Acute pancreatitis,Safety focus areas,True,False,False,False,True,Oral semaglutide 14 mg group,treatment,534,0.0,0.0,Acute pancreatitis,Acute pancreatitis,Pancreatitis,False,,oral semaglutide,True,True,14.0,oral,QD
NCT04707469,Acute pancreatitis,Safety focus areas,True,False,False,False,True,Oral semaglutide 25 mg group,treatment,534,1.0,0.0,Acute pancreatitis,Acute pancreatitis,Pancreatitis,False,,oral semaglutide,False,False,25.0,oral,QD
NCT04707469,Acute pancreatitis,Safety focus areas,True,False,False,False,True,Oral semaglutide 50 mg group,treatment,534,1.0,0.0,Acute pancreatitis,Acute pancreatitis,Pancreatitis,False,,oral semaglutide,False,False,50.0,oral,QD
NCT04707469,Cardiovascular disorders,Safety focus areas,True,False,False,False,True,Oral semaglutide 14 mg group,treatment,534,37.0,7.0,Cardiovascular disorders,Cardiovascular disorders,Cardiovascular disorders,True,other_summary,oral semaglutide,True,True,14.0,oral,QD
NCT04707469,Cardiovascular disorders,Safety focus areas,True,False,False,False,True,Oral semaglutide 25 mg group,treatment,534,42.0,8.0,Cardiovascular disorders,Cardiovascular disorders,Cardiovascular disorders,True,other_summary,oral semaglutide,False,False,25.0,oral,QD
NCT04707469,Cardiovascular disorders,Safety focus areas,True,False,False,False,True,Oral semaglutide 50 mg group,treatment,534,20.0,4.0,Cardiovascular disorders,Cardiovascular disorders,Cardiovascular disorders,True,other_summary,oral semaglutide,False,False,50.0,oral,QD
NCT04707469,Malignant neoplasm,Safety focus areas,True,False,False,False,True,Oral semaglutide 14 mg group,treatment,534,6.0,1.0,Malignant neoplasm,Malignant neoplasm,Cancer,False,,oral semaglutide,True,True,14.0,oral,QD
NCT04707469,Malignant neoplasm,Safety focus areas,True,False,False,False,True,Oral semaglutide 25 mg group,treatment,534,9.0,2.0,Malignant neoplasm,Malignant neoplasm,Cancer,False,,oral semaglutide,False,False,25.0,oral,QD
NCT04707469,Malignant neoplasm,Safety focus areas,True,False,False,False,True,Oral semaglutide 50 mg group,treatment,534,6.0,1.0,Malignant neoplasm,Malignant neoplasm,Cancer,False,,oral semaglutide,False,False,50.0,oral,QD
NCT04707469,Thyroid cancer,Safety focus areas,True,False,False,False,True,Oral semaglutide 14 mg group,treatment,534,0.0,0.0,Thyroid cancer,Thyroid cancer,Thyroid cancer,False,,oral semaglutide,True,True,14.0,oral,QD
NCT04707469,Thyroid cancer,Safety focus areas,True,False,False,False,True,Oral semaglutide 25 mg group,treatment,534,0.0,0.0,Thyroid cancer,Thyroid cancer,Thyroid cancer,False,,oral semaglutide,False,False,25.0,oral,QD
NCT04707469,Thyroid cancer,Safety focus areas,True,False,False,False,True,Oral semaglutide 50 mg group,treatment,534,0.0,0.0,Thyroid cancer,Thyroid cancer,Thyroid cancer,False,,oral semaglutide,False,False,50.0,oral,QD
NCT04707469,Diabetic retinopathy,Safety focus areas,True,False,False,False,True,Oral semaglutide 14 mg group,treatment,534,67.0,13.0,Diabetic retinopathy,Diabetic retinopathy,Diabetic retinopathy,False,,oral semaglutide,True,True,14.0,oral,QD
NCT04707469,Diabetic retinopathy,Safety focus areas,True,False,False,False,True,Oral semaglutide 25 mg group,treatment,534,53.0,10.0,Diabetic retinopathy,Diabetic retinopathy,Diabetic retinopathy,False,,oral semaglutide,False,False,25.0,oral,QD
NCT04707469,Diabetic retinopathy,Safety focus areas,True,False,False,False,True,Oral semaglutide 50 mg group,treatment,534,60.0,11.0,Diabetic retinopathy,Diabetic retinopathy,Diabetic retinopathy,False,,oral semaglutide,False,False,50.0,oral,QD
Exenatide (Exendin-4)_7,Nausea,Adverse events with an overall incidence ≥5% in any treatment arm,True,False,False,True,False,Placebo,control,113,26.0,23.0,Nausea,Nausea,Nausea,False,,Exenatide (Exendin-4),False,False,,,
Exenatide (Exendin-4)_7,Nausea,Adverse events with an overall incidence ≥5% in any treatment arm,True,False,False,True,False,5-µg exenatide,treatment,110,40.0,36.0,Nausea,Nausea,Nausea,False,,Exenatide (Exendin-4),True,True,0.005,SC,BID
Exenatide (Exendin-4)_7,Nausea,Adverse events with an overall incidence ≥5% in any treatment arm,True,False,False,True,False,10-µg exenatide,treatment,113,51.0,45.0,Nausea,Nausea,Nausea,False,,Exenatide (Exendin-4),True,True,0.01,SC,BID
Exenatide (Exendin-4)_7,Diarrhea,Adverse events with an overall incidence ≥5% in any treatment arm,True,False,False,False,False,Placebo,control,113,9.0,8.0,Diarrhea,Diarrhea,Diarrhea,False,,Exenatide (Exendin-4),False,False,,,
Exenatide (Exendin-4)_7,Diarrhea,Adverse events with an overall incidence ≥5% in any treatment arm,True,False,False,False,False,5-µg exenatide,treatment,110,13.0,12.0,Diarrhea,Diarrhea,Diarrhea,False,,Exenatide (Exendin-4),True,True,0.005,SC,BID
Exenatide (Exendin-4)_7,Diarrhea,Adverse events with an overall incidence ≥5% in any treatment arm,True,False,False,False,False,10-µg exenatide,treatment,113,18.0,16.0,Diarrhea,Diarrhea,Diarrhea,False,,Exenatide (Exendin-4),True,True,0.01,SC,BID
Exenatide (Exendin-4)_7,Upper respiratory tract infection,Adverse events with an overall incidence ≥5% in any treatment arm,True,False,False,False,False,Placebo,control,113,12.0,11.0,Upper respiratory tract infection,Upper respiratory tract infection,Upper respiratory tract infection,False,,Exenatide (Exendin-4),False,False,,,
Exenatide (Exendin-4)_7,Upper respiratory tract infection,Adverse events with an overall incidence ≥5% in any treatment arm,True,False,False,False,False,5-µg exenatide,treatment,110,15.0,14.0,Upper respiratory tract infection,Upper respiratory tract infection,Upper respiratory tract infection,False,,Exenatide (Exendin-4),True,True,0.005,SC,BID
Exenatide (Exendin-4)_7,Upper respiratory tract infection,Adverse events with an overall incidence ≥5% in any treatment arm,True,False,False,False,False,10-µg exenatide,treatment,113,11.0,10.0,Upper respiratory tract infection,Upper respiratory tract infection,Upper respiratory tract infection,False,,Exenatide (Exendin-4),True,True,0.01,SC,BID
Exenatide (Exendin-4)_7,Vomiting,Adverse events with an overall incidence ≥5% in any treatment arm,True,False,False,False,False,Placebo,control,113,4.0,4.0,Vomiting,Vomiting,Vomiting,False,,Exenatide (Exendin-4),False,False,,,
Exenatide (Exendin-4)_7,Vomiting,Adverse events with an overall incidence ≥5% in any treatment arm,True,False,False,False,False,5-µg exenatide,treatment,110,12.0,11.0,Vomiting,Vomiting,Vomiting,False,,Exenatide (Exendin-4),True,True,0.005,SC,BID
Exenatide (Exendin-4)_7,Vomiting,Adverse events with an overall incidence ≥5% in any treatment arm,True,False,False,False,False,10-µg exenatide,treatment,113,13.0,12.0,Vomiting,Vomiting,Vomiting,False,,Exenatide (Exendin-4),True,True,0.01,SC,BID
Exenatide (Exendin-4)_7,Dizziness,Adverse events with an overall incidence ≥5% in any treatment arm,True,False,False,False,False,Placebo,control,113,7.0,6.0,Dizziness,Dizziness,Dizziness,False,,Exenatide (Exendin-4),False,False,,,
Exenatide (Exendin-4)_7,Dizziness,Adverse events with an overall incidence ≥5% in any treatment arm,True,False,False,False,False,5-µg exenatide,treatment,110,10.0,9.0,Dizziness,Dizziness,Dizziness,False,,Exenatide (Exendin-4),True,True,0.005,SC,BID
Exenatide (Exendin-4)_7,Dizziness,Adverse events with an overall incidence ≥5% in any treatment arm,True,False,False,False,False,10-µg exenatide,treatment,113,5.0,4.0,Dizziness,Dizziness,Dizziness,False,,Exenatide (Exendin-4),True,True,0.01,SC,BID
Exenatide (Exendin-4)_7,Sinusitis,Adverse events with an overall incidence ≥5% in any treatment arm,True,False,False,False,False,Placebo,control,113,6.0,5.0,Sinusitis,Sinusitis,Sinusitis,False,,Exenatide (Exendin-4),False,False,,,
Exenatide (Exendin-4)_7,Sinusitis,Adverse events with an overall incidence ≥5% in any treatment arm,True,False,False,False,False,5-µg exenatide,treatment,110,5.0,5.0,Sinusitis,Sinusitis,Sinusitis,False,,Exenatide (Exendin-4),True,True,0.005,SC,BID
Exenatide (Exendin-4)_7,Sinusitis,Adverse events with an overall incidence ≥5% in any treatment arm,True,False,False,False,False,10-µg exenatide,treatment,113,7.0,6.0,Sinusitis,Sinusitis,Sinusitis,False,,Exenatide (Exendin-4),True,True,0.01,SC,BID
Exenatide (Exendin-4)_7,Hypoglycemia,Adverse events with an overall incidence ≥5% in any treatment arm,True,False,False,False,False,Placebo,control,113,6.0,5.0,Hypoglycemia,Hypoglycemia,Hypoglycemia,False,,Exenatide (Exendin-4),False,False,,,
Exenatide (Exendin-4)_7,Hypoglycemia,Adverse events with an overall incidence ≥5% in any treatment arm,True,False,False,False,False,5-µg exenatide,treatment,110,5.0,5.0,Hypoglycemia,Hypoglycemia,Hypoglycemia,False,,Exenatide (Exendin-4),True,True,0.005,SC,BID
Exenatide (Exendin-4)_7,Hypoglycemia,Adverse events with an overall incidence ≥5% in any treatment arm,True,False,False,False,False,10-µg exenatide,treatment,113,6.0,5.0,Hypoglycemia,Hypoglycemia,Hypoglycemia,False,,Exenatide (Exendin-4),True,True,0.01,SC,BID
Exenatide (Exendin-4)_7,Back pain,Adverse events with an overall incidence ≥5% in any treatment arm,True,False,False,False,False,Placebo,control,113,3.0,3.0,Back pain,Back pain,Musculoskeletal pain,False,,Exenatide (Exendin-4),False,False,,,
Exenatide (Exendin-4)_7,Back pain,Adverse events with an overall incidence ≥5% in any treatment arm,True,False,False,False,False,5-µg exenatide,treatment,110,3.0,3.0,Back pain,Back pain,Musculoskeletal pain,False,,Exenatide (Exendin-4),True,True,0.005,SC,BID
Exenatide (Exendin-4)_7,Back pain,Adverse events with an overall incidence ≥5% in any treatment arm,True,False,False,False,False,10-µg exenatide,treatment,113,7.0,6.0,Back pain,Back pain,Musculoskeletal pain,False,,Exenatide (Exendin-4),True,True,0.01,SC,BID
NCT04944992,Adverse events,Adverse events,True,False,False,False,False,Efinopegdutide,treatment,72,64.0,88.9,Adverse events,Any adverse event,Any adverse event,True,any_ae,Efinopegdutide,False,False,,,
NCT04944992,Drug-related adverse events,Drug-related adverse events,True,False,False,False,False,Efinopegdutide,treatment,72,46.0,63.9,Drug-related adverse events,Drug-related adverse events,Drug-related adverse events,True,other_summary,Efinopegdutide,False,False,,,
NCT04944992,Serious adverse events,Serious adverse events,False,True,False,False,False,Efinopegdutide,treatment,72,1.0,1.4,Serious adverse events,Serious adverse events,Serious adverse events,True,serious_ae,Efinopegdutide,False,False,,,
NCT04944992,Serious drug-related adverse events,Serious drug-related adverse events,False,True,False,False,False,Efinopegdutide,treatment,72,0.0,0.0,Serious drug-related adverse events,Serious drug-related adverse events,Serious adverse events,True,serious_ae,Efinopegdutide,False,False,,,
NCT04944992,Deaths,Deaths,False,False,True,False,False,Efinopegdutide,treatment,72,0.0,0.0,Deaths,Death,Fatal adverse events,True,fatal_ae,Efinopegdutide,False,False,,,
NCT04944992,Discontinued drug due to an adverse event,Discontinued drug due to an adverse event,False,False,False,True,False,Efinopegdutide,treatment,72,4.0,5.6,Discontinued drug due to an adverse event,Adverse event leading to discontinuation,Adverse event leading to discontinuation,True,ae_leading_to_discontinuation,Efinopegdutide,False,False,,,
NCT04944992,Discontinued drug due to a drug-related adverse event,Discontinued drug due to a drug-related adverse event,False,False,False,True,False,Efinopegdutide,treatment,72,3.0,4.2,Discontinued drug due to a drug-related adverse event,Adverse event leading to discontinuation,Adverse event leading to discontinuation,True,ae_leading_to_discontinuation,Efinopegdutide,False,False,,,
NCT04944992,Gastrointestinal adverse events: Abdominal pain,Gastrointestinal adverse events,True,False,False,False,False,Efinopegdutide,treatment,72,9.0,12.5,Gastrointestinal adverse events: Abdominal pain,Abdominal pain,Abdominal pain,False,,Efinopegdutide,False,False,,,
NCT04944992,Gastrointestinal adverse events: Constipation,Gastrointestinal adverse events,True,False,False,False,False,Efinopegdutide,treatment,72,12.0,16.7,Gastrointestinal adverse events: Constipation,Constipation,Constipation,False,,Efinopegdutide,False,False,,,
NCT04944992,Gastrointestinal adverse events: Nausea,Gastrointestinal adverse events,True,False,False,False,False,Efinopegdutide,treatment,72,20.0,27.8,Gastrointestinal adverse events: Nausea,Nausea,Nausea,False,,Efinopegdutide,False,False,,,
NCT00688701,Any TEAE,Adverse events reported in ≥5% of participants,True,False,False,False,False,Placebo combined,control,122,55.0,45.1,Any TEAE,Any adverse event,Any adverse event,True,any_ae,Lixisenatide,False,False,,,
NCT00688701,Any TEAE,Adverse events reported in ≥5% of participants,True,False,False,False,False,Lixisenatide 2-step,treatment,120,63.0,52.5,Any TEAE,Any adverse event,Any adverse event,True,any_ae,Lixisenatide,True,True,,SC,QD
NCT00688701,Any TEAE,Adverse events reported in ≥5% of participants,True,False,False,False,False,Lixisenatide 1-step,treatment,119,65.0,54.6,Any TEAE,Any adverse event,Any adverse event,True,any_ae,Lixisenatide,True,True,,SC,QD
NCT00688701,Any serious TEAE,Adverse events reported in ≥5% of participants,False,True,False,False,False,Placebo combined,control,122,5.0,4.1,Any serious TEAE,Serious adverse events,Serious adverse events,True,serious_ae,Lixisenatide,False,False,,,
NCT00688701,Any serious TEAE,Adverse events reported in ≥5% of participants,False,True,False,False,False,Lixisenatide 2-step,treatment,120,1.0,0.8,Any serious TEAE,Serious adverse events,Serious adverse events,True,serious_ae,Lixisenatide,True,True,,SC,QD
NCT00688701,Any serious TEAE,Adverse events reported in ≥5% of participants,False,True,False,False,False,Lixisenatide 1-step,treatment,119,0.0,0.0,Any serious TEAE,Serious adverse events,Serious adverse events,True,serious_ae,Lixisenatide,True,True,,SC,QD
NCT00688701,Discontinuation as a result of a TEAE,Adverse events reported in ≥5% of participants,False,False,False,True,False,Placebo combined,control,122,1.0,0.8,Discontinuation as a result of a TEAE,Adverse event leading to discontinuation,Adverse event leading to discontinuation,True,ae_leading_to_discontinuation,Lixisenatide,False,False,,,
NCT00688701,Discontinuation as a result of a TEAE,Adverse events reported in ≥5% of participants,False,False,False,True,False,Lixisenatide 2-step,treatment,120,5.0,4.2,Discontinuation as a result of a TEAE,Adverse event leading to discontinuation,Adverse event leading to discontinuation,True,ae_leading_to_discontinuation,Lixisenatide,True,True,,SC,QD
NCT00688701,Discontinuation as a result of a TEAE,Adverse events reported in ≥5% of participants,False,False,False,True,False,Lixisenatide 1-step,treatment,119,3.0,2.5,Discontinuation as a result of a TEAE,Adverse event leading to discontinuation,Adverse event leading to discontinuation,True,ae_leading_to_discontinuation,Lixisenatide,True,True,,SC,QD
NCT00688701,Gastrointestinal disorders (any),Adverse events reported in ≥5% of participants,True,False,False,False,False,Placebo combined,control,122,17.0,13.9,Gastrointestinal disorders (any),Gastrointestinal disorders (any),Gastrointestinal disorders (any),True,other_summary,Lixisenatide,False,False,,,
NCT00688701,Gastrointestinal disorders (any),Adverse events reported in ≥5% of participants,True,False,False,False,False,Lixisenatide 2-step,treatment,120,39.0,32.5,Gastrointestinal disorders (any),Gastrointestinal disorders (any),Gastrointestinal disorders (any),True,other_summary,Lixisenatide,True,True,,SC,QD
NCT00688701,Gastrointestinal disorders (any),Adverse events reported in ≥5% of participants,True,False,False,False,False,Lixisenatide 1-step,treatment,119,38.0,31.9,Gastrointestinal disorders (any),Gastrointestinal disorders (any),Gastrointestinal disorders (any),True,other_summary,Lixisenatide,True,True,,SC,QD
NCT00688701,Nausea,Adverse events reported in ≥5% of participants,True,False,False,False,False,Placebo combined,control,122,5.0,4.1,Nausea,Nausea,Nausea,False,,Lixisenatide,False,False,,,
NCT00688701,Nausea,Adverse events reported in ≥5% of participants,True,False,False,False,False,Lixisenatide 2-step,treatment,120,29.0,24.2,Nausea,Nausea,Nausea,False,,Lixisenatide,True,True,,SC,QD
NCT00688701,Nausea,Adverse events reported in ≥5% of participants,True,False,False,False,False,Lixisenatide 1-step,treatment,119,24.0,20.2,Nausea,Nausea,Nausea,False,,Lixisenatide,True,True,,SC,QD
NCT00688701,Headache,Adverse events reported in ≥5% of participants,True,False,False,False,False,Placebo combined,control,122,14.0,11.5,Headache,Headache,Headache,False,,Lixisenatide,False,False,,,
NCT00688701,Headache,Adverse events reported in ≥5% of participants,True,False,False,False,False,Lixisenatide 2-step,treatment,120,10.0,8.3,Headache,Headache,Headache,False,,Lixisenatide,True,True,,SC,QD
NCT00688701,Headache,Adverse events reported in ≥5% of participants,True,False,False,False,False,Lixisenatide 1-step,treatment,119,9.0,7.6,Headache,Headache,Headache,False,,Lixisenatide,True,True,,SC,QD
NCT00688701,Vomiting,Adverse events reported in ≥5% of participants,True,False,False,False,False,Placebo combined,control,122,0.0,0.0,Vomiting,Vomiting,Vomiting,False,,Lixisenatide,False,False,,,
NCT00688701,Vomiting,Adverse events reported in ≥5% of participants,True,False,False,False,False,Lixisenatide 2-step,treatment,120,9.0,7.5,Vomiting,Vomiting,Vomiting,False,,Lixisenatide,True,True,,SC,QD
NCT00688701,Vomiting,Adverse events reported in ≥5% of participants,True,False,False,False,False,Lixisenatide 1-step,treatment,119,8.0,6.7,Vomiting,Vomiting,Vomiting,False,,Lixisenatide,True,True,,SC,QD
NCT00688701,Dizziness,Adverse events reported in ≥5% of participants,True,False,False,False,False,Placebo combined,control,122,3.0,2.5,Dizziness,Dizziness,Dizziness,False,,Lixisenatide,False,False,,,
NCT00688701,Dizziness,Adverse events reported in ≥5% of participants,True,False,False,False,False,Lixisenatide 2-step,treatment,120,9.0,7.5,Dizziness,Dizziness,Dizziness,False,,Lixisenatide,True,True,,SC,QD
NCT00688701,Dizziness,Adverse events reported in ≥5% of participants,True,False,False,False,False,Lixisenatide 1-step,treatment,119,4.0,3.4,Dizziness,Dizziness,Dizziness,False,,Lixisenatide,True,True,,SC,QD
NCT00688701,Nasopharyngitis,Adverse events reported in ≥5% of participants,True,False,False,False,False,Placebo combined,control,122,4.0,3.3,Nasopharyngitis,Nasopharyngitis,Nasopharyngitis,False,,Lixisenatide,False,False,,,
NCT00688701,Nasopharyngitis,Adverse events reported in ≥5% of participants,True,False,False,False,False,Lixisenatide 2-step,treatment,120,6.0,5.0,Nasopharyngitis,Nasopharyngitis,Nasopharyngitis,False,,Lixisenatide,True,True,,SC,QD
NCT00688701,Nasopharyngitis,Adverse events reported in ≥5% of participants,True,False,False,False,False,Lixisenatide 1-step,treatment,119,5.0,4.2,Nasopharyngitis,Nasopharyngitis,Nasopharyngitis,False,,Lixisenatide,True,True,,SC,QD
NCT00688701,Symptomatic hypoglycemia,Adverse events reported in ≥5% of participants,True,False,False,False,False,Placebo combined,control,122,2.0,1.6,Symptomatic hypoglycemia,Symptomatic hypoglycemia,Hypoglycemia,False,,Lixisenatide,False,False,,,
NCT00688701,Symptomatic hypoglycemia,Adverse events reported in ≥5% of participants,True,False,False,False,False,Lixisenatide 2-step,treatment,120,3.0,2.5,Symptomatic hypoglycemia,Symptomatic hypoglycemia,Hypoglycemia,False,,Lixisenatide,True,True,,SC,QD
NCT00688701,Symptomatic hypoglycemia,Adverse events reported in ≥5% of participants,True,False,False,False,False,Lixisenatide 1-step,treatment,119,1.0,0.8,Symptomatic hypoglycemia,Symptomatic hypoglycemia,Hypoglycemia,False,,Lixisenatide,True,True,,SC,QD
NCT00308139,Upper respiratory tract infection,Treatment-emergent adverse events >5% incidence during open-ended assessment period,True,False,False,False,False,Exenatide QW,treatment,128,16.0,12.5,Upper respiratory tract infection,Upper respiratory tract infection,Upper respiratory tract infection,False,,Exenatide,True,True,,SC,QW
NCT00308139,Upper respiratory tract infection,Treatment-emergent adverse events >5% incidence during open-ended assessment period,True,False,False,False,False,Exenatide BID -> Exenatide QW,treatment,130,16.0,12.3,Upper respiratory tract infection,Upper respiratory tract infection,Upper respiratory tract infection,False,,Exenatide,True,True,,SC,
NCT00308139,Diarrhea,Treatment-emergent adverse events >5% incidence during open-ended assessment period,True,False,False,False,False,Exenatide QW,treatment,128,11.0,8.6,Diarrhea,Diarrhea,Diarrhea,False,,Exenatide,True,True,,SC,QW
NCT00308139,Diarrhea,Treatment-emergent adverse events >5% incidence during open-ended assessment period,True,False,False,False,False,Exenatide BID -> Exenatide QW,treatment,130,9.0,6.9,Diarrhea,Diarrhea,Diarrhea,False,,Exenatide,True,True,,SC,
NCT00308139,Nausea,Treatment-emergent adverse events >5% incidence during open-ended assessment period,True,False,False,False,False,Exenatide QW,treatment,128,9.0,7.0,Nausea,Nausea,Nausea,False,,Exenatide,True,True,,SC,QW
NCT00308139,Nausea,Treatment-emergent adverse events >5% incidence during open-ended assessment period,True,False,False,False,False,Exenatide BID -> Exenatide QW,treatment,130,10.0,7.7,Nausea,Nausea,Nausea,False,,Exenatide,True,True,,SC,
NCT00308139,Nasopharyngitis,Treatment-emergent adverse events >5% incidence during open-ended assessment period,True,False,False,False,False,Exenatide QW,treatment,128,10.0,7.8,Nasopharyngitis,Nasopharyngitis,Nasopharyngitis,False,,Exenatide,True,True,,SC,QW
NCT00308139,Sinusitis,Treatment-emergent adverse events >5% incidence during open-ended assessment period,True,False,False,False,False,Exenatide BID -> Exenatide QW,treatment,130,9.0,6.9,Sinusitis,Sinusitis,Sinusitis,False,,Exenatide,True,True,,SC,
NCT00308139,Vomiting,Treatment-emergent adverse events >5% incidence during open-ended assessment period,True,False,False,False,False,Exenatide QW,treatment,128,8.0,6.3,Vomiting,Vomiting,Vomiting,False,,Exenatide,True,True,,SC,QW
NCT00308139,Urinary tract infection,Treatment-emergent adverse events >5% incidence during open-ended assessment period,True,False,False,False,False,Exenatide BID -> Exenatide QW,treatment,130,7.0,5.4,Urinary tract infection,Urinary tract infection,Urinary tract infection,False,,Exenatide,True,True,,SC,
NCT00308139,Injection site bruising,Treatment-emergent adverse events >5% incidence during open-ended assessment period,True,False,False,False,False,Exenatide BID -> Exenatide QW,treatment,130,7.0,5.4,Injection site bruising,Injection-site bruising,Injection-site reactions,False,,Exenatide,True,True,,SC,
NCT05669599,Any adverse event,Overall,True,False,False,False,False,140 mg Every 4 Wk,treatment,77,73.0,95.0,Any adverse event,Any adverse event,Any adverse event,True,any_ae,Maridebart Cafraglutide,False,False,140.0,SC,Q4W
NCT05669599,Any adverse event,Overall,True,False,False,False,False,280 mg Every 4 Wk,treatment,77,75.0,97.0,Any adverse event,Any adverse event,Any adverse event,True,any_ae,Maridebart Cafraglutide,False,False,280.0,SC,Q4W
NCT05669599,Any adverse event,Overall,True,False,False,False,False,420 mg Every 4 Wk,treatment,79,78.0,99.0,Any adverse event,Any adverse event,Any adverse event,True,any_ae,Maridebart Cafraglutide,False,False,420.0,SC,Q4W
NCT05669599,Any adverse event,Overall,True,False,False,False,False,420 mg Every 8 Wk,treatment,51,49.0,96.0,Any adverse event,Any adverse event,Any adverse event,True,any_ae,Maridebart Cafraglutide,False,False,420.0,SC,Q8W
NCT05669599,Any adverse event,Overall,True,False,False,False,False,"420 mg Every 4 Wk, with 4-Wk DE",treatment,51,46.0,90.0,Any adverse event,Any adverse event,Any adverse event,True,any_ae,Maridebart Cafraglutide,False,False,420.0,SC,Q4W
NCT05669599,Any adverse event,Overall,True,False,False,False,False,"420 mg Every 4 Wk, with 12-Wk DE",treatment,52,49.0,94.0,Any adverse event,Any adverse event,Any adverse event,True,any_ae,Maridebart Cafraglutide,False,False,420.0,SC,Q4W
NCT05669599,Any adverse event,Overall,True,False,False,False,False,Placebo,control,76,52.0,68.0,Any adverse event,Any adverse event,Any adverse event,True,any_ae,Maridebart Cafraglutide,False,False,,,
NCT05669599,Any adverse event,Overall,True,False,False,False,False,140 mg Every 4 Wk,treatment,31,29.0,94.0,Any adverse event,Any adverse event,Any adverse event,True,any_ae,Maridebart Cafraglutide,False,False,140.0,SC,Q4W
NCT05669599,Any adverse event,Overall,True,False,False,False,False,280 mg Every 4 Wk,treatment,32,29.0,91.0,Any adverse event,Any adverse event,Any adverse event,True,any_ae,Maridebart Cafraglutide,False,False,280.0,SC,Q4W
NCT05669599,Any adverse event,Overall,True,False,False,False,False,420 mg Every 4 Wk,treatment,32,31.0,97.0,Any adverse event,Any adverse event,Any adverse event,True,any_ae,Maridebart Cafraglutide,False,False,420.0,SC,Q4W
NCT05669599,Any adverse event,Overall,True,False,False,False,False,Placebo,control,32,26.0,81.0,Any adverse event,Any adverse event,Any adverse event,True,any_ae,Maridebart Cafraglutide,False,False,,,
NCT05669599,Serious adverse event,Overall,False,True,False,False,False,140 mg Every 4 Wk,treatment,77,4.0,5.0,Serious adverse event,Serious adverse events,Serious adverse events,True,serious_ae,Maridebart Cafraglutide,False,False,140.0,SC,Q4W
NCT05669599,Serious adverse event,Overall,False,True,False,False,False,280 mg Every 4 Wk,treatment,77,4.0,5.0,Serious adverse event,Serious adverse events,Serious adverse events,True,serious_ae,Maridebart Cafraglutide,False,False,280.0,SC,Q4W
NCT05669599,Serious adverse event,Overall,False,True,False,False,False,420 mg Every 4 Wk,treatment,79,5.0,6.0,Serious adverse event,Serious adverse events,Serious adverse events,True,serious_ae,Maridebart Cafraglutide,False,False,420.0,SC,Q4W
NCT05669599,Serious adverse event,Overall,False,True,False,False,False,420 mg Every 8 Wk,treatment,51,7.0,14.0,Serious adverse event,Serious adverse events,Serious adverse events,True,serious_ae,Maridebart Cafraglutide,False,False,420.0,SC,Q8W
NCT05669599,Serious adverse event,Overall,False,True,False,False,False,"420 mg Every 4 Wk, with 4-Wk DE",treatment,51,0.0,0.0,Serious adverse event,Serious adverse events,Serious adverse events,True,serious_ae,Maridebart Cafraglutide,False,False,420.0,SC,Q4W
NCT05669599,Serious adverse event,Overall,False,True,False,False,False,"420 mg Every 4 Wk, with 12-Wk DE",treatment,52,3.0,6.0,Serious adverse event,Serious adverse events,Serious adverse events,True,serious_ae,Maridebart Cafraglutide,False,False,420.0,SC,Q4W
NCT05669599,Serious adverse event,Overall,False,True,False,False,False,Placebo,control,76,5.0,7.0,Serious adverse event,Serious adverse events,Serious adverse events,True,serious_ae,Maridebart Cafraglutide,False,False,,,
NCT05669599,Serious adverse event,Overall,False,True,False,False,False,140 mg Every 4 Wk,treatment,31,1.0,3.0,Serious adverse event,Serious adverse events,Serious adverse events,True,serious_ae,Maridebart Cafraglutide,False,False,140.0,SC,Q4W
NCT05669599,Serious adverse event,Overall,False,True,False,False,False,280 mg Every 4 Wk,treatment,32,2.0,6.0,Serious adverse event,Serious adverse events,Serious adverse events,True,serious_ae,Maridebart Cafraglutide,False,False,280.0,SC,Q4W
NCT05669599,Serious adverse event,Overall,False,True,False,False,False,420 mg Every 4 Wk,treatment,32,4.0,12.0,Serious adverse event,Serious adverse events,Serious adverse events,True,serious_ae,Maridebart Cafraglutide,False,False,420.0,SC,Q4W
NCT05669599,Serious adverse event,Overall,False,True,False,False,False,Placebo,control,32,0.0,0.0,Serious adverse event,Serious adverse events,Serious adverse events,True,serious_ae,Maridebart Cafraglutide,False,False,,,
NCT05669599,Death,Overall,False,False,True,False,False,"420 mg Every 4 Wk, with 12-Wk DE",treatment,52,1.0,2.0,Death,Death,Fatal adverse events,True,fatal_ae,Maridebart Cafraglutide,False,False,420.0,SC,Q4W
NCT05669599,Death,Overall,False,False,True,False,False,280 mg Every 4 Wk,treatment,32,1.0,3.0,Death,Death,Fatal adverse events,True,fatal_ae,Maridebart Cafraglutide,False,False,280.0,SC,Q4W
NCT05669599,Adverse events leading to discontinuation of trial regimen,Overall,False,False,False,True,False,140 mg Every 4 Wk,treatment,77,11.0,14.0,Adverse events leading to discontinuation of trial regimen,Adverse events leading to discontinuation,Adverse event leading to discontinuation,True,ae_leading_to_discontinuation,Maridebart Cafraglutide,False,False,140.0,SC,Q4W
NCT05669599,Adverse events leading to discontinuation of trial regimen,Overall,False,False,False,True,False,280 mg Every 4 Wk,treatment,77,11.0,14.0,Adverse events leading to discontinuation of trial regimen,Adverse events leading to discontinuation,Adverse event leading to discontinuation,True,ae_leading_to_discontinuation,Maridebart Cafraglutide,False,False,280.0,SC,Q4W
NCT05669599,Adverse events leading to discontinuation of trial regimen,Overall,False,False,False,True,False,420 mg Every 4 Wk,treatment,79,17.0,22.0,Adverse events leading to discontinuation of trial regimen,Adverse events leading to discontinuation,Adverse event leading to discontinuation,True,ae_leading_to_discontinuation,Maridebart Cafraglutide,False,False,420.0,SC,Q4W
NCT05669599,Adverse events leading to discontinuation of trial regimen,Overall,False,False,False,True,False,420 mg Every 8 Wk,treatment,51,15.0,29.0,Adverse events leading to discontinuation of trial regimen,Adverse events leading to discontinuation,Adverse event leading to discontinuation,True,ae_leading_to_discontinuation,Maridebart Cafraglutide,False,False,420.0,SC,Q8W
NCT05669599,Adverse events leading to discontinuation of trial regimen,Overall,False,False,False,True,False,"420 mg Every 4 Wk, with 4-Wk DE",treatment,51,5.0,10.0,Adverse events leading to discontinuation of trial regimen,Adverse events leading to discontinuation,Adverse event leading to discontinuation,True,ae_leading_to_discontinuation,Maridebart Cafraglutide,False,False,420.0,SC,Q4W
NCT05669599,Adverse events leading to discontinuation of trial regimen,Overall,False,False,False,True,False,"420 mg Every 4 Wk, with 12-Wk DE",treatment,52,6.0,12.0,Adverse events leading to discontinuation of trial regimen,Adverse events leading to discontinuation,Adverse event leading to discontinuation,True,ae_leading_to_discontinuation,Maridebart Cafraglutide,False,False,420.0,SC,Q4W
NCT05669599,Adverse events leading to discontinuation of trial regimen,Overall,False,False,False,True,False,Placebo,control,76,1.0,1.0,Adverse events leading to discontinuation of trial regimen,Adverse events leading to discontinuation,Adverse event leading to discontinuation,True,ae_leading_to_discontinuation,Maridebart Cafraglutide,False,False,,,
NCT05669599,Adverse events leading to discontinuation of trial regimen,Overall,False,False,False,True,False,140 mg Every 4 Wk,treatment,31,4.0,13.0,Adverse events leading to discontinuation of trial regimen,Adverse events leading to discontinuation,Adverse event leading to discontinuation,True,ae_leading_to_discontinuation,Maridebart Cafraglutide,False,False,140.0,SC,Q4W
NCT05669599,Adverse events leading to discontinuation of trial regimen,Overall,False,False,False,True,False,280 mg Every 4 Wk,treatment,32,6.0,19.0,Adverse events leading to discontinuation of trial regimen,Adverse events leading to discontinuation,Adverse event leading to discontinuation,True,ae_leading_to_discontinuation,Maridebart Cafraglutide,False,False,280.0,SC,Q4W
NCT05669599,Adverse events leading to discontinuation of trial regimen,Overall,False,False,False,True,False,420 mg Every 4 Wk,treatment,32,5.0,16.0,Adverse events leading to discontinuation of trial regimen,Adverse events leading to discontinuation,Adverse event leading to discontinuation,True,ae_leading_to_discontinuation,Maridebart Cafraglutide,False,False,420.0,SC,Q4W
NCT05669599,Adverse events leading to discontinuation of trial regimen,Overall,False,False,False,True,False,Placebo,control,32,1.0,3.0,Adverse events leading to discontinuation of trial regimen,Adverse events leading to discontinuation,Adverse event leading to discontinuation,True,ae_leading_to_discontinuation,Maridebart Cafraglutide,False,False,,,
NCT05669599,Gastrointestinal adverse event leading to discontinuation,Overall,False,False,False,True,False,140 mg Every 4 Wk,treatment,77,10.0,13.0,Gastrointestinal adverse event leading to discontinuation,Gastrointestinal AE leading to discontinuation,Adverse event leading to discontinuation,True,ae_leading_to_discontinuation,Maridebart Cafraglutide,False,False,140.0,SC,Q4W
NCT05669599,Gastrointestinal adverse event leading to discontinuation,Overall,False,False,False,True,False,280 mg Every 4 Wk,treatment,77,9.0,12.0,Gastrointestinal adverse event leading to discontinuation,Gastrointestinal AE leading to discontinuation,Adverse event leading to discontinuation,True,ae_leading_to_discontinuation,Maridebart Cafraglutide,False,False,280.0,SC,Q4W
NCT05669599,Gastrointestinal adverse event leading to discontinuation,Overall,False,False,False,True,False,420 mg Every 4 Wk,treatment,79,13.0,16.0,Gastrointestinal adverse event leading to discontinuation,Gastrointestinal AE leading to discontinuation,Adverse event leading to discontinuation,True,ae_leading_to_discontinuation,Maridebart Cafraglutide,False,False,420.0,SC,Q4W
NCT05669599,Gastrointestinal adverse event leading to discontinuation,Overall,False,False,False,True,False,420 mg Every 8 Wk,treatment,51,14.0,27.0,Gastrointestinal adverse event leading to discontinuation,Gastrointestinal AE leading to discontinuation,Adverse event leading to discontinuation,True,ae_leading_to_discontinuation,Maridebart Cafraglutide,False,False,420.0,SC,Q8W
NCT05669599,Gastrointestinal adverse event leading to discontinuation,Overall,False,False,False,True,False,"420 mg Every 4 Wk, with 4-Wk DE",treatment,51,4.0,8.0,Gastrointestinal adverse event leading to discontinuation,Gastrointestinal AE leading to discontinuation,Adverse event leading to discontinuation,True,ae_leading_to_discontinuation,Maridebart Cafraglutide,False,False,420.0,SC,Q4W
NCT05669599,Gastrointestinal adverse event leading to discontinuation,Overall,False,False,False,True,False,"420 mg Every 4 Wk, with 12-Wk DE",treatment,52,4.0,8.0,Gastrointestinal adverse event leading to discontinuation,Gastrointestinal AE leading to discontinuation,Adverse event leading to discontinuation,True,ae_leading_to_discontinuation,Maridebart Cafraglutide,False,False,420.0,SC,Q4W
NCT05669599,Gastrointestinal adverse event leading to discontinuation,Overall,False,False,False,True,False,Placebo,control,76,0.0,0.0,Gastrointestinal adverse event leading to discontinuation,Gastrointestinal AE leading to discontinuation,Adverse event leading to discontinuation,True,ae_leading_to_discontinuation,Maridebart Cafraglutide,False,False,,,
NCT05669599,Gastrointestinal adverse event leading to discontinuation,Overall,False,False,False,True,False,140 mg Every 4 Wk,treatment,31,2.0,6.0,Gastrointestinal adverse event leading to discontinuation,Gastrointestinal AE leading to discontinuation,Adverse event leading to discontinuation,True,ae_leading_to_discontinuation,Maridebart Cafraglutide,False,False,140.0,SC,Q4W
NCT05669599,Gastrointestinal adverse event leading to discontinuation,Overall,False,False,False,True,False,280 mg Every 4 Wk,treatment,32,5.0,16.0,Gastrointestinal adverse event leading to discontinuation,Gastrointestinal AE leading to discontinuation,Adverse event leading to discontinuation,True,ae_leading_to_discontinuation,Maridebart Cafraglutide,False,False,280.0,SC,Q4W
NCT05669599,Gastrointestinal adverse event leading to discontinuation,Overall,False,False,False,True,False,420 mg Every 4 Wk,treatment,32,4.0,12.0,Gastrointestinal adverse event leading to discontinuation,Gastrointestinal AE leading to discontinuation,Adverse event leading to discontinuation,True,ae_leading_to_discontinuation,Maridebart Cafraglutide,False,False,420.0,SC,Q4W
NCT05669599,Gastrointestinal adverse event leading to discontinuation,Overall,False,False,False,True,False,Placebo,control,32,0.0,0.0,Gastrointestinal adverse event leading to discontinuation,Gastrointestinal AE leading to discontinuation,Adverse event leading to discontinuation,True,ae_leading_to_discontinuation,Maridebart Cafraglutide,False,False,,,
NCT05669599,Vomiting,Most frequent adverse events leading to discontinuation,True,False,False,True,False,140 mg Every 4 Wk,treatment,77,9.0,12.0,Vomiting,Vomiting,Vomiting,False,,Maridebart Cafraglutide,False,False,140.0,SC,Q4W
NCT05669599,Vomiting,Most frequent adverse events leading to discontinuation,True,False,False,True,False,280 mg Every 4 Wk,treatment,77,8.0,10.0,Vomiting,Vomiting,Vomiting,False,,Maridebart Cafraglutide,False,False,280.0,SC,Q4W
NCT05669599,Vomiting,Most frequent adverse events leading to discontinuation,True,False,False,True,False,420 mg Every 4 Wk,treatment,79,12.0,15.0,Vomiting,Vomiting,Vomiting,False,,Maridebart Cafraglutide,False,False,420.0,SC,Q4W
NCT05669599,Vomiting,Most frequent adverse events leading to discontinuation,True,False,False,True,False,420 mg Every 8 Wk,treatment,51,12.0,24.0,Vomiting,Vomiting,Vomiting,False,,Maridebart Cafraglutide,False,False,420.0,SC,Q8W
NCT05669599,Vomiting,Most frequent adverse events leading to discontinuation,True,False,False,True,False,"420 mg Every 4 Wk, with 4-Wk DE",treatment,51,3.0,6.0,Vomiting,Vomiting,Vomiting,False,,Maridebart Cafraglutide,False,False,420.0,SC,Q4W
NCT05669599,Vomiting,Most frequent adverse events leading to discontinuation,True,False,False,True,False,"420 mg Every 4 Wk, with 12-Wk DE",treatment,52,1.0,2.0,Vomiting,Vomiting,Vomiting,False,,Maridebart Cafraglutide,False,False,420.0,SC,Q4W
NCT05669599,Vomiting,Most frequent adverse events leading to discontinuation,True,False,False,True,False,Placebo,control,76,0.0,0.0,Vomiting,Vomiting,Vomiting,False,,Maridebart Cafraglutide,False,False,,,
NCT05669599,Vomiting,Most frequent adverse events leading to discontinuation,True,False,False,True,False,140 mg Every 4 Wk,treatment,31,1.0,3.0,Vomiting,Vomiting,Vomiting,False,,Maridebart Cafraglutide,False,False,140.0,SC,Q4W
NCT05669599,Vomiting,Most frequent adverse events leading to discontinuation,True,False,False,True,False,280 mg Every 4 Wk,treatment,32,3.0,9.0,Vomiting,Vomiting,Vomiting,False,,Maridebart Cafraglutide,False,False,280.0,SC,Q4W
NCT05669599,Vomiting,Most frequent adverse events leading to discontinuation,True,False,False,True,False,420 mg Every 4 Wk,treatment,32,4.0,12.0,Vomiting,Vomiting,Vomiting,False,,Maridebart Cafraglutide,False,False,420.0,SC,Q4W
NCT05669599,Vomiting,Most frequent adverse events leading to discontinuation,True,False,False,True,False,Placebo,control,32,0.0,0.0,Vomiting,Vomiting,Vomiting,False,,Maridebart Cafraglutide,False,False,,,
NCT05669599,Nausea,Most frequent adverse events leading to discontinuation,True,False,False,True,False,140 mg Every 4 Wk,treatment,77,6.0,8.0,Nausea,Nausea,Nausea,False,,Maridebart Cafraglutide,False,False,140.0,SC,Q4W
NCT05669599,Nausea,Most frequent adverse events leading to discontinuation,True,False,False,True,False,280 mg Every 4 Wk,treatment,77,7.0,9.0,Nausea,Nausea,Nausea,False,,Maridebart Cafraglutide,False,False,280.0,SC,Q4W
NCT05669599,Nausea,Most frequent adverse events leading to discontinuation,True,False,False,True,False,420 mg Every 4 Wk,treatment,79,11.0,14.0,Nausea,Nausea,Nausea,False,,Maridebart Cafraglutide,False,False,420.0,SC,Q4W
NCT05669599,Nausea,Most frequent adverse events leading to discontinuation,True,False,False,True,False,420 mg Every 8 Wk,treatment,51,8.0,16.0,Nausea,Nausea,Nausea,False,,Maridebart Cafraglutide,False,False,420.0,SC,Q8W
NCT05669599,Nausea,Most frequent adverse events leading to discontinuation,True,False,False,True,False,"420 mg Every 4 Wk, with 4-Wk DE",treatment,51,3.0,6.0,Nausea,Nausea,Nausea,False,,Maridebart Cafraglutide,False,False,420.0,SC,Q4W
NCT05669599,Nausea,Most frequent adverse events leading to discontinuation,True,False,False,True,False,"420 mg Every 4 Wk, with 12-Wk DE",treatment,52,1.0,2.0,Nausea,Nausea,Nausea,False,,Maridebart Cafraglutide,False,False,420.0,SC,Q4W
NCT05669599,Nausea,Most frequent adverse events leading to discontinuation,True,False,False,True,False,Placebo,control,76,0.0,0.0,Nausea,Nausea,Nausea,False,,Maridebart Cafraglutide,False,False,,,
NCT05669599,Nausea,Most frequent adverse events leading to discontinuation,True,False,False,True,False,140 mg Every 4 Wk,treatment,31,1.0,3.0,Nausea,Nausea,Nausea,False,,Maridebart Cafraglutide,False,False,140.0,SC,Q4W
NCT05669599,Nausea,Most frequent adverse events leading to discontinuation,True,False,False,True,False,280 mg Every 4 Wk,treatment,32,2.0,6.0,Nausea,Nausea,Nausea,False,,Maridebart Cafraglutide,False,False,280.0,SC,Q4W
NCT05669599,Nausea,Most frequent adverse events leading to discontinuation,True,False,False,True,False,420 mg Every 4 Wk,treatment,32,1.0,3.0,Nausea,Nausea,Nausea,False,,Maridebart Cafraglutide,False,False,420.0,SC,Q4W
NCT05669599,Nausea,Most frequent adverse events leading to discontinuation,True,False,False,True,False,Placebo,control,32,0.0,0.0,Nausea,Nausea,Nausea,False,,Maridebart Cafraglutide,False,False,,,
NCT05669599,Retching,Most frequent adverse events leading to discontinuation,True,False,False,True,False,140 mg Every 4 Wk,treatment,77,2.0,3.0,Retching,Retching,Vomiting,False,,Maridebart Cafraglutide,False,False,140.0,SC,Q4W
NCT05669599,Retching,Most frequent adverse events leading to discontinuation,True,False,False,True,False,280 mg Every 4 Wk,treatment,77,1.0,1.0,Retching,Retching,Vomiting,False,,Maridebart Cafraglutide,False,False,280.0,SC,Q4W
NCT05669599,Retching,Most frequent adverse events leading to discontinuation,True,False,False,True,False,420 mg Every 4 Wk,treatment,79,1.0,1.0,Retching,Retching,Vomiting,False,,Maridebart Cafraglutide,False,False,420.0,SC,Q4W
NCT05669599,Retching,Most frequent adverse events leading to discontinuation,True,False,False,True,False,420 mg Every 8 Wk,treatment,51,3.0,6.0,Retching,Retching,Vomiting,False,,Maridebart Cafraglutide,False,False,420.0,SC,Q8W
NCT05669599,Retching,Most frequent adverse events leading to discontinuation,True,False,False,True,False,"420 mg Every 4 Wk, with 4-Wk DE",treatment,51,0.0,0.0,Retching,Retching,Vomiting,False,,Maridebart Cafraglutide,False,False,420.0,SC,Q4W
NCT05669599,Retching,Most frequent adverse events leading to discontinuation,True,False,False,True,False,"420 mg Every 4 Wk, with 12-Wk DE",treatment,52,0.0,0.0,Retching,Retching,Vomiting,False,,Maridebart Cafraglutide,False,False,420.0,SC,Q4W
NCT05669599,Retching,Most frequent adverse events leading to discontinuation,True,False,False,True,False,Placebo,control,76,0.0,0.0,Retching,Retching,Vomiting,False,,Maridebart Cafraglutide,False,False,,,
NCT05669599,Retching,Most frequent adverse events leading to discontinuation,True,False,False,True,False,140 mg Every 4 Wk,treatment,31,0.0,0.0,Retching,Retching,Vomiting,False,,Maridebart Cafraglutide,False,False,140.0,SC,Q4W
NCT05669599,Retching,Most frequent adverse events leading to discontinuation,True,False,False,True,False,280 mg Every 4 Wk,treatment,32,0.0,0.0,Retching,Retching,Vomiting,False,,Maridebart Cafraglutide,False,False,280.0,SC,Q4W
NCT05669599,Retching,Most frequent adverse events leading to discontinuation,True,False,False,True,False,420 mg Every 4 Wk,treatment,32,0.0,0.0,Retching,Retching,Vomiting,False,,Maridebart Cafraglutide,False,False,420.0,SC,Q4W
NCT05669599,Retching,Most frequent adverse events leading to discontinuation,True,False,False,True,False,Placebo,control,32,0.0,0.0,Retching,Retching,Vomiting,False,,Maridebart Cafraglutide,False,False,,,
NCT05669599,Headache,Most frequent adverse events leading to discontinuation,True,False,False,True,False,140 mg Every 4 Wk,treatment,77,1.0,1.0,Headache,Headache,Headache,False,,Maridebart Cafraglutide,False,False,140.0,SC,Q4W
NCT05669599,Headache,Most frequent adverse events leading to discontinuation,True,False,False,True,False,280 mg Every 4 Wk,treatment,77,1.0,1.0,Headache,Headache,Headache,False,,Maridebart Cafraglutide,False,False,280.0,SC,Q4W
NCT05669599,Headache,Most frequent adverse events leading to discontinuation,True,False,False,True,False,420 mg Every 4 Wk,treatment,79,2.0,3.0,Headache,Headache,Headache,False,,Maridebart Cafraglutide,False,False,420.0,SC,Q4W
NCT05669599,Headache,Most frequent adverse events leading to discontinuation,True,False,False,True,False,420 mg Every 8 Wk,treatment,51,2.0,4.0,Headache,Headache,Headache,False,,Maridebart Cafraglutide,False,False,420.0,SC,Q8W
NCT05669599,Headache,Most frequent adverse events leading to discontinuation,True,False,False,True,False,"420 mg Every 4 Wk, with 4-Wk DE",treatment,51,0.0,0.0,Headache,Headache,Headache,False,,Maridebart Cafraglutide,False,False,420.0,SC,Q4W
NCT05669599,Headache,Most frequent adverse events leading to discontinuation,True,False,False,True,False,"420 mg Every 4 Wk, with 12-Wk DE",treatment,52,0.0,0.0,Headache,Headache,Headache,False,,Maridebart Cafraglutide,False,False,420.0,SC,Q4W
NCT05669599,Headache,Most frequent adverse events leading to discontinuation,True,False,False,True,False,Placebo,control,76,0.0,0.0,Headache,Headache,Headache,False,,Maridebart Cafraglutide,False,False,,,
NCT05669599,Headache,Most frequent adverse events leading to discontinuation,True,False,False,True,False,140 mg Every 4 Wk,treatment,31,0.0,0.0,Headache,Headache,Headache,False,,Maridebart Cafraglutide,False,False,140.0,SC,Q4W
NCT05669599,Headache,Most frequent adverse events leading to discontinuation,True,False,False,True,False,280 mg Every 4 Wk,treatment,32,0.0,0.0,Headache,Headache,Headache,False,,Maridebart Cafraglutide,False,False,280.0,SC,Q4W
NCT05669599,Headache,Most frequent adverse events leading to discontinuation,True,False,False,True,False,420 mg Every 4 Wk,treatment,32,0.0,0.0,Headache,Headache,Headache,False,,Maridebart Cafraglutide,False,False,420.0,SC,Q4W
NCT05669599,Headache,Most frequent adverse events leading to discontinuation,True,False,False,True,False,Placebo,control,32,0.0,0.0,Headache,Headache,Headache,False,,Maridebart Cafraglutide,False,False,,,
NCT05669599,Diarrhea,Most frequent adverse events leading to discontinuation,True,False,False,True,False,280 mg Every 4 Wk,treatment,77,1.0,1.0,Diarrhea,Diarrhea,Diarrhea,False,,Maridebart Cafraglutide,False,False,280.0,SC,Q4W
NCT05669599,Diarrhea,Most frequent adverse events leading to discontinuation,True,False,False,True,False,420 mg Every 4 Wk,treatment,79,3.0,4.0,Diarrhea,Diarrhea,Diarrhea,False,,Maridebart Cafraglutide,False,False,420.0,SC,Q4W
NCT05669599,Diarrhea,Most frequent adverse events leading to discontinuation,True,False,False,True,False,"420 mg Every 4 Wk, with 4-Wk DE",treatment,51,1.0,2.0,Diarrhea,Diarrhea,Diarrhea,False,,Maridebart Cafraglutide,False,False,420.0,SC,Q4W
NCT05669599,Diarrhea,Most frequent adverse events leading to discontinuation,True,False,False,True,False,140 mg Every 4 Wk,treatment,31,1.0,3.0,Diarrhea,Diarrhea,Diarrhea,False,,Maridebart Cafraglutide,False,False,140.0,SC,Q4W
NCT05669599,Diarrhea,Most frequent adverse events leading to discontinuation,True,False,False,True,False,280 mg Every 4 Wk,treatment,32,1.0,3.0,Diarrhea,Diarrhea,Diarrhea,False,,Maridebart Cafraglutide,False,False,280.0,SC,Q4W
NCT05669599,Diarrhea,Most frequent adverse events leading to discontinuation,True,False,False,True,False,Placebo,control,32,0.0,0.0,Diarrhea,Diarrhea,Diarrhea,False,,Maridebart Cafraglutide,False,False,,,
NCT05669599,Fatigue,Most frequent adverse events leading to discontinuation,True,False,False,True,False,140 mg Every 4 Wk,treatment,77,1.0,1.0,Fatigue,Fatigue,Fatigue,False,,Maridebart Cafraglutide,False,False,140.0,SC,Q4W
NCT05669599,Fatigue,Most frequent adverse events leading to discontinuation,True,False,False,True,False,280 mg Every 4 Wk,treatment,77,1.0,1.0,Fatigue,Fatigue,Fatigue,False,,Maridebart Cafraglutide,False,False,280.0,SC,Q4W
NCT05669599,Fatigue,Most frequent adverse events leading to discontinuation,True,False,False,True,False,420 mg Every 4 Wk,treatment,79,2.0,3.0,Fatigue,Fatigue,Fatigue,False,,Maridebart Cafraglutide,False,False,420.0,SC,Q4W
NCT05669599,Fatigue,Most frequent adverse events leading to discontinuation,True,False,False,True,False,420 mg Every 8 Wk,treatment,51,1.0,2.0,Fatigue,Fatigue,Fatigue,False,,Maridebart Cafraglutide,False,False,420.0,SC,Q8W
NCT05669599,Fatigue,Most frequent adverse events leading to discontinuation,True,False,False,True,False,"420 mg Every 4 Wk, with 4-Wk DE",treatment,51,0.0,0.0,Fatigue,Fatigue,Fatigue,False,,Maridebart Cafraglutide,False,False,420.0,SC,Q4W
NCT05669599,Fatigue,Most frequent adverse events leading to discontinuation,True,False,False,True,False,"420 mg Every 4 Wk, with 12-Wk DE",treatment,52,0.0,0.0,Fatigue,Fatigue,Fatigue,False,,Maridebart Cafraglutide,False,False,420.0,SC,Q4W
NCT05669599,Fatigue,Most frequent adverse events leading to discontinuation,True,False,False,True,False,Placebo,control,76,0.0,0.0,Fatigue,Fatigue,Fatigue,False,,Maridebart Cafraglutide,False,False,,,
NCT05669599,Fatigue,Most frequent adverse events leading to discontinuation,True,False,False,True,False,140 mg Every 4 Wk,treatment,31,0.0,0.0,Fatigue,Fatigue,Fatigue,False,,Maridebart Cafraglutide,False,False,140.0,SC,Q4W
NCT05669599,Fatigue,Most frequent adverse events leading to discontinuation,True,False,False,True,False,280 mg Every 4 Wk,treatment,32,0.0,0.0,Fatigue,Fatigue,Fatigue,False,,Maridebart Cafraglutide,False,False,280.0,SC,Q4W
NCT05669599,Fatigue,Most frequent adverse events leading to discontinuation,True,False,False,True,False,420 mg Every 4 Wk,treatment,32,0.0,0.0,Fatigue,Fatigue,Fatigue,False,,Maridebart Cafraglutide,False,False,420.0,SC,Q4W
NCT05669599,Fatigue,Most frequent adverse events leading to discontinuation,True,False,False,True,False,Placebo,control,32,0.0,0.0,Fatigue,Fatigue,Fatigue,False,,Maridebart Cafraglutide,False,False,,,
NCT05669599,Constipation,Most frequent adverse events leading to discontinuation,True,False,False,True,False,140 mg Every 4 Wk,treatment,77,2.0,3.0,Constipation,Constipation,Constipation,False,,Maridebart Cafraglutide,False,False,140.0,SC,Q4W
NCT05669599,Constipation,Most frequent adverse events leading to discontinuation,True,False,False,True,False,280 mg Every 4 Wk,treatment,77,1.0,1.0,Constipation,Constipation,Constipation,False,,Maridebart Cafraglutide,False,False,280.0,SC,Q4W
NCT05669599,Constipation,Most frequent adverse events leading to discontinuation,True,False,False,True,False,420 mg Every 4 Wk,treatment,79,1.0,1.0,Constipation,Constipation,Constipation,False,,Maridebart Cafraglutide,False,False,420.0,SC,Q4W
NCT05669599,Constipation,Most frequent adverse events leading to discontinuation,True,False,False,True,False,420 mg Every 8 Wk,treatment,51,0.0,0.0,Constipation,Constipation,Constipation,False,,Maridebart Cafraglutide,False,False,420.0,SC,Q8W
NCT05669599,Constipation,Most frequent adverse events leading to discontinuation,True,False,False,True,False,"420 mg Every 4 Wk, with 4-Wk DE",treatment,51,0.0,0.0,Constipation,Constipation,Constipation,False,,Maridebart Cafraglutide,False,False,420.0,SC,Q4W
NCT05669599,Constipation,Most frequent adverse events leading to discontinuation,True,False,False,True,False,"420 mg Every 4 Wk, with 12-Wk DE",treatment,52,0.0,0.0,Constipation,Constipation,Constipation,False,,Maridebart Cafraglutide,False,False,420.0,SC,Q4W
NCT05669599,Constipation,Most frequent adverse events leading to discontinuation,True,False,False,True,False,Placebo,control,76,0.0,0.0,Constipation,Constipation,Constipation,False,,Maridebart Cafraglutide,False,False,,,
NCT05669599,Constipation,Most frequent adverse events leading to discontinuation,True,False,False,True,False,140 mg Every 4 Wk,treatment,31,0.0,0.0,Constipation,Constipation,Constipation,False,,Maridebart Cafraglutide,False,False,140.0,SC,Q4W
NCT05669599,Constipation,Most frequent adverse events leading to discontinuation,True,False,False,True,False,280 mg Every 4 Wk,treatment,32,0.0,0.0,Constipation,Constipation,Constipation,False,,Maridebart Cafraglutide,False,False,280.0,SC,Q4W
NCT05669599,Constipation,Most frequent adverse events leading to discontinuation,True,False,False,True,False,420 mg Every 4 Wk,treatment,32,0.0,0.0,Constipation,Constipation,Constipation,False,,Maridebart Cafraglutide,False,False,420.0,SC,Q4W
NCT05669599,Constipation,Most frequent adverse events leading to discontinuation,True,False,False,True,False,Placebo,control,32,0.0,0.0,Constipation,Constipation,Constipation,False,,Maridebart Cafraglutide,False,False,,,
NCT05669599,GERD,Most frequent adverse events leading to discontinuation,True,False,False,True,False,140 mg Every 4 Wk,treatment,77,2.0,3.0,GERD,Gastroesophageal reflux disease,Gastroesophageal reflux disease,False,,Maridebart Cafraglutide,False,False,140.0,SC,Q4W
NCT05669599,GERD,Most frequent adverse events leading to discontinuation,True,False,False,True,False,420 mg Every 8 Wk,treatment,51,1.0,2.0,GERD,Gastroesophageal reflux disease,Gastroesophageal reflux disease,False,,Maridebart Cafraglutide,False,False,420.0,SC,Q8W
NCT05669599,Injection-site reaction,Most frequent adverse events leading to discontinuation,True,False,False,True,True,140 mg Every 4 Wk,treatment,77,1.0,1.0,Injection-site reaction,Injection-site reaction,Injection-site reactions,False,,Maridebart Cafraglutide,False,False,140.0,SC,Q4W
NCT05669599,Injection-site reaction,Most frequent adverse events leading to discontinuation,True,False,False,True,True,420 mg Every 4 Wk,treatment,79,1.0,1.0,Injection-site reaction,Injection-site reaction,Injection-site reactions,False,,Maridebart Cafraglutide,False,False,420.0,SC,Q4W
NCT05669599,Injection-site reaction,Most frequent adverse events leading to discontinuation,True,False,False,True,True,"420 mg Every 4 Wk, with 4-Wk DE",treatment,51,1.0,2.0,Injection-site reaction,Injection-site reaction,Injection-site reactions,False,,Maridebart Cafraglutide,False,False,420.0,SC,Q4W
NCT05669599,Malaise,Most frequent adverse events leading to discontinuation,True,False,False,True,False,280 mg Every 4 Wk,treatment,77,2.0,3.0,Malaise,Malaise,Malaise,False,,Maridebart Cafraglutide,False,False,280.0,SC,Q4W
NCT05669599,Malaise,Most frequent adverse events leading to discontinuation,True,False,False,True,False,420 mg Every 4 Wk,treatment,79,1.0,1.0,Malaise,Malaise,Malaise,False,,Maridebart Cafraglutide,False,False,420.0,SC,Q4W
NCT05669599,Nausea,Most frequent adverse events,True,False,False,False,False,140 mg Every 4 Wk,treatment,77,59.0,77.0,Nausea,Nausea,Nausea,False,,Maridebart Cafraglutide,False,False,140.0,SC,Q4W
NCT05669599,Nausea,Most frequent adverse events,True,False,False,False,False,280 mg Every 4 Wk,treatment,77,60.0,78.0,Nausea,Nausea,Nausea,False,,Maridebart Cafraglutide,False,False,280.0,SC,Q4W
NCT05669599,Nausea,Most frequent adverse events,True,False,False,False,False,420 mg Every 4 Wk,treatment,79,69.0,87.0,Nausea,Nausea,Nausea,False,,Maridebart Cafraglutide,False,False,420.0,SC,Q4W
NCT05669599,Nausea,Most frequent adverse events,True,False,False,False,False,420 mg Every 8 Wk,treatment,51,42.0,82.0,Nausea,Nausea,Nausea,False,,Maridebart Cafraglutide,False,False,420.0,SC,Q8W
NCT05669599,Nausea,Most frequent adverse events,True,False,False,False,False,"420 mg Every 4 Wk, with 4-Wk DE",treatment,51,36.0,71.0,Nausea,Nausea,Nausea,False,,Maridebart Cafraglutide,False,False,420.0,SC,Q4W
NCT05669599,Nausea,Most frequent adverse events,True,False,False,False,False,"420 mg Every 4 Wk, with 12-Wk DE",treatment,52,38.0,73.0,Nausea,Nausea,Nausea,False,,Maridebart Cafraglutide,False,False,420.0,SC,Q4W
NCT05669599,Nausea,Most frequent adverse events,True,False,False,False,False,Placebo,control,76,19.0,25.0,Nausea,Nausea,Nausea,False,,Maridebart Cafraglutide,False,False,,,
NCT05669599,Nausea,Most frequent adverse events,True,False,False,False,False,140 mg Every 4 Wk,treatment,31,18.0,58.0,Nausea,Nausea,Nausea,False,,Maridebart Cafraglutide,False,False,140.0,SC,Q4W
NCT05669599,Nausea,Most frequent adverse events,True,False,False,False,False,280 mg Every 4 Wk,treatment,32,13.0,41.0,Nausea,Nausea,Nausea,False,,Maridebart Cafraglutide,False,False,280.0,SC,Q4W
NCT05669599,Nausea,Most frequent adverse events,True,False,False,False,False,420 mg Every 4 Wk,treatment,32,19.0,59.0,Nausea,Nausea,Nausea,False,,Maridebart Cafraglutide,False,False,420.0,SC,Q4W
NCT05669599,Nausea,Most frequent adverse events,True,False,False,False,False,Placebo,control,32,3.0,9.0,Nausea,Nausea,Nausea,False,,Maridebart Cafraglutide,False,False,,,
NCT05669599,Vomiting,Most frequent adverse events,True,False,False,False,False,140 mg Every 4 Wk,treatment,77,52.0,68.0,Vomiting,Vomiting,Vomiting,False,,Maridebart Cafraglutide,False,False,140.0,SC,Q4W
NCT05669599,Vomiting,Most frequent adverse events,True,False,False,False,False,280 mg Every 4 Wk,treatment,77,56.0,73.0,Vomiting,Vomiting,Vomiting,False,,Maridebart Cafraglutide,False,False,280.0,SC,Q4W
NCT05669599,Vomiting,Most frequent adverse events,True,False,False,False,False,420 mg Every 4 Wk,treatment,79,69.0,87.0,Vomiting,Vomiting,Vomiting,False,,Maridebart Cafraglutide,False,False,420.0,SC,Q4W
NCT05669599,Vomiting,Most frequent adverse events,True,False,False,False,False,420 mg Every 8 Wk,treatment,51,47.0,92.0,Vomiting,Vomiting,Vomiting,False,,Maridebart Cafraglutide,False,False,420.0,SC,Q8W
NCT05669599,Vomiting,Most frequent adverse events,True,False,False,False,False,"420 mg Every 4 Wk, with 4-Wk DE",treatment,51,22.0,43.0,Vomiting,Vomiting,Vomiting,False,,Maridebart Cafraglutide,False,False,420.0,SC,Q4W
NCT05669599,Vomiting,Most frequent adverse events,True,False,False,False,False,"420 mg Every 4 Wk, with 12-Wk DE",treatment,52,23.0,44.0,Vomiting,Vomiting,Vomiting,False,,Maridebart Cafraglutide,False,False,420.0,SC,Q4W
NCT05669599,Vomiting,Most frequent adverse events,True,False,False,False,False,Placebo,control,76,2.0,3.0,Vomiting,Vomiting,Vomiting,False,,Maridebart Cafraglutide,False,False,,,
NCT05669599,Vomiting,Most frequent adverse events,True,False,False,False,False,140 mg Every 4 Wk,treatment,31,14.0,45.0,Vomiting,Vomiting,Vomiting,False,,Maridebart Cafraglutide,False,False,140.0,SC,Q4W
NCT05669599,Vomiting,Most frequent adverse events,True,False,False,False,False,280 mg Every 4 Wk,treatment,32,16.0,50.0,Vomiting,Vomiting,Vomiting,False,,Maridebart Cafraglutide,False,False,280.0,SC,Q4W
NCT05669599,Vomiting,Most frequent adverse events,True,False,False,False,False,420 mg Every 4 Wk,treatment,32,24.0,75.0,Vomiting,Vomiting,Vomiting,False,,Maridebart Cafraglutide,False,False,420.0,SC,Q4W
NCT05669599,Vomiting,Most frequent adverse events,True,False,False,False,False,Placebo,control,32,2.0,6.0,Vomiting,Vomiting,Vomiting,False,,Maridebart Cafraglutide,False,False,,,
NCT05669599,Constipation,Most frequent adverse events,True,False,False,False,False,140 mg Every 4 Wk,treatment,77,23.0,30.0,Constipation,Constipation,Constipation,False,,Maridebart Cafraglutide,False,False,140.0,SC,Q4W
NCT05669599,Constipation,Most frequent adverse events,True,False,False,False,False,280 mg Every 4 Wk,treatment,77,19.0,25.0,Constipation,Constipation,Constipation,False,,Maridebart Cafraglutide,False,False,280.0,SC,Q4W
NCT05669599,Constipation,Most frequent adverse events,True,False,False,False,False,420 mg Every 4 Wk,treatment,79,19.0,24.0,Constipation,Constipation,Constipation,False,,Maridebart Cafraglutide,False,False,420.0,SC,Q4W
NCT05669599,Constipation,Most frequent adverse events,True,False,False,False,False,420 mg Every 8 Wk,treatment,51,18.0,35.0,Constipation,Constipation,Constipation,False,,Maridebart Cafraglutide,False,False,420.0,SC,Q8W
NCT05669599,Constipation,Most frequent adverse events,True,False,False,False,False,"420 mg Every 4 Wk, with 4-Wk DE",treatment,51,12.0,24.0,Constipation,Constipation,Constipation,False,,Maridebart Cafraglutide,False,False,420.0,SC,Q4W
NCT05669599,Constipation,Most frequent adverse events,True,False,False,False,False,"420 mg Every 4 Wk, with 12-Wk DE",treatment,52,11.0,21.0,Constipation,Constipation,Constipation,False,,Maridebart Cafraglutide,False,False,420.0,SC,Q4W
NCT05669599,Constipation,Most frequent adverse events,True,False,False,False,False,Placebo,control,76,4.0,5.0,Constipation,Constipation,Constipation,False,,Maridebart Cafraglutide,False,False,,,
NCT05669599,Constipation,Most frequent adverse events,True,False,False,False,False,140 mg Every 4 Wk,treatment,31,4.0,13.0,Constipation,Constipation,Constipation,False,,Maridebart Cafraglutide,False,False,140.0,SC,Q4W
NCT05669599,Constipation,Most frequent adverse events,True,False,False,False,False,280 mg Every 4 Wk,treatment,32,3.0,9.0,Constipation,Constipation,Constipation,False,,Maridebart Cafraglutide,False,False,280.0,SC,Q4W
NCT05669599,Constipation,Most frequent adverse events,True,False,False,False,False,420 mg Every 4 Wk,treatment,32,6.0,19.0,Constipation,Constipation,Constipation,False,,Maridebart Cafraglutide,False,False,420.0,SC,Q4W
NCT05669599,Constipation,Most frequent adverse events,True,False,False,False,False,Placebo,control,32,0.0,0.0,Constipation,Constipation,Constipation,False,,Maridebart Cafraglutide,False,False,,,
NCT05669599,Retching,Most frequent adverse events,True,False,False,False,False,140 mg Every 4 Wk,treatment,77,13.0,17.0,Retching,Retching,Vomiting,False,,Maridebart Cafraglutide,False,False,140.0,SC,Q4W
NCT05669599,Retching,Most frequent adverse events,True,False,False,False,False,280 mg Every 4 Wk,treatment,77,11.0,14.0,Retching,Retching,Vomiting,False,,Maridebart Cafraglutide,False,False,280.0,SC,Q4W
NCT05669599,Retching,Most frequent adverse events,True,False,False,False,False,420 mg Every 4 Wk,treatment,79,18.0,23.0,Retching,Retching,Vomiting,False,,Maridebart Cafraglutide,False,False,420.0,SC,Q4W
NCT05669599,Retching,Most frequent adverse events,True,False,False,False,False,420 mg Every 8 Wk,treatment,51,11.0,22.0,Retching,Retching,Vomiting,False,,Maridebart Cafraglutide,False,False,420.0,SC,Q8W
NCT05669599,Retching,Most frequent adverse events,True,False,False,False,False,"420 mg Every 4 Wk, with 4-Wk DE",treatment,51,5.0,10.0,Retching,Retching,Vomiting,False,,Maridebart Cafraglutide,False,False,420.0,SC,Q4W
NCT05669599,Retching,Most frequent adverse events,True,False,False,False,False,"420 mg Every 4 Wk, with 12-Wk DE",treatment,52,8.0,15.0,Retching,Retching,Vomiting,False,,Maridebart Cafraglutide,False,False,420.0,SC,Q4W
NCT05669599,Retching,Most frequent adverse events,True,False,False,False,False,Placebo,control,76,1.0,1.0,Retching,Retching,Vomiting,False,,Maridebart Cafraglutide,False,False,,,
NCT05669599,Retching,Most frequent adverse events,True,False,False,False,False,140 mg Every 4 Wk,treatment,31,1.0,3.0,Retching,Retching,Vomiting,False,,Maridebart Cafraglutide,False,False,140.0,SC,Q4W
NCT05669599,Retching,Most frequent adverse events,True,False,False,False,False,280 mg Every 4 Wk,treatment,32,2.0,6.0,Retching,Retching,Vomiting,False,,Maridebart Cafraglutide,False,False,280.0,SC,Q4W
NCT05669599,Retching,Most frequent adverse events,True,False,False,False,False,420 mg Every 4 Wk,treatment,32,2.0,6.0,Retching,Retching,Vomiting,False,,Maridebart Cafraglutide,False,False,420.0,SC,Q4W
NCT05669599,Retching,Most frequent adverse events,True,False,False,False,False,Placebo,control,32,0.0,0.0,Retching,Retching,Vomiting,False,,Maridebart Cafraglutide,False,False,,,
NCT05669599,Diarrhea,Most frequent adverse events,True,False,False,False,False,140 mg Every 4 Wk,treatment,77,8.0,10.0,Diarrhea,Diarrhea,Diarrhea,False,,Maridebart Cafraglutide,False,False,140.0,SC,Q4W
NCT05669599,Diarrhea,Most frequent adverse events,True,False,False,False,False,280 mg Every 4 Wk,treatment,77,5.0,6.0,Diarrhea,Diarrhea,Diarrhea,False,,Maridebart Cafraglutide,False,False,280.0,SC,Q4W
NCT05669599,Diarrhea,Most frequent adverse events,True,False,False,False,False,420 mg Every 4 Wk,treatment,79,17.0,22.0,Diarrhea,Diarrhea,Diarrhea,False,,Maridebart Cafraglutide,False,False,420.0,SC,Q4W
NCT05669599,Diarrhea,Most frequent adverse events,True,False,False,False,False,420 mg Every 8 Wk,treatment,51,6.0,12.0,Diarrhea,Diarrhea,Diarrhea,False,,Maridebart Cafraglutide,False,False,420.0,SC,Q8W
NCT05669599,Diarrhea,Most frequent adverse events,True,False,False,False,False,"420 mg Every 4 Wk, with 4-Wk DE",treatment,51,7.0,14.0,Diarrhea,Diarrhea,Diarrhea,False,,Maridebart Cafraglutide,False,False,420.0,SC,Q4W
NCT05669599,Diarrhea,Most frequent adverse events,True,False,False,False,False,"420 mg Every 4 Wk, with 12-Wk DE",treatment,52,10.0,19.0,Diarrhea,Diarrhea,Diarrhea,False,,Maridebart Cafraglutide,False,False,420.0,SC,Q4W
NCT05669599,Diarrhea,Most frequent adverse events,True,False,False,False,False,Placebo,control,76,4.0,5.0,Diarrhea,Diarrhea,Diarrhea,False,,Maridebart Cafraglutide,False,False,,,
NCT05669599,Diarrhea,Most frequent adverse events,True,False,False,False,False,140 mg Every 4 Wk,treatment,31,3.0,10.0,Diarrhea,Diarrhea,Diarrhea,False,,Maridebart Cafraglutide,False,False,140.0,SC,Q4W
NCT05669599,Diarrhea,Most frequent adverse events,True,False,False,False,False,280 mg Every 4 Wk,treatment,32,5.0,16.0,Diarrhea,Diarrhea,Diarrhea,False,,Maridebart Cafraglutide,False,False,280.0,SC,Q4W
NCT05669599,Diarrhea,Most frequent adverse events,True,False,False,False,False,420 mg Every 4 Wk,treatment,32,5.0,16.0,Diarrhea,Diarrhea,Diarrhea,False,,Maridebart Cafraglutide,False,False,420.0,SC,Q4W
NCT05669599,Diarrhea,Most frequent adverse events,True,False,False,False,False,Placebo,control,32,3.0,9.0,Diarrhea,Diarrhea,Diarrhea,False,,Maridebart Cafraglutide,False,False,,,
NCT05669599,Headache,Most frequent adverse events,True,False,False,False,False,140 mg Every 4 Wk,treatment,77,11.0,14.0,Headache,Headache,Headache,False,,Maridebart Cafraglutide,False,False,140.0,SC,Q4W
NCT05669599,Headache,Most frequent adverse events,True,False,False,False,False,280 mg Every 4 Wk,treatment,77,8.0,10.0,Headache,Headache,Headache,False,,Maridebart Cafraglutide,False,False,280.0,SC,Q4W
NCT05669599,Headache,Most frequent adverse events,True,False,False,False,False,420 mg Every 4 Wk,treatment,79,13.0,16.0,Headache,Headache,Headache,False,,Maridebart Cafraglutide,False,False,420.0,SC,Q4W
NCT05669599,Headache,Most frequent adverse events,True,False,False,False,False,420 mg Every 8 Wk,treatment,51,10.0,20.0,Headache,Headache,Headache,False,,Maridebart Cafraglutide,False,False,420.0,SC,Q8W
NCT05669599,Headache,Most frequent adverse events,True,False,False,False,False,"420 mg Every 4 Wk, with 4-Wk DE",treatment,51,3.0,6.0,Headache,Headache,Headache,False,,Maridebart Cafraglutide,False,False,420.0,SC,Q4W
NCT05669599,Headache,Most frequent adverse events,True,False,False,False,False,"420 mg Every 4 Wk, with 12-Wk DE",treatment,52,5.0,10.0,Headache,Headache,Headache,False,,Maridebart Cafraglutide,False,False,420.0,SC,Q4W
NCT05669599,Headache,Most frequent adverse events,True,False,False,False,False,Placebo,control,76,5.0,7.0,Headache,Headache,Headache,False,,Maridebart Cafraglutide,False,False,,,
NCT05669599,Headache,Most frequent adverse events,True,False,False,False,False,140 mg Every 4 Wk,treatment,31,1.0,3.0,Headache,Headache,Headache,False,,Maridebart Cafraglutide,False,False,140.0,SC,Q4W
NCT05669599,Headache,Most frequent adverse events,True,False,False,False,False,280 mg Every 4 Wk,treatment,32,1.0,3.0,Headache,Headache,Headache,False,,Maridebart Cafraglutide,False,False,280.0,SC,Q4W
NCT05669599,Headache,Most frequent adverse events,True,False,False,False,False,420 mg Every 4 Wk,treatment,32,3.0,9.0,Headache,Headache,Headache,False,,Maridebart Cafraglutide,False,False,420.0,SC,Q4W
NCT05669599,Headache,Most frequent adverse events,True,False,False,False,False,Placebo,control,32,4.0,12.0,Headache,Headache,Headache,False,,Maridebart Cafraglutide,False,False,,,
NCT05669599,GERD,Most frequent adverse events,True,False,False,False,False,140 mg Every 4 Wk,treatment,77,8.0,10.0,GERD,Gastroesophageal reflux disease,Gastroesophageal reflux disease,False,,Maridebart Cafraglutide,False,False,140.0,SC,Q4W
NCT05669599,GERD,Most frequent adverse events,True,False,False,False,False,280 mg Every 4 Wk,treatment,77,8.0,10.0,GERD,Gastroesophageal reflux disease,Gastroesophageal reflux disease,False,,Maridebart Cafraglutide,False,False,280.0,SC,Q4W
NCT05669599,GERD,Most frequent adverse events,True,False,False,False,False,420 mg Every 4 Wk,treatment,79,8.0,10.0,GERD,Gastroesophageal reflux disease,Gastroesophageal reflux disease,False,,Maridebart Cafraglutide,False,False,420.0,SC,Q4W
NCT05669599,GERD,Most frequent adverse events,True,False,False,False,False,420 mg Every 8 Wk,treatment,51,7.0,14.0,GERD,Gastroesophageal reflux disease,Gastroesophageal reflux disease,False,,Maridebart Cafraglutide,False,False,420.0,SC,Q8W
NCT05669599,GERD,Most frequent adverse events,True,False,False,False,False,"420 mg Every 4 Wk, with 4-Wk DE",treatment,51,4.0,8.0,GERD,Gastroesophageal reflux disease,Gastroesophageal reflux disease,False,,Maridebart Cafraglutide,False,False,420.0,SC,Q4W
NCT05669599,GERD,Most frequent adverse events,True,False,False,False,False,"420 mg Every 4 Wk, with 12-Wk DE",treatment,52,7.0,13.0,GERD,Gastroesophageal reflux disease,Gastroesophageal reflux disease,False,,Maridebart Cafraglutide,False,False,420.0,SC,Q4W
NCT05669599,GERD,Most frequent adverse events,True,False,False,False,False,Placebo,control,76,0.0,0.0,GERD,Gastroesophageal reflux disease,Gastroesophageal reflux disease,False,,Maridebart Cafraglutide,False,False,,,
NCT05669599,GERD,Most frequent adverse events,True,False,False,False,False,140 mg Every 4 Wk,treatment,31,2.0,6.0,GERD,Gastroesophageal reflux disease,Gastroesophageal reflux disease,False,,Maridebart Cafraglutide,False,False,140.0,SC,Q4W
NCT05669599,GERD,Most frequent adverse events,True,False,False,False,False,280 mg Every 4 Wk,treatment,32,2.0,6.0,GERD,Gastroesophageal reflux disease,Gastroesophageal reflux disease,False,,Maridebart Cafraglutide,False,False,280.0,SC,Q4W
NCT05669599,GERD,Most frequent adverse events,True,False,False,False,False,420 mg Every 4 Wk,treatment,32,2.0,6.0,GERD,Gastroesophageal reflux disease,Gastroesophageal reflux disease,False,,Maridebart Cafraglutide,False,False,420.0,SC,Q4W
NCT05669599,GERD,Most frequent adverse events,True,False,False,False,False,Placebo,control,32,0.0,0.0,GERD,Gastroesophageal reflux disease,Gastroesophageal reflux disease,False,,Maridebart Cafraglutide,False,False,,,
NCT05669599,Hypersensitivity,Adverse events of special interest,False,False,False,False,True,140 mg Every 4 Wk,treatment,77,3.0,4.0,Hypersensitivity,Hypersensitivity,Hypersensitivity,False,,Maridebart Cafraglutide,False,False,140.0,SC,Q4W
NCT05669599,Hypersensitivity,Adverse events of special interest,False,False,False,False,True,280 mg Every 4 Wk,treatment,77,4.0,5.0,Hypersensitivity,Hypersensitivity,Hypersensitivity,False,,Maridebart Cafraglutide,False,False,280.0,SC,Q4W
NCT05669599,Hypersensitivity,Adverse events of special interest,False,False,False,False,True,420 mg Every 4 Wk,treatment,79,2.0,3.0,Hypersensitivity,Hypersensitivity,Hypersensitivity,False,,Maridebart Cafraglutide,False,False,420.0,SC,Q4W
NCT05669599,Hypersensitivity,Adverse events of special interest,False,False,False,False,True,420 mg Every 8 Wk,treatment,51,3.0,6.0,Hypersensitivity,Hypersensitivity,Hypersensitivity,False,,Maridebart Cafraglutide,False,False,420.0,SC,Q8W
NCT05669599,Hypersensitivity,Adverse events of special interest,False,False,False,False,True,"420 mg Every 4 Wk, with 4-Wk DE",treatment,51,4.0,8.0,Hypersensitivity,Hypersensitivity,Hypersensitivity,False,,Maridebart Cafraglutide,False,False,420.0,SC,Q4W
NCT05669599,Hypersensitivity,Adverse events of special interest,False,False,False,False,True,"420 mg Every 4 Wk, with 12-Wk DE",treatment,52,4.0,8.0,Hypersensitivity,Hypersensitivity,Hypersensitivity,False,,Maridebart Cafraglutide,False,False,420.0,SC,Q4W
NCT05669599,Hypersensitivity,Adverse events of special interest,False,False,False,False,True,Placebo,control,76,3.0,4.0,Hypersensitivity,Hypersensitivity,Hypersensitivity,False,,Maridebart Cafraglutide,False,False,,,
NCT05669599,Hypersensitivity,Adverse events of special interest,False,False,False,False,True,140 mg Every 4 Wk,treatment,31,1.0,3.0,Hypersensitivity,Hypersensitivity,Hypersensitivity,False,,Maridebart Cafraglutide,False,False,140.0,SC,Q4W
NCT05669599,Hypersensitivity,Adverse events of special interest,False,False,False,False,True,280 mg Every 4 Wk,treatment,32,1.0,3.0,Hypersensitivity,Hypersensitivity,Hypersensitivity,False,,Maridebart Cafraglutide,False,False,280.0,SC,Q4W
NCT05669599,Hypersensitivity,Adverse events of special interest,False,False,False,False,True,420 mg Every 4 Wk,treatment,32,1.0,3.0,Hypersensitivity,Hypersensitivity,Hypersensitivity,False,,Maridebart Cafraglutide,False,False,420.0,SC,Q4W
NCT05669599,Hypersensitivity,Adverse events of special interest,False,False,False,False,True,Placebo,control,32,0.0,0.0,Hypersensitivity,Hypersensitivity,Hypersensitivity,False,,Maridebart Cafraglutide,False,False,,,
NCT05669599,Injection-site reactions,Adverse events of special interest,False,False,False,False,True,140 mg Every 4 Wk,treatment,77,10.0,13.0,Injection-site reactions,Injection-site reaction,Injection-site reactions,False,,Maridebart Cafraglutide,False,False,140.0,SC,Q4W
NCT05669599,Injection-site reactions,Adverse events of special interest,False,False,False,False,True,280 mg Every 4 Wk,treatment,77,5.0,6.0,Injection-site reactions,Injection-site reaction,Injection-site reactions,False,,Maridebart Cafraglutide,False,False,280.0,SC,Q4W
NCT05669599,Injection-site reactions,Adverse events of special interest,False,False,False,False,True,420 mg Every 4 Wk,treatment,79,8.0,10.0,Injection-site reactions,Injection-site reaction,Injection-site reactions,False,,Maridebart Cafraglutide,False,False,420.0,SC,Q4W
NCT05669599,Injection-site reactions,Adverse events of special interest,False,False,False,False,True,420 mg Every 8 Wk,treatment,51,0.0,0.0,Injection-site reactions,Injection-site reaction,Injection-site reactions,False,,Maridebart Cafraglutide,False,False,420.0,SC,Q8W
NCT05669599,Injection-site reactions,Adverse events of special interest,False,False,False,False,True,"420 mg Every 4 Wk, with 4-Wk DE",treatment,51,8.0,16.0,Injection-site reactions,Injection-site reaction,Injection-site reactions,False,,Maridebart Cafraglutide,False,False,420.0,SC,Q4W
NCT05669599,Injection-site reactions,Adverse events of special interest,False,False,False,False,True,"420 mg Every 4 Wk, with 12-Wk DE",treatment,52,6.0,12.0,Injection-site reactions,Injection-site reaction,Injection-site reactions,False,,Maridebart Cafraglutide,False,False,420.0,SC,Q4W
NCT05669599,Injection-site reactions,Adverse events of special interest,False,False,False,False,True,Placebo,control,76,2.0,3.0,Injection-site reactions,Injection-site reaction,Injection-site reactions,False,,Maridebart Cafraglutide,False,False,,,
NCT05669599,Injection-site reactions,Adverse events of special interest,False,False,False,False,True,140 mg Every 4 Wk,treatment,31,2.0,6.0,Injection-site reactions,Injection-site reaction,Injection-site reactions,False,,Maridebart Cafraglutide,False,False,140.0,SC,Q4W
NCT05669599,Injection-site reactions,Adverse events of special interest,False,False,False,False,True,280 mg Every 4 Wk,treatment,32,3.0,9.0,Injection-site reactions,Injection-site reaction,Injection-site reactions,False,,Maridebart Cafraglutide,False,False,280.0,SC,Q4W
NCT05669599,Injection-site reactions,Adverse events of special interest,False,False,False,False,True,420 mg Every 4 Wk,treatment,32,1.0,3.0,Injection-site reactions,Injection-site reaction,Injection-site reactions,False,,Maridebart Cafraglutide,False,False,420.0,SC,Q4W
NCT05669599,Injection-site reactions,Adverse events of special interest,False,False,False,False,True,Placebo,control,32,2.0,6.0,Injection-site reactions,Injection-site reaction,Injection-site reactions,False,,Maridebart Cafraglutide,False,False,,,
NCT05669599,Severe or serious GI events,Adverse events of special interest,False,True,False,False,True,140 mg Every 4 Wk,treatment,77,6.0,8.0,Severe or serious GI events,Severe or serious gastrointestinal events,Severe or serious gastrointestinal events,True,other_summary,Maridebart Cafraglutide,False,False,140.0,SC,Q4W
NCT05669599,Severe or serious GI events,Adverse events of special interest,False,True,False,False,True,280 mg Every 4 Wk,treatment,77,2.0,3.0,Severe or serious GI events,Severe or serious gastrointestinal events,Severe or serious gastrointestinal events,True,other_summary,Maridebart Cafraglutide,False,False,280.0,SC,Q4W
NCT05669599,Severe or serious GI events,Adverse events of special interest,False,True,False,False,True,420 mg Every 4 Wk,treatment,79,9.0,11.0,Severe or serious GI events,Severe or serious gastrointestinal events,Severe or serious gastrointestinal events,True,other_summary,Maridebart Cafraglutide,False,False,420.0,SC,Q4W
NCT05669599,Severe or serious GI events,Adverse events of special interest,False,True,False,False,True,420 mg Every 8 Wk,treatment,51,5.0,10.0,Severe or serious GI events,Severe or serious gastrointestinal events,Severe or serious gastrointestinal events,True,other_summary,Maridebart Cafraglutide,False,False,420.0,SC,Q8W
NCT05669599,Severe or serious GI events,Adverse events of special interest,False,True,False,False,True,"420 mg Every 4 Wk, with 4-Wk DE",treatment,51,1.0,2.0,Severe or serious GI events,Severe or serious gastrointestinal events,Severe or serious gastrointestinal events,True,other_summary,Maridebart Cafraglutide,False,False,420.0,SC,Q4W
NCT05669599,Severe or serious GI events,Adverse events of special interest,False,True,False,False,True,"420 mg Every 4 Wk, with 12-Wk DE",treatment,52,1.0,2.0,Severe or serious GI events,Severe or serious gastrointestinal events,Severe or serious gastrointestinal events,True,other_summary,Maridebart Cafraglutide,False,False,420.0,SC,Q4W
NCT05669599,Severe or serious GI events,Adverse events of special interest,False,True,False,False,True,Placebo,control,76,0.0,0.0,Severe or serious GI events,Severe or serious gastrointestinal events,Severe or serious gastrointestinal events,True,other_summary,Maridebart Cafraglutide,False,False,,,
NCT05669599,Severe or serious GI events,Adverse events of special interest,False,True,False,False,True,140 mg Every 4 Wk,treatment,31,0.0,0.0,Severe or serious GI events,Severe or serious gastrointestinal events,Severe or serious gastrointestinal events,True,other_summary,Maridebart Cafraglutide,False,False,140.0,SC,Q4W
NCT05669599,Severe or serious GI events,Adverse events of special interest,False,True,False,False,True,280 mg Every 4 Wk,treatment,32,1.0,3.0,Severe or serious GI events,Severe or serious gastrointestinal events,Severe or serious gastrointestinal events,True,other_summary,Maridebart Cafraglutide,False,False,280.0,SC,Q4W
NCT05669599,Severe or serious GI events,Adverse events of special interest,False,True,False,False,True,420 mg Every 4 Wk,treatment,32,3.0,9.0,Severe or serious GI events,Severe or serious gastrointestinal events,Severe or serious gastrointestinal events,True,other_summary,Maridebart Cafraglutide,False,False,420.0,SC,Q4W
NCT05669599,Severe or serious GI events,Adverse events of special interest,False,True,False,False,True,Placebo,control,32,0.0,0.0,Severe or serious GI events,Severe or serious gastrointestinal events,Severe or serious gastrointestinal events,True,other_summary,Maridebart Cafraglutide,False,False,,,
NCT05669599,Acute renal events,Adverse events of special interest,False,True,False,False,True,420 mg Every 8 Wk,treatment,51,1.0,2.0,Acute renal events,Acute kidney injury,Renal impairment,False,,Maridebart Cafraglutide,False,False,420.0,SC,Q8W
NCT05669599,Acute gallbladder diseases,Adverse events of special interest,False,False,False,False,True,140 mg Every 4 Wk,treatment,77,1.0,1.0,Acute gallbladder diseases,Acute gallbladder disease,Gallbladder disease,False,,Maridebart Cafraglutide,False,False,140.0,SC,Q4W
NCT05669599,Acute gallbladder diseases,Adverse events of special interest,False,False,False,False,True,280 mg Every 4 Wk,treatment,77,1.0,1.0,Acute gallbladder diseases,Acute gallbladder disease,Gallbladder disease,False,,Maridebart Cafraglutide,False,False,280.0,SC,Q4W
NCT05669599,Acute gallbladder diseases,Adverse events of special interest,False,False,False,False,True,420 mg Every 4 Wk,treatment,79,5.0,6.0,Acute gallbladder diseases,Acute gallbladder disease,Gallbladder disease,False,,Maridebart Cafraglutide,False,False,420.0,SC,Q4W
NCT05669599,Acute gallbladder diseases,Adverse events of special interest,False,False,False,False,True,420 mg Every 8 Wk,treatment,51,1.0,2.0,Acute gallbladder diseases,Acute gallbladder disease,Gallbladder disease,False,,Maridebart Cafraglutide,False,False,420.0,SC,Q8W
NCT05669599,Acute gallbladder diseases,Adverse events of special interest,False,False,False,False,True,"420 mg Every 4 Wk, with 12-Wk DE",treatment,52,2.0,4.0,Acute gallbladder diseases,Acute gallbladder disease,Gallbladder disease,False,,Maridebart Cafraglutide,False,False,420.0,SC,Q4W
NCT05669599,Acute gallbladder diseases,Adverse events of special interest,False,False,False,False,True,280 mg Every 4 Wk,treatment,32,1.0,3.0,Acute gallbladder diseases,Acute gallbladder disease,Gallbladder disease,False,,Maridebart Cafraglutide,False,False,280.0,SC,Q4W
NCT05669599,Heart-rate increase,Adverse events of special interest,False,False,False,False,True,280 mg Every 4 Wk,treatment,77,4.0,5.0,Heart-rate increase,Increased heart rate,Tachycardia,False,,Maridebart Cafraglutide,False,False,280.0,SC,Q4W
NCT05669599,Heart-rate increase,Adverse events of special interest,False,False,False,False,True,420 mg Every 8 Wk,treatment,51,1.0,2.0,Heart-rate increase,Increased heart rate,Tachycardia,False,,Maridebart Cafraglutide,False,False,420.0,SC,Q8W
NCT05669599,Heart-rate increase,Adverse events of special interest,False,False,False,False,True,"420 mg Every 4 Wk, with 4-Wk DE",treatment,51,1.0,2.0,Heart-rate increase,Increased heart rate,Tachycardia,False,,Maridebart Cafraglutide,False,False,420.0,SC,Q4W
NCT05669599,Heart-rate increase,Adverse events of special interest,False,False,False,False,True,Placebo,control,76,1.0,1.0,Heart-rate increase,Increased heart rate,Tachycardia,False,,Maridebart Cafraglutide,False,False,,,
NCT05669599,Heart-rate increase,Adverse events of special interest,False,False,False,False,True,280 mg Every 4 Wk,treatment,32,2.0,6.0,Heart-rate increase,Increased heart rate,Tachycardia,False,,Maridebart Cafraglutide,False,False,280.0,SC,Q4W
NCT05669599,Heart-rate increase,Adverse events of special interest,False,False,False,False,True,Placebo,control,32,2.0,6.0,Heart-rate increase,Increased heart rate,Tachycardia,False,,Maridebart Cafraglutide,False,False,,,
NCT05669599,Depressive disorder or suicidal behavior or ideation,Adverse events of special interest,False,True,False,True,True,140 mg Every 4 Wk,treatment,77,1.0,1.0,Depressive disorder or suicidal behavior or ideation,Depression or suicidality,Depression and suicidality,False,,Maridebart Cafraglutide,False,False,140.0,SC,Q4W
NCT05669599,Depressive disorder or suicidal behavior or ideation,Adverse events of special interest,False,True,False,True,True,420 mg Every 4 Wk,treatment,79,4.0,5.0,Depressive disorder or suicidal behavior or ideation,Depression or suicidality,Depression and suicidality,False,,Maridebart Cafraglutide,False,False,420.0,SC,Q4W
NCT05669599,Depressive disorder or suicidal behavior or ideation,Adverse events of special interest,False,True,False,True,True,420 mg Every 8 Wk,treatment,51,5.0,10.0,Depressive disorder or suicidal behavior or ideation,Depression or suicidality,Depression and suicidality,False,,Maridebart Cafraglutide,False,False,420.0,SC,Q8W
NCT05669599,Depressive disorder or suicidal behavior or ideation,Adverse events of special interest,False,True,False,True,True,"420 mg Every 4 Wk, with 4-Wk DE",treatment,51,1.0,2.0,Depressive disorder or suicidal behavior or ideation,Depression or suicidality,Depression and suicidality,False,,Maridebart Cafraglutide,False,False,420.0,SC,Q4W
NCT05669599,Depressive disorder or suicidal behavior or ideation,Adverse events of special interest,False,True,False,True,True,Placebo,control,32,1.0,3.0,Depressive disorder or suicidal behavior or ideation,Depression or suicidality,Depression and suicidality,False,,Maridebart Cafraglutide,False,False,,,
NCT00381342,Hypoglycemia,Treatment-emergent adverse events reported in ≥2% of exenatide-treated patients,True,False,False,False,False,Exenatide 5 μg,treatment,77,4.0,5.0,Hypoglycemia,Hypoglycemia,Hypoglycemia,False,,Exenatide,True,True,0.005,SC,BID
NCT00381342,Hypoglycemia,Treatment-emergent adverse events reported in ≥2% of exenatide-treated patients,True,False,False,False,False,Exenatide 10 μg,treatment,78,3.0,4.0,Hypoglycemia,Hypoglycemia,Hypoglycemia,False,,Exenatide,True,True,0.01,SC,BID
NCT00381342,Hypoglycemia,Treatment-emergent adverse events reported in ≥2% of exenatide-treated patients,True,False,False,False,False,Placebo,control,77,1.0,1.0,Hypoglycemia,Hypoglycemia,Hypoglycemia,False,,Exenatide,False,False,,,
NCT00381342,Headache,Treatment-emergent adverse events reported in ≥2% of exenatide-treated patients,True,False,False,True,False,Exenatide 5 μg,treatment,77,4.0,5.0,Headache,Headache,Headache,False,,Exenatide,True,True,0.005,SC,BID
NCT00381342,Headache,Treatment-emergent adverse events reported in ≥2% of exenatide-treated patients,True,False,False,True,False,Exenatide 10 μg,treatment,78,2.0,3.0,Headache,Headache,Headache,False,,Exenatide,True,True,0.01,SC,BID
NCT00381342,Headache,Treatment-emergent adverse events reported in ≥2% of exenatide-treated patients,True,False,False,False,False,Placebo,control,77,3.0,4.0,Headache,Headache,Headache,False,,Exenatide,False,False,,,
NCT00381342,Influenza,Treatment-emergent adverse events reported in ≥2% of exenatide-treated patients,True,False,False,False,False,Exenatide 5 μg,treatment,77,3.0,4.0,Influenza,Influenza,Influenza,False,,Exenatide,True,True,0.005,SC,BID
NCT00381342,Influenza,Treatment-emergent adverse events reported in ≥2% of exenatide-treated patients,True,False,False,False,False,Exenatide 10 μg,treatment,78,5.0,6.0,Influenza,Influenza,Influenza,False,,Exenatide,True,True,0.01,SC,BID
NCT00381342,Influenza,Treatment-emergent adverse events reported in ≥2% of exenatide-treated patients,True,False,False,False,False,Placebo,control,77,3.0,4.0,Influenza,Influenza,Influenza,False,,Exenatide,False,False,,,
NCT00381342,Vomiting,Treatment-emergent adverse events reported in ≥2% of exenatide-treated patients,True,False,False,False,False,Exenatide 5 μg,treatment,77,3.0,4.0,Vomiting,Vomiting,Vomiting,False,,Exenatide,True,True,0.005,SC,BID
NCT00381342,Vomiting,Treatment-emergent adverse events reported in ≥2% of exenatide-treated patients,True,False,False,False,False,Exenatide 10 μg,treatment,78,3.0,4.0,Vomiting,Vomiting,Vomiting,False,,Exenatide,True,True,0.01,SC,BID
NCT00381342,Back pain,Treatment-emergent adverse events reported in ≥2% of exenatide-treated patients,True,False,False,False,False,Exenatide 5 μg,treatment,77,3.0,4.0,Back pain,Back pain,Musculoskeletal pain,False,,Exenatide,True,True,0.005,SC,BID
NCT00381342,Back pain,Treatment-emergent adverse events reported in ≥2% of exenatide-treated patients,True,False,False,False,False,Exenatide 10 μg,treatment,78,2.0,3.0,Back pain,Back pain,Musculoskeletal pain,False,,Exenatide,True,True,0.01,SC,BID
NCT00381342,Back pain,Treatment-emergent adverse events reported in ≥2% of exenatide-treated patients,True,False,False,False,False,Placebo,control,77,1.0,1.0,Back pain,Back pain,Musculoskeletal pain,False,,Exenatide,False,False,,,
NCT00381342,Nausea,Treatment-emergent adverse events reported in ≥2% of exenatide-treated patients,True,False,False,True,False,Exenatide 5 μg,treatment,77,2.0,3.0,Nausea,Nausea,Nausea,False,,Exenatide,True,True,0.005,SC,BID
NCT00381342,Nausea,Treatment-emergent adverse events reported in ≥2% of exenatide-treated patients,True,False,False,True,False,Exenatide 10 μg,treatment,78,10.0,13.0,Nausea,Nausea,Nausea,False,,Exenatide,True,True,0.01,SC,BID
NCT00381342,Nasopharyngitis,Treatment-emergent adverse events reported in ≥2% of exenatide-treated patients,True,False,False,False,False,Exenatide 5 μg,treatment,77,2.0,3.0,Nasopharyngitis,Nasopharyngitis,Nasopharyngitis,False,,Exenatide,True,True,0.005,SC,BID
NCT00381342,Nasopharyngitis,Treatment-emergent adverse events reported in ≥2% of exenatide-treated patients,True,False,False,False,False,Exenatide 10 μg,treatment,78,4.0,5.0,Nasopharyngitis,Nasopharyngitis,Nasopharyngitis,False,,Exenatide,True,True,0.01,SC,BID
NCT00381342,Nasopharyngitis,Treatment-emergent adverse events reported in ≥2% of exenatide-treated patients,True,False,False,False,False,Placebo,control,77,1.0,1.0,Nasopharyngitis,Nasopharyngitis,Nasopharyngitis,False,,Exenatide,False,False,,,
NCT00381342,Upper respiratory tract infection,Treatment-emergent adverse events reported in ≥2% of exenatide-treated patients,True,False,False,False,False,Exenatide 5 μg,treatment,77,2.0,3.0,Upper respiratory tract infection,Upper respiratory tract infection,Upper respiratory tract infection,False,,Exenatide,True,True,0.005,SC,BID
NCT00381342,Upper respiratory tract infection,Treatment-emergent adverse events reported in ≥2% of exenatide-treated patients,True,False,False,False,False,Placebo,control,77,3.0,4.0,Upper respiratory tract infection,Upper respiratory tract infection,Upper respiratory tract infection,False,,Exenatide,False,False,,,
NCT00381342,Neck pain,Treatment-emergent adverse events reported in ≥2% of exenatide-treated patients,True,False,False,False,False,Exenatide 5 μg,treatment,77,2.0,3.0,Neck pain,Neck pain,Musculoskeletal pain,False,,Exenatide,True,True,0.005,SC,BID
NCT00381342,Dyspepsia,Treatment-emergent adverse events reported in ≥2% of exenatide-treated patients,True,False,False,False,False,Exenatide 10 μg,treatment,78,4.0,5.0,Dyspepsia,Dyspepsia,Dyspepsia,False,,Exenatide,True,True,0.01,SC,BID
NCT00381342,Diarrhea,Treatment-emergent adverse events reported in ≥2% of exenatide-treated patients,True,False,False,False,False,Exenatide 10 μg,treatment,78,2.0,3.0,Diarrhea,Diarrhea,Diarrhea,False,,Exenatide,True,True,0.01,SC,BID
NCT00381342,Dizziness,Treatment-emergent adverse events reported in ≥2% of exenatide-treated patients,True,False,False,False,False,Exenatide 10 μg,treatment,78,2.0,3.0,Dizziness,Dizziness,Dizziness,False,,Exenatide,True,True,0.01,SC,BID
NCT00381342,Pain,Treatment-emergent adverse events reported in ≥2% of exenatide-treated patients,True,False,False,False,False,Exenatide 10 μg,treatment,78,2.0,3.0,Pain,Pain,Pain,False,,Exenatide,True,True,0.01,SC,BID
NCT00381342,Pain in extremity,Treatment-emergent adverse events reported in ≥2% of exenatide-treated patients,True,False,False,False,False,Exenatide 10 μg,treatment,78,2.0,3.0,Pain in extremity,Pain in extremity,Musculoskeletal pain,False,,Exenatide,True,True,0.01,SC,BID
NCT02465515,Severe hypoglycaemia,Prespecified adverse events of special interest,True,False,False,False,True,Albiglutide,treatment,4717,31.0,1.0,Severe hypoglycaemia,Severe hypoglycemia,Hypoglycemia,False,,Albiglutide,True,True,,SC,QW
NCT02465515,Severe hypoglycaemia,Prespecified adverse events of special interest,True,False,False,False,True,Placebo,control,4715,55.0,1.0,Severe hypoglycaemia,Severe hypoglycemia,Hypoglycemia,False,,Albiglutide,False,False,,,
NCT02465515,Pancreatitis,Prespecified adverse events of special interest,True,False,False,False,True,Albiglutide,treatment,4717,10.0,0.0,Pancreatitis,Pancreatitis,Pancreatitis,False,,Albiglutide,True,True,,SC,QW
NCT02465515,Pancreatitis,Prespecified adverse events of special interest,True,False,False,False,True,Placebo,control,4715,7.0,0.0,Pancreatitis,Pancreatitis,Pancreatitis,False,,Albiglutide,False,False,,,
NCT02465515,Injection site reactions,Prespecified adverse events of special interest,True,False,False,False,True,Albiglutide,treatment,4717,86.0,2.0,Injection site reactions,Injection-site reaction,Injection-site reactions,False,,Albiglutide,True,True,,SC,QW
NCT02465515,Injection site reactions,Prespecified adverse events of special interest,True,False,False,False,True,Placebo,control,4715,29.0,1.0,Injection site reactions,Injection-site reaction,Injection-site reactions,False,,Albiglutide,False,False,,,
NCT02465515,Thyroid cancer,Prespecified adverse events of special interest,True,False,False,False,True,Albiglutide,treatment,4717,0.0,0.0,Thyroid cancer,Thyroid cancer,Thyroid cancer,False,,Albiglutide,True,True,,SC,QW
NCT02465515,Thyroid cancer,Prespecified adverse events of special interest,True,False,False,False,True,Placebo,control,4715,0.0,0.0,Thyroid cancer,Thyroid cancer,Thyroid cancer,False,,Albiglutide,False,False,,,
NCT02465515,Haematological neoplasia,Prespecified adverse events of special interest,True,False,False,False,True,Albiglutide,treatment,4717,9.0,0.0,Haematological neoplasia,Hematologic malignancy,Cancer,False,,Albiglutide,True,True,,SC,QW
NCT02465515,Haematological neoplasia,Prespecified adverse events of special interest,True,False,False,False,True,Placebo,control,4715,5.0,0.0,Haematological neoplasia,Hematologic malignancy,Cancer,False,,Albiglutide,False,False,,,
NCT02465515,Pancreatic cancer,Prespecified adverse events of special interest,True,False,False,False,True,Albiglutide,treatment,4717,6.0,0.0,Pancreatic cancer,Pancreatic cancer,Pancreatic cancer,False,,Albiglutide,True,True,,SC,QW
NCT02465515,Pancreatic cancer,Prespecified adverse events of special interest,True,False,False,False,True,Placebo,control,4715,5.0,0.0,Pancreatic cancer,Pancreatic cancer,Pancreatic cancer,False,,Albiglutide,False,False,,,
NCT02465515,Hypersensitivity syndrome or symptoms,Prespecified adverse events of special interest,True,False,False,False,True,Albiglutide,treatment,4717,45.0,1.0,Hypersensitivity syndrome or symptoms,Hypersensitivity,Hypersensitivity,False,,Albiglutide,True,True,,SC,QW
NCT02465515,Hypersensitivity syndrome or symptoms,Prespecified adverse events of special interest,True,False,False,False,True,Placebo,control,4715,48.0,1.0,Hypersensitivity syndrome or symptoms,Hypersensitivity,Hypersensitivity,False,,Albiglutide,False,False,,,
NCT02465515,Hepatobiliary disorders,Prespecified adverse events of special interest,True,False,False,False,True,Albiglutide,treatment,4717,51.0,1.0,Hepatobiliary disorders,Hepatobiliary disorders,Hepatobiliary disorders,True,other_summary,Albiglutide,True,True,,SC,QW
NCT02465515,Hepatobiliary disorders,Prespecified adverse events of special interest,True,False,False,False,True,Placebo,control,4715,41.0,1.0,Hepatobiliary disorders,Hepatobiliary disorders,Hepatobiliary disorders,True,other_summary,Albiglutide,False,False,,,
NCT02465515,Alanine aminotransferase of at least 3 times the ULN,Prespecified adverse events of special interest,True,False,False,False,True,Albiglutide,treatment,4717,17.0,0.0,Alanine aminotransferase of at least 3 times the ULN,Alanine aminotransferase increased ≥3×ULN,Liver enzyme increased,False,,Albiglutide,True,True,,SC,QW
NCT02465515,Alanine aminotransferase of at least 3 times the ULN,Prespecified adverse events of special interest,True,False,False,False,True,Placebo,control,4715,30.0,1.0,Alanine aminotransferase of at least 3 times the ULN,Alanine aminotransferase increased ≥3×ULN,Liver enzyme increased,False,,Albiglutide,False,False,,,
NCT02465515,Alanine aminotransferase of at least 5 times the ULN,Prespecified adverse events of special interest,True,False,False,False,True,Albiglutide,treatment,4717,6.0,0.0,Alanine aminotransferase of at least 5 times the ULN,Alanine aminotransferase increased ≥5×ULN,Liver enzyme increased,False,,Albiglutide,True,True,,SC,QW
NCT02465515,Alanine aminotransferase of at least 5 times the ULN,Prespecified adverse events of special interest,True,False,False,False,True,Placebo,control,4715,17.0,0.0,Alanine aminotransferase of at least 5 times the ULN,Alanine aminotransferase increased ≥5×ULN,Liver enzyme increased,False,,Albiglutide,False,False,,,
NCT02465515,Bilirubin of at least twice the ULN,Prespecified adverse events of special interest,True,False,False,False,True,Albiglutide,treatment,4717,12.0,0.0,Bilirubin of at least twice the ULN,Bilirubin increased ≥2×ULN,Hyperbilirubinemia,False,,Albiglutide,True,True,,SC,QW
NCT02465515,Bilirubin of at least twice the ULN,Prespecified adverse events of special interest,True,False,False,False,True,Placebo,control,4715,7.0,0.0,Bilirubin of at least twice the ULN,Bilirubin increased ≥2×ULN,Hyperbilirubinemia,False,,Albiglutide,False,False,,,
NCT02465515,Serious gastrointestinal events,Prespecified adverse events of special interest,True,True,False,False,True,Albiglutide,treatment,4717,92.0,2.0,Serious gastrointestinal events,Serious gastrointestinal events,Serious gastrointestinal events,True,other_summary,Albiglutide,True,True,,SC,QW
NCT02465515,Serious gastrointestinal events,Prespecified adverse events of special interest,True,True,False,False,True,Placebo,control,4715,87.0,2.0,Serious gastrointestinal events,Serious gastrointestinal events,Serious gastrointestinal events,True,other_summary,Albiglutide,False,False,,,
NCT02465515,Appendicitis,Prespecified adverse events of special interest,True,False,False,False,True,Albiglutide,treatment,4717,3.0,0.0,Appendicitis,Appendicitis,Appendicitis,False,,Albiglutide,True,True,,SC,QW
NCT02465515,Appendicitis,Prespecified adverse events of special interest,True,False,False,False,True,Placebo,control,4715,8.0,0.0,Appendicitis,Appendicitis,Appendicitis,False,,Albiglutide,False,False,,,
NCT02465515,Atrial fibrillation or flutter,Prespecified adverse events of special interest,True,False,False,False,True,Albiglutide,treatment,4717,108.0,2.0,Atrial fibrillation or flutter,Atrial fibrillation/flutter,Cardiac arrhythmia,False,,Albiglutide,True,True,,SC,QW
NCT02465515,Atrial fibrillation or flutter,Prespecified adverse events of special interest,True,False,False,False,True,Placebo,control,4715,131.0,3.0,Atrial fibrillation or flutter,Atrial fibrillation/flutter,Cardiac arrhythmia,False,,Albiglutide,False,False,,,
NCT02465515,Pneumonia,Prespecified adverse events of special interest,True,False,False,False,True,Albiglutide,treatment,4717,131.0,3.0,Pneumonia,Pneumonia,Pneumonia,False,,Albiglutide,True,True,,SC,QW
NCT02465515,Pneumonia,Prespecified adverse events of special interest,True,False,False,False,True,Placebo,control,4715,138.0,3.0,Pneumonia,Pneumonia,Pneumonia,False,,Albiglutide,False,False,,,
NCT02465515,Renal impairment,Prespecified adverse events of special interest,True,False,False,False,True,Albiglutide,treatment,4717,279.0,6.0,Renal impairment,Renal impairment,Renal impairment,False,,Albiglutide,True,True,,SC,QW
NCT02465515,Renal impairment,Prespecified adverse events of special interest,True,False,False,False,True,Placebo,control,4715,319.0,7.0,Renal impairment,Renal impairment,Renal impairment,False,,Albiglutide,False,False,,,
NCT02465515,Diabetic retinopathy,Prespecified adverse events of special interest,True,False,False,False,True,Albiglutide,treatment,4717,78.0,2.0,Diabetic retinopathy,Diabetic retinopathy,Diabetic retinopathy,False,,Albiglutide,True,True,,SC,QW
NCT02465515,Diabetic retinopathy,Prespecified adverse events of special interest,True,False,False,False,True,Placebo,control,4715,89.0,2.0,Diabetic retinopathy,Diabetic retinopathy,Diabetic retinopathy,False,,Albiglutide,False,False,,,
NCT04184622,Participants with ≥1 adverse event during treatment period,Adverse events,True,False,False,False,False,"Tirzepatide, 5 mg",treatment,630,510.0,81.0,Participants with ≥1 adverse event during treatment period,Any adverse event,Any adverse event,True,any_ae,Tirzepatide,True,True,5.0,SC,QW
NCT04184622,Participants with ≥1 adverse event during treatment period,Adverse events,True,False,False,False,False,"Tirzepatide, 10 mg",treatment,636,520.0,81.8,Participants with ≥1 adverse event during treatment period,Any adverse event,Any adverse event,True,any_ae,Tirzepatide,True,True,10.0,SC,QW
NCT04184622,Participants with ≥1 adverse event during treatment period,Adverse events,True,False,False,False,False,"Tirzepatide, 15 mg",treatment,630,497.0,78.9,Participants with ≥1 adverse event during treatment period,Any adverse event,Any adverse event,True,any_ae,Tirzepatide,True,True,15.0,SC,QW
NCT04184622,Participants with ≥1 adverse event during treatment period,Adverse events,True,False,False,False,False,Placebo,control,643,463.0,72.0,Participants with ≥1 adverse event during treatment period,Any adverse event,Any adverse event,True,any_ae,Tirzepatide,False,False,,,
NCT04184622,Serious adverse events,Serious adverse events,False,True,False,False,False,"Tirzepatide, 5 mg",treatment,630,40.0,6.3,Serious adverse events,Serious adverse events,Serious adverse events,True,serious_ae,Tirzepatide,True,True,5.0,SC,QW
NCT04184622,Serious adverse events,Serious adverse events,False,True,False,False,False,"Tirzepatide, 10 mg",treatment,636,44.0,6.9,Serious adverse events,Serious adverse events,Serious adverse events,True,serious_ae,Tirzepatide,True,True,10.0,SC,QW
NCT04184622,Serious adverse events,Serious adverse events,False,True,False,False,False,"Tirzepatide, 15 mg",treatment,630,32.0,5.1,Serious adverse events,Serious adverse events,Serious adverse events,True,serious_ae,Tirzepatide,True,True,15.0,SC,QW
NCT04184622,Serious adverse events,Serious adverse events,False,True,False,False,False,Placebo,control,643,44.0,6.8,Serious adverse events,Serious adverse events,Serious adverse events,True,serious_ae,Tirzepatide,False,False,,,
NCT04184622,Death,Fatal adverse events,False,False,True,False,False,"Tirzepatide, 5 mg",treatment,630,4.0,0.6,Death,Death,Fatal adverse events,True,fatal_ae,Tirzepatide,True,True,5.0,SC,QW
NCT04184622,Death,Fatal adverse events,False,False,True,False,False,"Tirzepatide, 10 mg",treatment,636,2.0,0.3,Death,Death,Fatal adverse events,True,fatal_ae,Tirzepatide,True,True,10.0,SC,QW
NCT04184622,Death,Fatal adverse events,False,False,True,False,False,"Tirzepatide, 15 mg",treatment,630,1.0,0.2,Death,Death,Fatal adverse events,True,fatal_ae,Tirzepatide,True,True,15.0,SC,QW
NCT04184622,Death,Fatal adverse events,False,False,True,False,False,Placebo,control,643,4.0,0.6,Death,Death,Fatal adverse events,True,fatal_ae,Tirzepatide,False,False,,,
NCT04184622,Adverse events leading to discontinuation of trial drug or placebo,Adverse events leading to discontinuation,False,False,False,True,False,"Tirzepatide, 5 mg",treatment,630,27.0,4.3,Adverse events leading to discontinuation of trial drug or placebo,Adverse events leading to discontinuation,Adverse event leading to discontinuation,True,ae_leading_to_discontinuation,Tirzepatide,True,True,5.0,SC,QW
NCT04184622,Adverse events leading to discontinuation of trial drug or placebo,Adverse events leading to discontinuation,False,False,False,True,False,"Tirzepatide, 10 mg",treatment,636,45.0,7.1,Adverse events leading to discontinuation of trial drug or placebo,Adverse events leading to discontinuation,Adverse event leading to discontinuation,True,ae_leading_to_discontinuation,Tirzepatide,True,True,10.0,SC,QW
NCT04184622,Adverse events leading to discontinuation of trial drug or placebo,Adverse events leading to discontinuation,False,False,False,True,False,"Tirzepatide, 15 mg",treatment,630,39.0,6.2,Adverse events leading to discontinuation of trial drug or placebo,Adverse events leading to discontinuation,Adverse event leading to discontinuation,True,ae_leading_to_discontinuation,Tirzepatide,True,True,15.0,SC,QW
NCT04184622,Adverse events leading to discontinuation of trial drug or placebo,Adverse events leading to discontinuation,False,False,False,True,False,Placebo,control,643,17.0,2.6,Adverse events leading to discontinuation of trial drug or placebo,Adverse events leading to discontinuation,Adverse event leading to discontinuation,True,ae_leading_to_discontinuation,Tirzepatide,False,False,,,
NCT04184622,Nausea,Adverse events,True,False,False,False,False,"Tirzepatide, 5 mg",treatment,630,155.0,24.6,Nausea,Nausea,Nausea,False,,Tirzepatide,True,True,5.0,SC,QW
NCT04184622,Nausea,Adverse events,True,False,False,False,False,"Tirzepatide, 10 mg",treatment,636,212.0,33.3,Nausea,Nausea,Nausea,False,,Tirzepatide,True,True,10.0,SC,QW
NCT04184622,Nausea,Adverse events,True,False,False,False,False,"Tirzepatide, 15 mg",treatment,630,195.0,31.0,Nausea,Nausea,Nausea,False,,Tirzepatide,True,True,15.0,SC,QW
NCT04184622,Nausea,Adverse events,True,False,False,False,False,Placebo,control,643,61.0,9.5,Nausea,Nausea,Nausea,False,,Tirzepatide,False,False,,,
NCT04184622,Diarrhea,Adverse events,True,False,False,False,False,"Tirzepatide, 5 mg",treatment,630,118.0,18.7,Diarrhea,Diarrhea,Diarrhea,False,,Tirzepatide,True,True,5.0,SC,QW
NCT04184622,Diarrhea,Adverse events,True,False,False,False,False,"Tirzepatide, 10 mg",treatment,636,135.0,21.2,Diarrhea,Diarrhea,Diarrhea,False,,Tirzepatide,True,True,10.0,SC,QW
NCT04184622,Diarrhea,Adverse events,True,False,False,False,False,"Tirzepatide, 15 mg",treatment,630,145.0,23.0,Diarrhea,Diarrhea,Diarrhea,False,,Tirzepatide,True,True,15.0,SC,QW
NCT04184622,Diarrhea,Adverse events,True,False,False,False,False,Placebo,control,643,47.0,7.3,Diarrhea,Diarrhea,Diarrhea,False,,Tirzepatide,False,False,,,
NCT04184622,Covid-19,Adverse events,True,False,False,False,False,"Tirzepatide, 5 mg",treatment,630,94.0,14.9,Covid-19,COVID-19,COVID-19,False,,Tirzepatide,True,True,5.0,SC,QW
NCT04184622,Covid-19,Adverse events,True,False,False,False,False,"Tirzepatide, 10 mg",treatment,636,98.0,15.4,Covid-19,COVID-19,COVID-19,False,,Tirzepatide,True,True,10.0,SC,QW
NCT04184622,Covid-19,Adverse events,True,False,False,False,False,"Tirzepatide, 15 mg",treatment,630,82.0,13.0,Covid-19,COVID-19,COVID-19,False,,Tirzepatide,True,True,15.0,SC,QW
NCT04184622,Covid-19,Adverse events,True,False,False,False,False,Placebo,control,643,90.0,14.0,Covid-19,COVID-19,COVID-19,False,,Tirzepatide,False,False,,,
NCT04184622,Constipation,Adverse events,True,False,False,False,False,"Tirzepatide, 5 mg",treatment,630,106.0,16.8,Constipation,Constipation,Constipation,False,,Tirzepatide,True,True,5.0,SC,QW
NCT04184622,Constipation,Adverse events,True,False,False,False,False,"Tirzepatide, 10 mg",treatment,636,109.0,17.1,Constipation,Constipation,Constipation,False,,Tirzepatide,True,True,10.0,SC,QW
NCT04184622,Constipation,Adverse events,True,False,False,False,False,"Tirzepatide, 15 mg",treatment,630,74.0,11.7,Constipation,Constipation,Constipation,False,,Tirzepatide,True,True,15.0,SC,QW
NCT04184622,Constipation,Adverse events,True,False,False,False,False,Placebo,control,643,37.0,5.8,Constipation,Constipation,Constipation,False,,Tirzepatide,False,False,,,
NCT04184622,Dyspepsia,Adverse events,True,False,False,False,False,"Tirzepatide, 5 mg",treatment,630,56.0,8.9,Dyspepsia,Dyspepsia,Dyspepsia,False,,Tirzepatide,True,True,5.0,SC,QW
NCT04184622,Dyspepsia,Adverse events,True,False,False,False,False,"Tirzepatide, 10 mg",treatment,636,62.0,9.7,Dyspepsia,Dyspepsia,Dyspepsia,False,,Tirzepatide,True,True,10.0,SC,QW
NCT04184622,Dyspepsia,Adverse events,True,False,False,False,False,"Tirzepatide, 15 mg",treatment,630,71.0,11.3,Dyspepsia,Dyspepsia,Dyspepsia,False,,Tirzepatide,True,True,15.0,SC,QW
NCT04184622,Dyspepsia,Adverse events,True,False,False,False,False,Placebo,control,643,27.0,4.2,Dyspepsia,Dyspepsia,Dyspepsia,False,,Tirzepatide,False,False,,,
NCT04184622,Vomiting,Adverse events,True,False,False,False,False,"Tirzepatide, 5 mg",treatment,630,52.0,8.3,Vomiting,Vomiting,Vomiting,False,,Tirzepatide,True,True,5.0,SC,QW
NCT04184622,Vomiting,Adverse events,True,False,False,False,False,"Tirzepatide, 10 mg",treatment,636,68.0,10.7,Vomiting,Vomiting,Vomiting,False,,Tirzepatide,True,True,10.0,SC,QW
NCT04184622,Vomiting,Adverse events,True,False,False,False,False,"Tirzepatide, 15 mg",treatment,630,77.0,12.2,Vomiting,Vomiting,Vomiting,False,,Tirzepatide,True,True,15.0,SC,QW
NCT04184622,Vomiting,Adverse events,True,False,False,False,False,Placebo,control,643,11.0,1.7,Vomiting,Vomiting,Vomiting,False,,Tirzepatide,False,False,,,
NCT04184622,Decreased appetite,Adverse events,True,False,False,False,False,"Tirzepatide, 5 mg",treatment,630,59.0,9.4,Decreased appetite,Decreased appetite,Decreased appetite,False,,Tirzepatide,True,True,5.0,SC,QW
NCT04184622,Decreased appetite,Adverse events,True,False,False,False,False,"Tirzepatide, 10 mg",treatment,636,73.0,11.5,Decreased appetite,Decreased appetite,Decreased appetite,False,,Tirzepatide,True,True,10.0,SC,QW
NCT04184622,Decreased appetite,Adverse events,True,False,False,False,False,"Tirzepatide, 15 mg",treatment,630,54.0,8.6,Decreased appetite,Decreased appetite,Decreased appetite,False,,Tirzepatide,True,True,15.0,SC,QW
NCT04184622,Decreased appetite,Adverse events,True,False,False,False,False,Placebo,control,643,21.0,3.3,Decreased appetite,Decreased appetite,Decreased appetite,False,,Tirzepatide,False,False,,,
NCT04184622,Headache,Adverse events,True,False,False,False,False,"Tirzepatide, 5 mg",treatment,630,41.0,6.5,Headache,Headache,Headache,False,,Tirzepatide,True,True,5.0,SC,QW
NCT04184622,Headache,Adverse events,True,False,False,False,False,"Tirzepatide, 10 mg",treatment,636,43.0,6.8,Headache,Headache,Headache,False,,Tirzepatide,True,True,10.0,SC,QW
NCT04184622,Headache,Adverse events,True,False,False,False,False,"Tirzepatide, 15 mg",treatment,630,41.0,6.5,Headache,Headache,Headache,False,,Tirzepatide,True,True,15.0,SC,QW
NCT04184622,Headache,Adverse events,True,False,False,False,False,Placebo,control,643,42.0,6.5,Headache,Headache,Headache,False,,Tirzepatide,False,False,,,
NCT04184622,Abdominal pain,Adverse events,True,False,False,False,False,"Tirzepatide, 5 mg",treatment,630,31.0,4.9,Abdominal pain,Abdominal pain,Abdominal pain,False,,Tirzepatide,True,True,5.0,SC,QW
NCT04184622,Abdominal pain,Adverse events,True,False,False,False,False,"Tirzepatide, 10 mg",treatment,636,34.0,5.3,Abdominal pain,Abdominal pain,Abdominal pain,False,,Tirzepatide,True,True,10.0,SC,QW
NCT04184622,Abdominal pain,Adverse events,True,False,False,False,False,"Tirzepatide, 15 mg",treatment,630,31.0,4.9,Abdominal pain,Abdominal pain,Abdominal pain,False,,Tirzepatide,True,True,15.0,SC,QW
NCT04184622,Abdominal pain,Adverse events,True,False,False,False,False,Placebo,control,643,21.0,3.3,Abdominal pain,Abdominal pain,Abdominal pain,False,,Tirzepatide,False,False,,,
NCT04184622,Alopecia,Adverse events,True,False,False,False,False,"Tirzepatide, 5 mg",treatment,630,32.0,5.1,Alopecia,Alopecia,Alopecia,False,,Tirzepatide,True,True,5.0,SC,QW
NCT04184622,Alopecia,Adverse events,True,False,False,False,False,"Tirzepatide, 10 mg",treatment,636,31.0,4.9,Alopecia,Alopecia,Alopecia,False,,Tirzepatide,True,True,10.0,SC,QW
NCT04184622,Alopecia,Adverse events,True,False,False,False,False,"Tirzepatide, 15 mg",treatment,630,36.0,5.7,Alopecia,Alopecia,Alopecia,False,,Tirzepatide,True,True,15.0,SC,QW
NCT04184622,Alopecia,Adverse events,True,False,False,False,False,Placebo,control,643,6.0,0.9,Alopecia,Alopecia,Alopecia,False,,Tirzepatide,False,False,,,
NCT04184622,Dizziness,Adverse events,True,False,False,False,False,"Tirzepatide, 5 mg",treatment,630,26.0,4.1,Dizziness,Dizziness,Dizziness,False,,Tirzepatide,True,True,5.0,SC,QW
NCT04184622,Dizziness,Adverse events,True,False,False,False,False,"Tirzepatide, 10 mg",treatment,636,35.0,5.5,Dizziness,Dizziness,Dizziness,False,,Tirzepatide,True,True,10.0,SC,QW
NCT04184622,Dizziness,Adverse events,True,False,False,False,False,"Tirzepatide, 15 mg",treatment,630,26.0,4.1,Dizziness,Dizziness,Dizziness,False,,Tirzepatide,True,True,15.0,SC,QW
NCT04184622,Dizziness,Adverse events,True,False,False,False,False,Placebo,control,643,15.0,2.3,Dizziness,Dizziness,Dizziness,False,,Tirzepatide,False,False,,,
NCT04184622,Eructation,Adverse events,True,False,False,False,False,"Tirzepatide, 5 mg",treatment,630,24.0,3.8,Eructation,Eructation,GI gas-related symptoms,False,,Tirzepatide,True,True,5.0,SC,QW
NCT04184622,Eructation,Adverse events,True,False,False,False,False,"Tirzepatide, 10 mg",treatment,636,33.0,5.2,Eructation,Eructation,GI gas-related symptoms,False,,Tirzepatide,True,True,10.0,SC,QW
NCT04184622,Eructation,Adverse events,True,False,False,False,False,"Tirzepatide, 15 mg",treatment,630,35.0,5.6,Eructation,Eructation,GI gas-related symptoms,False,,Tirzepatide,True,True,15.0,SC,QW
NCT04184622,Eructation,Adverse events,True,False,False,False,False,Placebo,control,643,4.0,0.6,Eructation,Eructation,GI gas-related symptoms,False,,Tirzepatide,False,False,,,
NCT04184622,Injection-site reaction,Adverse events,True,False,False,False,False,"Tirzepatide, 5 mg",treatment,630,18.0,2.9,Injection-site reaction,Injection-site reaction,Injection-site reactions,False,,Tirzepatide,True,True,5.0,SC,QW
NCT04184622,Injection-site reaction,Adverse events,True,False,False,False,False,"Tirzepatide, 10 mg",treatment,636,36.0,5.7,Injection-site reaction,Injection-site reaction,Injection-site reactions,False,,Tirzepatide,True,True,10.0,SC,QW
NCT04184622,Injection-site reaction,Adverse events,True,False,False,False,False,"Tirzepatide, 15 mg",treatment,630,29.0,4.6,Injection-site reaction,Injection-site reaction,Injection-site reactions,False,,Tirzepatide,True,True,15.0,SC,QW
NCT04184622,Injection-site reaction,Adverse events,True,False,False,False,False,Placebo,control,643,2.0,0.3,Injection-site reaction,Injection-site reaction,Injection-site reactions,False,,Tirzepatide,False,False,,,
NCT04184622,Hepatic events,Adverse events of special interest,False,False,False,False,True,"Tirzepatide, 5 mg",treatment,630,2.0,0.3,Hepatic events,Hepatic events,Hepatic events,True,other_summary,Tirzepatide,True,True,5.0,SC,QW
NCT04184622,Hepatic events,Adverse events of special interest,False,False,False,False,True,"Tirzepatide, 10 mg",treatment,636,2.0,0.3,Hepatic events,Hepatic events,Hepatic events,True,other_summary,Tirzepatide,True,True,10.0,SC,QW
NCT04184622,Hepatic events,Adverse events of special interest,False,False,False,False,True,"Tirzepatide, 15 mg",treatment,630,0.0,0.0,Hepatic events,Hepatic events,Hepatic events,True,other_summary,Tirzepatide,True,True,15.0,SC,QW
NCT04184622,Hepatic events,Adverse events of special interest,False,False,False,False,True,Placebo,control,643,0.0,0.0,Hepatic events,Hepatic events,Hepatic events,True,other_summary,Tirzepatide,False,False,,,
NCT04184622,Cancer,Adverse events of special interest,False,False,False,False,True,"Tirzepatide, 5 mg",treatment,630,9.0,1.4,Cancer,Cancer,Cancer,True,other_summary,Tirzepatide,True,True,5.0,SC,QW
NCT04184622,Cancer,Adverse events of special interest,False,False,False,False,True,"Tirzepatide, 10 mg",treatment,636,3.0,0.5,Cancer,Cancer,Cancer,True,other_summary,Tirzepatide,True,True,10.0,SC,QW
NCT04184622,Cancer,Adverse events of special interest,False,False,False,False,True,"Tirzepatide, 15 mg",treatment,630,5.0,0.8,Cancer,Cancer,Cancer,True,other_summary,Tirzepatide,True,True,15.0,SC,QW
NCT04184622,Cancer,Adverse events of special interest,False,False,False,False,True,Placebo,control,643,7.0,1.1,Cancer,Cancer,Cancer,True,other_summary,Tirzepatide,False,False,,,
NCT04184622,Pancreatitis (adjudication-confirmed),Adverse events of special interest,False,True,False,False,True,"Tirzepatide, 5 mg",treatment,630,1.0,0.2,Pancreatitis (adjudication-confirmed),Pancreatitis,Pancreatitis,False,,Tirzepatide,True,True,5.0,SC,QW
NCT04184622,Pancreatitis (adjudication-confirmed),Adverse events of special interest,False,True,False,False,True,"Tirzepatide, 10 mg",treatment,636,1.0,0.2,Pancreatitis (adjudication-confirmed),Pancreatitis,Pancreatitis,False,,Tirzepatide,True,True,10.0,SC,QW
NCT04184622,Pancreatitis (adjudication-confirmed),Adverse events of special interest,False,True,False,False,True,"Tirzepatide, 15 mg",treatment,630,1.0,0.2,Pancreatitis (adjudication-confirmed),Pancreatitis,Pancreatitis,False,,Tirzepatide,True,True,15.0,SC,QW
NCT04184622,Pancreatitis (adjudication-confirmed),Adverse events of special interest,False,True,False,False,True,Placebo,control,643,1.0,0.2,Pancreatitis (adjudication-confirmed),Pancreatitis,Pancreatitis,False,,Tirzepatide,False,False,,,
NCT04184622,Major (adjudication-confirmed) adverse cardiovascular events,Adverse events of special interest,False,True,False,False,True,"Tirzepatide, 5 mg",treatment,630,4.0,0.6,Major (adjudication-confirmed) adverse cardiovascular events,Major adverse cardiovascular events (adjudicated),Major adverse cardiovascular events,True,other_summary,Tirzepatide,True,True,5.0,SC,QW
NCT04184622,Major (adjudication-confirmed) adverse cardiovascular events,Adverse events of special interest,False,True,False,False,True,"Tirzepatide, 10 mg",treatment,636,5.0,0.8,Major (adjudication-confirmed) adverse cardiovascular events,Major adverse cardiovascular events (adjudicated),Major adverse cardiovascular events,True,other_summary,Tirzepatide,True,True,10.0,SC,QW
NCT04184622,Major (adjudication-confirmed) adverse cardiovascular events,Adverse events of special interest,False,True,False,False,True,"Tirzepatide, 15 mg",treatment,630,0.0,0.0,Major (adjudication-confirmed) adverse cardiovascular events,Major adverse cardiovascular events (adjudicated),Major adverse cardiovascular events,True,other_summary,Tirzepatide,True,True,15.0,SC,QW
NCT04184622,Major (adjudication-confirmed) adverse cardiovascular events,Adverse events of special interest,False,True,False,False,True,Placebo,control,643,5.0,0.8,Major (adjudication-confirmed) adverse cardiovascular events,Major adverse cardiovascular events (adjudicated),Major adverse cardiovascular events,True,other_summary,Tirzepatide,False,False,,,
NCT04184622,Cardiac disorders,Adverse events of special interest,False,True,False,False,True,"Tirzepatide, 5 mg",treatment,630,0.0,0.0,Cardiac disorders,Cardiac disorders,Cardiac disorders,True,other_summary,Tirzepatide,True,True,5.0,SC,QW
NCT04184622,Cardiac disorders,Adverse events of special interest,False,True,False,False,True,"Tirzepatide, 10 mg",treatment,636,1.0,0.2,Cardiac disorders,Cardiac disorders,Cardiac disorders,True,other_summary,Tirzepatide,True,True,10.0,SC,QW
NCT04184622,Cardiac disorders,Adverse events of special interest,False,True,False,False,True,"Tirzepatide, 15 mg",treatment,630,2.0,0.3,Cardiac disorders,Cardiac disorders,Cardiac disorders,True,other_summary,Tirzepatide,True,True,15.0,SC,QW
NCT04184622,Cardiac disorders,Adverse events of special interest,False,True,False,False,True,Placebo,control,643,1.0,0.2,Cardiac disorders,Cardiac disorders,Cardiac disorders,True,other_summary,Tirzepatide,False,False,,,
NCT04184622,Severe or serious gastrointestinal events,Adverse events of special interest,False,True,False,False,True,"Tirzepatide, 5 mg",treatment,630,11.0,1.7,Severe or serious gastrointestinal events,Severe or serious gastrointestinal events,Severe or serious gastrointestinal events,True,other_summary,Tirzepatide,True,True,5.0,SC,QW
NCT04184622,Severe or serious gastrointestinal events,Adverse events of special interest,False,True,False,False,True,"Tirzepatide, 10 mg",treatment,636,20.0,3.1,Severe or serious gastrointestinal events,Severe or serious gastrointestinal events,Severe or serious gastrointestinal events,True,other_summary,Tirzepatide,True,True,10.0,SC,QW
NCT04184622,Severe or serious gastrointestinal events,Adverse events of special interest,False,True,False,False,True,"Tirzepatide, 15 mg",treatment,630,21.0,3.3,Severe or serious gastrointestinal events,Severe or serious gastrointestinal events,Severe or serious gastrointestinal events,True,other_summary,Tirzepatide,True,True,15.0,SC,QW
NCT04184622,Severe or serious gastrointestinal events,Adverse events of special interest,False,True,False,False,True,Placebo,control,643,7.0,1.1,Severe or serious gastrointestinal events,Severe or serious gastrointestinal events,Severe or serious gastrointestinal events,True,other_summary,Tirzepatide,False,False,,,
NCT04184622,Gallbladder disease,Adverse events of special interest,False,True,False,False,True,"Tirzepatide, 5 mg",treatment,630,5.0,0.8,Gallbladder disease,Gallbladder disease,Gallbladder disease,True,other_summary,Tirzepatide,True,True,5.0,SC,QW
NCT04184622,Gallbladder disease,Adverse events of special interest,False,True,False,False,True,"Tirzepatide, 10 mg",treatment,636,11.0,1.7,Gallbladder disease,Gallbladder disease,Gallbladder disease,True,other_summary,Tirzepatide,True,True,10.0,SC,QW
NCT04184622,Gallbladder disease,Adverse events of special interest,False,True,False,False,True,"Tirzepatide, 15 mg",treatment,630,6.0,1.0,Gallbladder disease,Gallbladder disease,Gallbladder disease,True,other_summary,Tirzepatide,True,True,15.0,SC,QW
NCT04184622,Gallbladder disease,Adverse events of special interest,False,True,False,False,True,Placebo,control,643,5.0,0.8,Gallbladder disease,Gallbladder disease,Gallbladder disease,True,other_summary,Tirzepatide,False,False,,,
NCT04184622,Renal events,Adverse events of special interest,False,True,False,False,True,"Tirzepatide, 5 mg",treatment,630,2.0,0.3,Renal events,Renal impairment,Renal impairment,False,,Tirzepatide,True,True,5.0,SC,QW
NCT04184622,Renal events,Adverse events of special interest,False,True,False,False,True,"Tirzepatide, 10 mg",treatment,636,2.0,0.3,Renal events,Renal impairment,Renal impairment,False,,Tirzepatide,True,True,10.0,SC,QW
NCT04184622,Renal events,Adverse events of special interest,False,True,False,False,True,"Tirzepatide, 15 mg",treatment,630,2.0,0.3,Renal events,Renal impairment,Renal impairment,False,,Tirzepatide,True,True,15.0,SC,QW
NCT04184622,Renal events,Adverse events of special interest,False,True,False,False,True,Placebo,control,643,1.0,0.2,Renal events,Renal impairment,Renal impairment,False,,Tirzepatide,False,False,,,
NCT04184622,Major depressive disorder or suicidal ideation,Adverse events of special interest,False,True,False,False,True,"Tirzepatide, 5 mg",treatment,630,1.0,0.2,Major depressive disorder or suicidal ideation,Major depressive disorder or suicidal ideation,Depression and suicidality,False,,Tirzepatide,True,True,5.0,SC,QW
NCT04184622,Major depressive disorder or suicidal ideation,Adverse events of special interest,False,True,False,False,True,"Tirzepatide, 10 mg",treatment,636,2.0,0.3,Major depressive disorder or suicidal ideation,Major depressive disorder or suicidal ideation,Depression and suicidality,False,,Tirzepatide,True,True,10.0,SC,QW
NCT04184622,Major depressive disorder or suicidal ideation,Adverse events of special interest,False,True,False,False,True,"Tirzepatide, 15 mg",treatment,630,2.0,0.3,Major depressive disorder or suicidal ideation,Major depressive disorder or suicidal ideation,Depression and suicidality,False,,Tirzepatide,True,True,15.0,SC,QW
NCT04184622,Major depressive disorder or suicidal ideation,Adverse events of special interest,False,True,False,False,True,Placebo,control,643,0.0,0.0,Major depressive disorder or suicidal ideation,Major depressive disorder or suicidal ideation,Depression and suicidality,False,,Tirzepatide,False,False,,,
NCT04184622,Hypersensitivity,Adverse events of special interest,False,True,False,False,True,"Tirzepatide, 5 mg",treatment,630,0.0,0.0,Hypersensitivity,Hypersensitivity,Hypersensitivity,False,,Tirzepatide,True,True,5.0,SC,QW
NCT04184622,Hypersensitivity,Adverse events of special interest,False,True,False,False,True,"Tirzepatide, 10 mg",treatment,636,1.0,0.2,Hypersensitivity,Hypersensitivity,Hypersensitivity,False,,Tirzepatide,True,True,10.0,SC,QW
NCT04184622,Hypersensitivity,Adverse events of special interest,False,True,False,False,True,"Tirzepatide, 15 mg",treatment,630,1.0,0.2,Hypersensitivity,Hypersensitivity,Hypersensitivity,False,,Tirzepatide,True,True,15.0,SC,QW
NCT04184622,Hypersensitivity,Adverse events of special interest,False,True,False,False,True,Placebo,control,643,0.0,0.0,Hypersensitivity,Hypersensitivity,Hypersensitivity,False,,Tirzepatide,False,False,,,
NCT04184622,Hypoglycemia (blood glucose <54 mg/dl),Adverse events of special interest,False,True,False,False,True,"Tirzepatide, 5 mg",treatment,630,9.0,1.4,Hypoglycemia (blood glucose <54 mg/dl),Hypoglycemia (<54 mg/dL),Hypoglycemia,False,,Tirzepatide,True,True,5.0,SC,QW
NCT04184622,Hypoglycemia (blood glucose <54 mg/dl),Adverse events of special interest,False,True,False,False,True,"Tirzepatide, 10 mg",treatment,636,10.0,1.6,Hypoglycemia (blood glucose <54 mg/dl),Hypoglycemia (<54 mg/dL),Hypoglycemia,False,,Tirzepatide,True,True,10.0,SC,QW
NCT04184622,Hypoglycemia (blood glucose <54 mg/dl),Adverse events of special interest,False,True,False,False,True,"Tirzepatide, 15 mg",treatment,630,10.0,1.6,Hypoglycemia (blood glucose <54 mg/dl),Hypoglycemia (<54 mg/dL),Hypoglycemia,False,,Tirzepatide,True,True,15.0,SC,QW
NCT04184622,Hypoglycemia (blood glucose <54 mg/dl),Adverse events of special interest,False,True,False,False,True,Placebo,control,643,1.0,0.2,Hypoglycemia (blood glucose <54 mg/dl),Hypoglycemia (<54 mg/dL),Hypoglycemia,False,,Tirzepatide,False,False,,,
NCT04184622,Cholelithiasis,Other adverse events of interest,False,False,False,False,False,"Tirzepatide, 5 mg",treatment,630,7.0,1.1,Cholelithiasis,Cholelithiasis,Gallbladder disease,False,,Tirzepatide,True,True,5.0,SC,QW
NCT04184622,Cholelithiasis,Other adverse events of interest,False,False,False,False,False,"Tirzepatide, 10 mg",treatment,636,9.0,1.4,Cholelithiasis,Cholelithiasis,Gallbladder disease,False,,Tirzepatide,True,True,10.0,SC,QW
NCT04184622,Cholelithiasis,Other adverse events of interest,False,False,False,False,False,"Tirzepatide, 15 mg",treatment,630,4.0,0.6,Cholelithiasis,Cholelithiasis,Gallbladder disease,False,,Tirzepatide,True,True,15.0,SC,QW
NCT04184622,Cholelithiasis,Other adverse events of interest,False,False,False,False,False,Placebo,control,643,6.0,0.9,Cholelithiasis,Cholelithiasis,Gallbladder disease,False,,Tirzepatide,False,False,,,
NCT04184622,Cholecystitis,Other adverse events of interest,False,False,False,False,False,"Tirzepatide, 5 mg",treatment,630,4.0,0.6,Cholecystitis,Cholecystitis,Gallbladder disease,False,,Tirzepatide,True,True,5.0,SC,QW
NCT04184622,Cholecystitis,Other adverse events of interest,False,False,False,False,False,"Tirzepatide, 10 mg",treatment,636,3.0,0.5,Cholecystitis,Cholecystitis,Gallbladder disease,False,,Tirzepatide,True,True,10.0,SC,QW
NCT04184622,Cholecystitis,Other adverse events of interest,False,False,False,False,False,"Tirzepatide, 15 mg",treatment,630,0.0,0.0,Cholecystitis,Cholecystitis,Gallbladder disease,False,,Tirzepatide,True,True,15.0,SC,QW
NCT04184622,Cholecystitis,Other adverse events of interest,False,False,False,False,False,Placebo,control,643,0.0,0.0,Cholecystitis,Cholecystitis,Gallbladder disease,False,,Tirzepatide,False,False,,,
NCT04184622,Acute cholecystitis,Other adverse events of interest,False,False,False,False,False,"Tirzepatide, 5 mg",treatment,630,1.0,0.2,Acute cholecystitis,Acute cholecystitis,Gallbladder disease,False,,Tirzepatide,True,True,5.0,SC,QW
NCT04184622,Acute cholecystitis,Other adverse events of interest,False,False,False,False,False,"Tirzepatide, 10 mg",treatment,636,4.0,0.6,Acute cholecystitis,Acute cholecystitis,Gallbladder disease,False,,Tirzepatide,True,True,10.0,SC,QW
NCT04184622,Acute cholecystitis,Other adverse events of interest,False,False,False,False,False,"Tirzepatide, 15 mg",treatment,630,1.0,0.2,Acute cholecystitis,Acute cholecystitis,Gallbladder disease,False,,Tirzepatide,True,True,15.0,SC,QW
NCT04184622,Acute cholecystitis,Other adverse events of interest,False,False,False,False,False,Placebo,control,643,0.0,0.0,Acute cholecystitis,Acute cholecystitis,Gallbladder disease,False,,Tirzepatide,False,False,,,
NCT04184622,Chronic cholecystitis,Other adverse events of interest,False,False,False,False,False,"Tirzepatide, 5 mg",treatment,630,1.0,0.2,Chronic cholecystitis,Chronic cholecystitis,Gallbladder disease,False,,Tirzepatide,True,True,5.0,SC,QW
NCT04184622,Chronic cholecystitis,Other adverse events of interest,False,False,False,False,False,"Tirzepatide, 10 mg",treatment,636,1.0,0.2,Chronic cholecystitis,Chronic cholecystitis,Gallbladder disease,False,,Tirzepatide,True,True,10.0,SC,QW
NCT04184622,Chronic cholecystitis,Other adverse events of interest,False,False,False,False,False,"Tirzepatide, 15 mg",treatment,630,3.0,0.5,Chronic cholecystitis,Chronic cholecystitis,Gallbladder disease,False,,Tirzepatide,True,True,15.0,SC,QW
NCT04184622,Chronic cholecystitis,Other adverse events of interest,False,False,False,False,False,Placebo,control,643,3.0,0.5,Chronic cholecystitis,Chronic cholecystitis,Gallbladder disease,False,,Tirzepatide,False,False,,,
Exenatide (Byetta)_15,Nausea,Frequent treatment-emergent adverse events (≥5% incidence and greater incidence with Byetta treatment) excluding hypoglycemia,True,False,False,False,False,Placebo,control,483,87.0,18.0,Nausea,Nausea,Nausea,False,,Exenatide (Byetta),False,False,,,
Exenatide (Byetta)_15,Nausea,Frequent treatment-emergent adverse events (≥5% incidence and greater incidence with Byetta treatment) excluding hypoglycemia,True,False,False,False,False,Exenatide,treatment,963,423.0,44.0,Nausea,Nausea,Nausea,False,,Exenatide (Byetta),True,True,,SC,BID
Exenatide (Byetta)_15,Vomiting,Frequent treatment-emergent adverse events (≥5% incidence and greater incidence with Byetta treatment) excluding hypoglycemia,True,False,False,False,False,Placebo,control,483,19.0,4.0,Vomiting,Vomiting,Vomiting,False,,Exenatide (Byetta),False,False,,,
Exenatide (Byetta)_15,Vomiting,Frequent treatment-emergent adverse events (≥5% incidence and greater incidence with Byetta treatment) excluding hypoglycemia,True,False,False,False,False,Exenatide,treatment,963,125.0,13.0,Vomiting,Vomiting,Vomiting,False,,Exenatide (Byetta),True,True,,SC,BID
Exenatide (Byetta)_15,Diarrhea,Frequent treatment-emergent adverse events (≥5% incidence and greater incidence with Byetta treatment) excluding hypoglycemia,True,False,False,False,False,Placebo,control,483,29.0,6.0,Diarrhea,Diarrhea,Diarrhea,False,,Exenatide (Byetta),False,False,,,
Exenatide (Byetta)_15,Diarrhea,Frequent treatment-emergent adverse events (≥5% incidence and greater incidence with Byetta treatment) excluding hypoglycemia,True,False,False,False,False,Exenatide,treatment,963,125.0,13.0,Diarrhea,Diarrhea,Diarrhea,False,,Exenatide (Byetta),True,True,,SC,BID
Exenatide (Byetta)_15,Feeling jittery,Frequent treatment-emergent adverse events (≥5% incidence and greater incidence with Byetta treatment) excluding hypoglycemia,True,False,False,False,False,Placebo,control,483,19.0,4.0,Feeling jittery,Nervousness,Anxiety,False,,Exenatide (Byetta),False,False,,,
Exenatide (Byetta)_15,Feeling jittery,Frequent treatment-emergent adverse events (≥5% incidence and greater incidence with Byetta treatment) excluding hypoglycemia,True,False,False,False,False,Exenatide,treatment,963,87.0,9.0,Feeling jittery,Nervousness,Anxiety,False,,Exenatide (Byetta),True,True,,SC,BID
Exenatide (Byetta)_15,Dizziness,Frequent treatment-emergent adverse events (≥5% incidence and greater incidence with Byetta treatment) excluding hypoglycemia,True,False,False,False,False,Placebo,control,483,29.0,6.0,Dizziness,Dizziness,Dizziness,False,,Exenatide (Byetta),False,False,,,
Exenatide (Byetta)_15,Dizziness,Frequent treatment-emergent adverse events (≥5% incidence and greater incidence with Byetta treatment) excluding hypoglycemia,True,False,False,False,False,Exenatide,treatment,963,87.0,9.0,Dizziness,Dizziness,Dizziness,False,,Exenatide (Byetta),True,True,,SC,BID
Exenatide (Byetta)_15,Headache,Frequent treatment-emergent adverse events (≥5% incidence and greater incidence with Byetta treatment) excluding hypoglycemia,True,False,False,False,False,Placebo,control,483,29.0,6.0,Headache,Headache,Headache,False,,Exenatide (Byetta),False,False,,,
Exenatide (Byetta)_15,Headache,Frequent treatment-emergent adverse events (≥5% incidence and greater incidence with Byetta treatment) excluding hypoglycemia,True,False,False,False,False,Exenatide,treatment,963,87.0,9.0,Headache,Headache,Headache,False,,Exenatide (Byetta),True,True,,SC,BID
Exenatide (Byetta)_15,Dyspepsia,Frequent treatment-emergent adverse events (≥5% incidence and greater incidence with Byetta treatment) excluding hypoglycemia,True,False,False,False,False,Placebo,control,483,14.0,3.0,Dyspepsia,Dyspepsia,Dyspepsia,False,,Exenatide (Byetta),False,False,,,
Exenatide (Byetta)_15,Dyspepsia,Frequent treatment-emergent adverse events (≥5% incidence and greater incidence with Byetta treatment) excluding hypoglycemia,True,False,False,False,False,Exenatide,treatment,963,58.0,6.0,Dyspepsia,Dyspepsia,Dyspepsia,False,,Exenatide (Byetta),True,True,,SC,BID
NCT00707031,Any AE,Overall adverse events,True,False,False,False,False,Lixisenatide 20 µg QD,treatment,318,221.0,69.5,Any AE,Any adverse event,Any adverse event,True,any_ae,Lixisenatide,True,True,0.02,SC,QD
NCT00707031,Any AE,Overall adverse events,True,False,False,False,False,Exenatide 10 µg BID,control,316,228.0,72.2,Any AE,Any adverse event,Any adverse event,True,any_ae,Lixisenatide,True,True,0.01,SC,BID
NCT00707031,Any serious AE,Serious adverse events,False,True,False,False,False,Lixisenatide 20 µg QD,treatment,318,9.0,2.8,Any serious AE,Serious adverse events,Serious adverse events,True,serious_ae,Lixisenatide,True,True,0.02,SC,QD
NCT00707031,Any serious AE,Serious adverse events,False,True,False,False,False,Exenatide 10 µg BID,control,316,7.0,2.2,Any serious AE,Serious adverse events,Serious adverse events,True,serious_ae,Lixisenatide,True,True,0.01,SC,BID
NCT00707031,Death,Fatal adverse events,False,False,True,False,False,Lixisenatide 20 µg QD,treatment,318,1.0,0.3,Death,Death,Fatal adverse events,True,fatal_ae,Lixisenatide,True,True,0.02,SC,QD
NCT00707031,Death,Fatal adverse events,False,False,True,False,False,Exenatide 10 µg BID,control,316,1.0,0.3,Death,Death,Fatal adverse events,True,fatal_ae,Lixisenatide,True,True,0.01,SC,BID
NCT00707031,AE leading to discontinuation,Adverse events leading to discontinuation,False,False,False,True,False,Lixisenatide 20 µg QD,treatment,318,33.0,10.4,AE leading to discontinuation,Adverse event leading to discontinuation,Adverse event leading to discontinuation,True,ae_leading_to_discontinuation,Lixisenatide,True,True,0.02,SC,QD
NCT00707031,AE leading to discontinuation,Adverse events leading to discontinuation,False,False,False,True,False,Exenatide 10 µg BID,control,316,41.0,13.0,AE leading to discontinuation,Adverse event leading to discontinuation,Adverse event leading to discontinuation,True,ae_leading_to_discontinuation,Lixisenatide,True,True,0.01,SC,BID
NCT00707031,Gastrointestinal disorders (any),Gastrointestinal disorders,True,False,False,False,False,Lixisenatide 20 µg QD,treatment,318,137.0,43.1,Gastrointestinal disorders (any),Gastrointestinal disorders (any),Gastrointestinal disorders (any),True,other_summary,Lixisenatide,True,True,0.02,SC,QD
NCT00707031,Gastrointestinal disorders (any),Gastrointestinal disorders,True,False,False,False,False,Exenatide 10 µg BID,control,316,160.0,50.6,Gastrointestinal disorders (any),Gastrointestinal disorders (any),Gastrointestinal disorders (any),True,other_summary,Lixisenatide,True,True,0.01,SC,BID
NCT00707031,Nausea,Gastrointestinal disorders,True,False,False,False,False,Lixisenatide 20 µg QD,treatment,318,78.0,24.5,Nausea,Nausea,Nausea,False,,Lixisenatide,True,True,0.02,SC,QD
NCT00707031,Nausea,Gastrointestinal disorders,True,False,False,False,False,Exenatide 10 µg BID,control,316,111.0,35.1,Nausea,Nausea,Nausea,False,,Lixisenatide,True,True,0.01,SC,BID
NCT00707031,Vomiting,Gastrointestinal disorders,True,False,False,False,False,Lixisenatide 20 µg QD,treatment,318,32.0,10.1,Vomiting,Vomiting,Vomiting,False,,Lixisenatide,True,True,0.02,SC,QD
NCT00707031,Vomiting,Gastrointestinal disorders,True,False,False,False,False,Exenatide 10 µg BID,control,316,42.0,13.3,Vomiting,Vomiting,Vomiting,False,,Lixisenatide,True,True,0.01,SC,BID
NCT00707031,Diarrhea,Gastrointestinal disorders,True,False,False,False,False,Lixisenatide 20 µg QD,treatment,318,33.0,10.4,Diarrhea,Diarrhea,Diarrhea,False,,Lixisenatide,True,True,0.02,SC,QD
NCT00707031,Diarrhea,Gastrointestinal disorders,True,False,False,False,False,Exenatide 10 µg BID,control,316,42.0,13.3,Diarrhea,Diarrhea,Diarrhea,False,,Lixisenatide,True,True,0.01,SC,BID
NCT00707031,Symptomatic hypoglycemia,Hypoglycemia,True,False,False,False,False,Lixisenatide 20 µg QD,treatment,318,8.0,2.5,Symptomatic hypoglycemia,Symptomatic hypoglycemia,Hypoglycemia,False,,Lixisenatide,True,True,0.02,SC,QD
NCT00707031,Symptomatic hypoglycemia,Hypoglycemia,True,False,False,False,False,Exenatide 10 µg BID,control,316,25.0,7.9,Symptomatic hypoglycemia,Symptomatic hypoglycemia,Hypoglycemia,False,,Lixisenatide,True,True,0.01,SC,BID
NCT00707031,Severe hypoglycemia,Hypoglycemia,False,True,False,False,False,Lixisenatide 20 µg QD,treatment,318,0.0,0.0,Severe hypoglycemia,Severe hypoglycemia,Hypoglycemia,False,,Lixisenatide,True,True,0.02,SC,QD
NCT00707031,Severe hypoglycemia,Hypoglycemia,False,True,False,False,False,Exenatide 10 µg BID,control,316,0.0,0.0,Severe hypoglycemia,Severe hypoglycemia,Hypoglycemia,False,,Lixisenatide,True,True,0.01,SC,BID
NCT05035095,Any adverse events,Adverse events reported in 5% of patients or more by MedDRA preferred term,True,False,False,False,False,Oral semaglutide 50 mg,treatment,334,307.0,92.0,Any adverse events,Any adverse event,Any adverse event,True,any_ae,Oral semaglutide,True,True,50.0,oral,QD
NCT05035095,Any adverse events,Adverse events reported in 5% of patients or more by MedDRA preferred term,True,False,False,False,False,Placebo,control,333,285.0,86.0,Any adverse events,Any adverse event,Any adverse event,True,any_ae,Oral semaglutide,False,False,,,
NCT05035095,Serious adverse events,Adverse events reported in 5% of patients or more by MedDRA preferred term,False,True,False,False,False,Oral semaglutide 50 mg,treatment,334,32.0,10.0,Serious adverse events,Serious adverse events,Serious adverse events,True,serious_ae,Oral semaglutide,True,True,50.0,oral,QD
NCT05035095,Serious adverse events,Adverse events reported in 5% of patients or more by MedDRA preferred term,False,True,False,False,False,Placebo,control,333,29.0,9.0,Serious adverse events,Serious adverse events,Serious adverse events,True,serious_ae,Oral semaglutide,False,False,,,
NCT05035095,Adverse events leading to trial product discontinuation,Adverse events reported in 5% of patients or more by MedDRA preferred term,False,False,False,True,False,Oral semaglutide 50 mg,treatment,334,19.0,6.0,Adverse events leading to trial product discontinuation,Adverse events leading to discontinuation,Adverse event leading to discontinuation,True,ae_leading_to_discontinuation,Oral semaglutide,True,True,50.0,oral,QD
NCT05035095,Adverse events leading to trial product discontinuation,Adverse events reported in 5% of patients or more by MedDRA preferred term,False,False,False,True,False,Placebo,control,333,12.0,4.0,Adverse events leading to trial product discontinuation,Adverse events leading to discontinuation,Adverse event leading to discontinuation,True,ae_leading_to_discontinuation,Oral semaglutide,False,False,,,
NCT05035095,Gastrointestinal disorders,Adverse events reported in 5% of patients or more by MedDRA preferred term,False,False,False,False,True,Oral semaglutide 50 mg,treatment,334,12.0,4.0,Gastrointestinal disorders,Gastrointestinal disorders,Gastrointestinal disorders,True,other_summary,Oral semaglutide,True,True,50.0,oral,QD
NCT05035095,Gastrointestinal disorders,Adverse events reported in 5% of patients or more by MedDRA preferred term,False,False,False,False,True,Placebo,control,333,5.0,2.0,Gastrointestinal disorders,Gastrointestinal disorders,Gastrointestinal disorders,True,other_summary,Oral semaglutide,False,False,,,
NCT05035095,Fatal events,Adverse events reported in 5% of patients or more by MedDRA preferred term,False,False,True,False,False,Oral semaglutide 50 mg,treatment,334,0.0,0.0,Fatal events,Fatal adverse events,Fatal adverse events,True,fatal_ae,Oral semaglutide,True,True,50.0,oral,QD
NCT05035095,Fatal events,Adverse events reported in 5% of patients or more by MedDRA preferred term,False,False,True,False,False,Placebo,control,333,0.0,0.0,Fatal events,Fatal adverse events,Fatal adverse events,True,fatal_ae,Oral semaglutide,False,False,,,
NCT05035095,Nausea,Adverse events reported in 5% of patients or more by MedDRA preferred term,True,False,False,False,True,Oral semaglutide 50 mg,treatment,334,173.0,52.0,Nausea,Nausea,Nausea,False,,Oral semaglutide,True,True,50.0,oral,QD
NCT05035095,Nausea,Adverse events reported in 5% of patients or more by MedDRA preferred term,True,False,False,False,True,Placebo,control,333,51.0,15.0,Nausea,Nausea,Nausea,False,,Oral semaglutide,False,False,,,
NCT05035095,COVID-19,Adverse events reported in 5% of patients or more by MedDRA preferred term,True,False,False,False,False,Oral semaglutide 50 mg,treatment,334,120.0,36.0,COVID-19,COVID-19,COVID-19,False,,Oral semaglutide,True,True,50.0,oral,QD
NCT05035095,COVID-19,Adverse events reported in 5% of patients or more by MedDRA preferred term,True,False,False,False,False,Placebo,control,333,116.0,35.0,COVID-19,COVID-19,COVID-19,False,,Oral semaglutide,False,False,,,
NCT05035095,Constipation,Adverse events reported in 5% of patients or more by MedDRA preferred term,True,False,False,False,True,Oral semaglutide 50 mg,treatment,334,92.0,28.0,Constipation,Constipation,Constipation,False,,Oral semaglutide,True,True,50.0,oral,QD
NCT05035095,Constipation,Adverse events reported in 5% of patients or more by MedDRA preferred term,True,False,False,False,True,Placebo,control,333,50.0,15.0,Constipation,Constipation,Constipation,False,,Oral semaglutide,False,False,,,
NCT05035095,Diarrhoea,Adverse events reported in 5% of patients or more by MedDRA preferred term,True,False,False,False,True,Oral semaglutide 50 mg,treatment,334,89.0,27.0,Diarrhoea,Diarrhea,Diarrhea,False,,Oral semaglutide,True,True,50.0,oral,QD
NCT05035095,Diarrhoea,Adverse events reported in 5% of patients or more by MedDRA preferred term,True,False,False,False,True,Placebo,control,333,56.0,17.0,Diarrhoea,Diarrhea,Diarrhea,False,,Oral semaglutide,False,False,,,
NCT05035095,Vomiting,Adverse events reported in 5% of patients or more by MedDRA preferred term,True,False,False,False,True,Oral semaglutide 50 mg,treatment,334,80.0,24.0,Vomiting,Vomiting,Vomiting,False,,Oral semaglutide,True,True,50.0,oral,QD
NCT05035095,Vomiting,Adverse events reported in 5% of patients or more by MedDRA preferred term,True,False,False,False,True,Placebo,control,333,12.0,4.0,Vomiting,Vomiting,Vomiting,False,,Oral semaglutide,False,False,,,
NCT05035095,Decreased appetite,Adverse events reported in 5% of patients or more by MedDRA preferred term,True,False,False,False,True,Oral semaglutide 50 mg,treatment,334,56.0,17.0,Decreased appetite,Decreased appetite,Decreased appetite,False,,Oral semaglutide,True,True,50.0,oral,QD
NCT05035095,Decreased appetite,Adverse events reported in 5% of patients or more by MedDRA preferred term,True,False,False,False,True,Placebo,control,333,24.0,7.0,Decreased appetite,Decreased appetite,Decreased appetite,False,,Oral semaglutide,False,False,,,
NCT05035095,Dyspepsia,Adverse events reported in 5% of patients or more by MedDRA preferred term,True,False,False,False,True,Oral semaglutide 50 mg,treatment,334,47.0,14.0,Dyspepsia,Dyspepsia,Dyspepsia,False,,Oral semaglutide,True,True,50.0,oral,QD
NCT05035095,Dyspepsia,Adverse events reported in 5% of patients or more by MedDRA preferred term,True,False,False,False,True,Placebo,control,333,17.0,5.0,Dyspepsia,Dyspepsia,Dyspepsia,False,,Oral semaglutide,False,False,,,
NCT05035095,Headache,Adverse events reported in 5% of patients or more by MedDRA preferred term,True,False,False,False,False,Oral semaglutide 50 mg,treatment,334,46.0,14.0,Headache,Headache,Headache,False,,Oral semaglutide,True,True,50.0,oral,QD
NCT05035095,Headache,Adverse events reported in 5% of patients or more by MedDRA preferred term,True,False,False,False,False,Placebo,control,333,29.0,9.0,Headache,Headache,Headache,False,,Oral semaglutide,False,False,,,
NCT05035095,Nasopharyngitis,Adverse events reported in 5% of patients or more by MedDRA preferred term,True,False,False,False,False,Oral semaglutide 50 mg,treatment,334,38.0,11.0,Nasopharyngitis,Nasopharyngitis,Nasopharyngitis,False,,Oral semaglutide,True,True,50.0,oral,QD
NCT05035095,Nasopharyngitis,Adverse events reported in 5% of patients or more by MedDRA preferred term,True,False,False,False,False,Placebo,control,333,49.0,15.0,Nasopharyngitis,Nasopharyngitis,Nasopharyngitis,False,,Oral semaglutide,False,False,,,
NCT05035095,Abdominal pain upper,Adverse events reported in 5% of patients or more by MedDRA preferred term,True,False,False,False,True,Oral semaglutide 50 mg,treatment,334,32.0,10.0,Abdominal pain upper,Upper abdominal pain,Abdominal pain,False,,Oral semaglutide,True,True,50.0,oral,QD
NCT05035095,Abdominal pain upper,Adverse events reported in 5% of patients or more by MedDRA preferred term,True,False,False,False,True,Placebo,control,333,12.0,4.0,Abdominal pain upper,Upper abdominal pain,Abdominal pain,False,,Oral semaglutide,False,False,,,
NCT05035095,Eructation,Adverse events reported in 5% of patients or more by MedDRA preferred term,True,False,False,False,True,Oral semaglutide 50 mg,treatment,334,32.0,10.0,Eructation,Eructation,GI gas-related symptoms,False,,Oral semaglutide,True,True,50.0,oral,QD
NCT05035095,Eructation,Adverse events reported in 5% of patients or more by MedDRA preferred term,True,False,False,False,True,Placebo,control,333,7.0,2.0,Eructation,Eructation,GI gas-related symptoms,False,,Oral semaglutide,False,False,,,
NCT05035095,Gastro-oesophageal reflux disease,Adverse events reported in 5% of patients or more by MedDRA preferred term,True,False,False,False,True,Oral semaglutide 50 mg,treatment,334,29.0,9.0,Gastro-oesophageal reflux disease,Gastroesophageal reflux disease,Gastroesophageal reflux disease,False,,Oral semaglutide,True,True,50.0,oral,QD
NCT05035095,Gastro-oesophageal reflux disease,Adverse events reported in 5% of patients or more by MedDRA preferred term,True,False,False,False,True,Placebo,control,333,11.0,3.0,Gastro-oesophageal reflux disease,Gastroesophageal reflux disease,Gastroesophageal reflux disease,False,,Oral semaglutide,False,False,,,
NCT05035095,Dizziness,Adverse events reported in 5% of patients or more by MedDRA preferred term,True,False,False,False,False,Oral semaglutide 50 mg,treatment,334,27.0,8.0,Dizziness,Dizziness,Dizziness,False,,Oral semaglutide,True,True,50.0,oral,QD
NCT05035095,Dizziness,Adverse events reported in 5% of patients or more by MedDRA preferred term,True,False,False,False,False,Placebo,control,333,16.0,5.0,Dizziness,Dizziness,Dizziness,False,,Oral semaglutide,False,False,,,
NCT05035095,Influenza,Adverse events reported in 5% of patients or more by MedDRA preferred term,True,False,False,False,False,Oral semaglutide 50 mg,treatment,334,26.0,8.0,Influenza,Influenza,Influenza,False,,Oral semaglutide,True,True,50.0,oral,QD
NCT05035095,Influenza,Adverse events reported in 5% of patients or more by MedDRA preferred term,True,False,False,False,False,Placebo,control,333,18.0,5.0,Influenza,Influenza,Influenza,False,,Oral semaglutide,False,False,,,
NCT05035095,Abdominal distension,Adverse events reported in 5% of patients or more by MedDRA preferred term,True,False,False,False,True,Oral semaglutide 50 mg,treatment,334,25.0,7.0,Abdominal distension,Abdominal distension,GI gas-related symptoms,False,,Oral semaglutide,True,True,50.0,oral,QD
NCT05035095,Abdominal distension,Adverse events reported in 5% of patients or more by MedDRA preferred term,True,False,False,False,True,Placebo,control,333,16.0,5.0,Abdominal distension,Abdominal distension,GI gas-related symptoms,False,,Oral semaglutide,False,False,,,
NCT05035095,Fatigue,Adverse events reported in 5% of patients or more by MedDRA preferred term,True,False,False,False,False,Oral semaglutide 50 mg,treatment,334,24.0,7.0,Fatigue,Fatigue,Fatigue,False,,Oral semaglutide,True,True,50.0,oral,QD
NCT05035095,Fatigue,Adverse events reported in 5% of patients or more by MedDRA preferred term,True,False,False,False,False,Placebo,control,333,20.0,6.0,Fatigue,Fatigue,Fatigue,False,,Oral semaglutide,False,False,,,
NCT05035095,Alopecia,Adverse events reported in 5% of patients or more by MedDRA preferred term,True,False,False,False,False,Oral semaglutide 50 mg,treatment,334,23.0,7.0,Alopecia,Alopecia,Alopecia,False,,Oral semaglutide,True,True,50.0,oral,QD
NCT05035095,Alopecia,Adverse events reported in 5% of patients or more by MedDRA preferred term,True,False,False,False,False,Placebo,control,333,9.0,3.0,Alopecia,Alopecia,Alopecia,False,,Oral semaglutide,False,False,,,
NCT05035095,Abdominal pain,Adverse events reported in 5% of patients or more by MedDRA preferred term,True,False,False,False,True,Oral semaglutide 50 mg,treatment,334,22.0,7.0,Abdominal pain,Abdominal pain,Abdominal pain,False,,Oral semaglutide,True,True,50.0,oral,QD
NCT05035095,Abdominal pain,Adverse events reported in 5% of patients or more by MedDRA preferred term,True,False,False,False,True,Placebo,control,333,16.0,5.0,Abdominal pain,Abdominal pain,Abdominal pain,False,,Oral semaglutide,False,False,,,
NCT05035095,Arthralgia,Adverse events reported in 5% of patients or more by MedDRA preferred term,True,False,False,False,False,Oral semaglutide 50 mg,treatment,334,22.0,7.0,Arthralgia,Arthralgia,Joint disorders,False,,Oral semaglutide,True,True,50.0,oral,QD
NCT05035095,Arthralgia,Adverse events reported in 5% of patients or more by MedDRA preferred term,True,False,False,False,False,Placebo,control,333,38.0,11.0,Arthralgia,Arthralgia,Joint disorders,False,,Oral semaglutide,False,False,,,
NCT05035095,Flatulence,Adverse events reported in 5% of patients or more by MedDRA preferred term,True,False,False,False,True,Oral semaglutide 50 mg,treatment,334,19.0,6.0,Flatulence,Flatulence,GI gas-related symptoms,False,,Oral semaglutide,True,True,50.0,oral,QD
NCT05035095,Flatulence,Adverse events reported in 5% of patients or more by MedDRA preferred term,True,False,False,False,True,Placebo,control,333,13.0,4.0,Flatulence,Flatulence,GI gas-related symptoms,False,,Oral semaglutide,False,False,,,
NCT05035095,Upper-respiratory-tract infection,Adverse events reported in 5% of patients or more by MedDRA preferred term,True,False,False,False,False,Oral semaglutide 50 mg,treatment,334,19.0,6.0,Upper-respiratory-tract infection,Upper respiratory tract infection,Upper respiratory tract infection,False,,Oral semaglutide,True,True,50.0,oral,QD
NCT05035095,Upper-respiratory-tract infection,Adverse events reported in 5% of patients or more by MedDRA preferred term,True,False,False,False,False,Placebo,control,333,20.0,6.0,Upper-respiratory-tract infection,Upper respiratory tract infection,Upper respiratory tract infection,False,,Oral semaglutide,False,False,,,
NCT05035095,Urinary-tract infection,Adverse events reported in 5% of patients or more by MedDRA preferred term,True,False,False,False,False,Oral semaglutide 50 mg,treatment,334,19.0,6.0,Urinary-tract infection,Urinary tract infection,Urinary tract infection,False,,Oral semaglutide,True,True,50.0,oral,QD
NCT05035095,Urinary-tract infection,Adverse events reported in 5% of patients or more by MedDRA preferred term,True,False,False,False,False,Placebo,control,333,8.0,2.0,Urinary-tract infection,Urinary tract infection,Urinary tract infection,False,,Oral semaglutide,False,False,,,
NCT05035095,Gastroenteritis,Adverse events reported in 5% of patients or more by MedDRA preferred term,True,False,False,False,True,Oral semaglutide 50 mg,treatment,334,18.0,5.0,Gastroenteritis,Gastroenteritis,Gastroenteritis,False,,Oral semaglutide,True,True,50.0,oral,QD
NCT05035095,Gastroenteritis,Adverse events reported in 5% of patients or more by MedDRA preferred term,True,False,False,False,True,Placebo,control,333,10.0,3.0,Gastroenteritis,Gastroenteritis,Gastroenteritis,False,,Oral semaglutide,False,False,,,
NCT05035095,Back pain,Adverse events reported in 5% of patients or more by MedDRA preferred term,True,False,False,False,False,Oral semaglutide 50 mg,treatment,334,16.0,5.0,Back pain,Back pain,Musculoskeletal pain,False,,Oral semaglutide,True,True,50.0,oral,QD
NCT05035095,Back pain,Adverse events reported in 5% of patients or more by MedDRA preferred term,True,False,False,False,False,Placebo,control,333,24.0,7.0,Back pain,Back pain,Musculoskeletal pain,False,,Oral semaglutide,False,False,,,
NCT05035095,Sinusitis,Adverse events reported in 5% of patients or more by MedDRA preferred term,True,False,False,False,False,Oral semaglutide 50 mg,treatment,334,12.0,4.0,Sinusitis,Sinusitis,Sinusitis,False,,Oral semaglutide,True,True,50.0,oral,QD
NCT05035095,Sinusitis,Adverse events reported in 5% of patients or more by MedDRA preferred term,True,False,False,False,False,Placebo,control,333,18.0,5.0,Sinusitis,Sinusitis,Sinusitis,False,,Oral semaglutide,False,False,,,
NCT05035095,Hypertension,Adverse events reported in 5% of patients or more by MedDRA preferred term,True,False,False,False,False,Oral semaglutide 50 mg,treatment,334,10.0,3.0,Hypertension,Hypertension,Hypertension,False,,Oral semaglutide,True,True,50.0,oral,QD
NCT05035095,Hypertension,Adverse events reported in 5% of patients or more by MedDRA preferred term,True,False,False,False,False,Placebo,control,333,22.0,7.0,Hypertension,Hypertension,Hypertension,False,,Oral semaglutide,False,False,,,
NCT05035095,Gastrointestinal disorders,Safety areas of interest,True,False,False,False,True,Oral semaglutide 50 mg,treatment,334,268.0,80.0,Gastrointestinal disorders,Gastrointestinal disorders,Gastrointestinal disorders,True,other_summary,Oral semaglutide,True,True,50.0,oral,QD
NCT05035095,Gastrointestinal disorders,Safety areas of interest,True,False,False,False,True,Placebo,control,333,154.0,46.0,Gastrointestinal disorders,Gastrointestinal disorders,Gastrointestinal disorders,True,other_summary,Oral semaglutide,False,False,,,
NCT05035095,Cardiovascular disorders,Safety areas of interest,True,False,False,False,True,Oral semaglutide 50 mg,treatment,334,39.0,12.0,Cardiovascular disorders,Cardiovascular disorders,Cardiovascular disorders,True,other_summary,Oral semaglutide,True,True,50.0,oral,QD
NCT05035095,Cardiovascular disorders,Safety areas of interest,True,False,False,False,True,Placebo,control,333,44.0,13.0,Cardiovascular disorders,Cardiovascular disorders,Cardiovascular disorders,True,other_summary,Oral semaglutide,False,False,,,
NCT05035095,Psychiatric disorders,Safety areas of interest,True,False,False,False,True,Oral semaglutide 50 mg,treatment,334,31.0,9.0,Psychiatric disorders,Psychiatric disorders,Psychiatric disorders,True,other_summary,Oral semaglutide,True,True,50.0,oral,QD
NCT05035095,Psychiatric disorders,Safety areas of interest,True,False,False,False,True,Placebo,control,333,34.0,10.0,Psychiatric disorders,Psychiatric disorders,Psychiatric disorders,True,other_summary,Oral semaglutide,False,False,,,
NCT05035095,Benign and malignant neoplasms,Safety areas of interest,True,False,False,False,True,Oral semaglutide 50 mg,treatment,334,30.0,9.0,Benign and malignant neoplasms,Benign and malignant neoplasms,Neoplasms,True,other_summary,Oral semaglutide,True,True,50.0,oral,QD
NCT05035095,Benign and malignant neoplasms,Safety areas of interest,True,False,False,False,True,Placebo,control,333,17.0,5.0,Benign and malignant neoplasms,Benign and malignant neoplasms,Neoplasms,True,other_summary,Oral semaglutide,False,False,,,
NCT05035095,Allergic reactions,Safety areas of interest,True,False,False,False,False,Oral semaglutide 50 mg,treatment,334,26.0,8.0,Allergic reactions,Hypersensitivity,Hypersensitivity,False,,Oral semaglutide,True,True,50.0,oral,QD
NCT05035095,Allergic reactions,Safety areas of interest,True,False,False,False,False,Placebo,control,333,17.0,5.0,Allergic reactions,Hypersensitivity,Hypersensitivity,False,,Oral semaglutide,False,False,,,
NCT05035095,Gallbladder-related disorders,Safety areas of interest,True,False,False,False,True,Oral semaglutide 50 mg,treatment,334,13.0,4.0,Gallbladder-related disorders,Gallbladder-related disorders,Gallbladder-related disorders,True,other_summary,Oral semaglutide,True,True,50.0,oral,QD
NCT05035095,Gallbladder-related disorders,Safety areas of interest,True,False,False,False,True,Placebo,control,333,4.0,1.0,Gallbladder-related disorders,Gallbladder-related disorders,Gallbladder-related disorders,True,other_summary,Oral semaglutide,False,False,,,
NCT05035095,Hepatobiliary disorders,Safety areas of interest,True,False,False,False,True,Oral semaglutide 50 mg,treatment,334,13.0,4.0,Hepatobiliary disorders,Hepatobiliary disorders,Hepatobiliary disorders,True,other_summary,Oral semaglutide,True,True,50.0,oral,QD
NCT05035095,Hepatobiliary disorders,Safety areas of interest,True,False,False,False,True,Placebo,control,333,4.0,1.0,Hepatobiliary disorders,Hepatobiliary disorders,Hepatobiliary disorders,True,other_summary,Oral semaglutide,False,False,,,
NCT05035095,Cholelithiasis,Safety areas of interest,True,False,False,False,True,Oral semaglutide 50 mg,treatment,334,11.0,3.0,Cholelithiasis,Cholelithiasis,Gallbladder disease,False,,Oral semaglutide,True,True,50.0,oral,QD
NCT05035095,Cholelithiasis,Safety areas of interest,True,False,False,False,True,Placebo,control,333,4.0,1.0,Cholelithiasis,Cholelithiasis,Gallbladder disease,False,,Oral semaglutide,False,False,,,
NCT05035095,Hepatic disorders,Safety areas of interest,True,False,False,False,True,Oral semaglutide 50 mg,treatment,334,6.0,2.0,Hepatic disorders,Hepatic disorders,Hepatic disorders,True,other_summary,Oral semaglutide,True,True,50.0,oral,QD
NCT05035095,Hepatic disorders,Safety areas of interest,True,False,False,False,True,Placebo,control,333,9.0,3.0,Hepatic disorders,Hepatic disorders,Hepatic disorders,True,other_summary,Oral semaglutide,False,False,,,
NCT05035095,Malignant neoplasms,Safety areas of interest,True,False,False,False,True,Oral semaglutide 50 mg,treatment,334,5.0,1.0,Malignant neoplasms,Malignant neoplasm,Cancer,False,,Oral semaglutide,True,True,50.0,oral,QD
NCT05035095,Malignant neoplasms,Safety areas of interest,True,False,False,False,True,Placebo,control,333,4.0,1.0,Malignant neoplasms,Malignant neoplasm,Cancer,False,,Oral semaglutide,False,False,,,
NCT05035095,Hypoglycaemia,Safety areas of interest,True,False,False,False,True,Oral semaglutide 50 mg,treatment,334,3.0,1.0,Hypoglycaemia,Hypoglycemia,Hypoglycemia,False,,Oral semaglutide,True,True,50.0,oral,QD
NCT05035095,Hypoglycaemia,Safety areas of interest,True,False,False,False,True,Placebo,control,333,1.0,0.0,Hypoglycaemia,Hypoglycemia,Hypoglycemia,False,,Oral semaglutide,False,False,,,
NCT05035095,Acute pancreatitis,Safety areas of interest,True,False,False,False,True,Oral semaglutide 50 mg,treatment,334,0.0,0.0,Acute pancreatitis,Acute pancreatitis,Pancreatitis,False,,Oral semaglutide,True,True,50.0,oral,QD
NCT05035095,Acute pancreatitis,Safety areas of interest,True,False,False,False,True,Placebo,control,333,0.0,0.0,Acute pancreatitis,Acute pancreatitis,Pancreatitis,False,,Oral semaglutide,False,False,,,
NCT05035095,Acute renal failure,Safety areas of interest,True,False,False,False,True,Oral semaglutide 50 mg,treatment,334,0.0,0.0,Acute renal failure,Acute kidney injury,Renal impairment,False,,Oral semaglutide,True,True,50.0,oral,QD
NCT05035095,Acute renal failure,Safety areas of interest,True,False,False,False,True,Placebo,control,333,2.0,1.0,Acute renal failure,Acute kidney injury,Renal impairment,False,,Oral semaglutide,False,False,,,
NCT04881760,Any adverse event during treatment,Adverse events during treatment,True,False,False,False,False,Placebo Group,control,70,49.0,70.0,Any adverse event during treatment,Any adverse event,Any adverse event,True,any_ae,Retatrutide,False,False,,,
NCT04881760,Any adverse event during treatment,Adverse events during treatment,True,False,False,False,False,1 mg,treatment,69,58.0,84.0,Any adverse event during treatment,Any adverse event,Any adverse event,True,any_ae,Retatrutide,False,False,1.0,SC,QW
NCT04881760,Any adverse event during treatment,Adverse events during treatment,True,False,False,False,False,"4 mg (ID, 2 mg)",treatment,33,24.0,73.0,Any adverse event during treatment,Any adverse event,Any adverse event,True,any_ae,Retatrutide,True,True,4.0,SC,QW
NCT04881760,Any adverse event during treatment,Adverse events during treatment,True,False,False,False,False,"4 mg (ID, 4 mg)",treatment,33,28.0,85.0,Any adverse event during treatment,Any adverse event,Any adverse event,True,any_ae,Retatrutide,True,True,4.0,SC,QW
NCT04881760,Any adverse event during treatment,Adverse events during treatment,True,False,False,False,False,"8 mg (ID, 2 mg)",treatment,35,28.0,80.0,Any adverse event during treatment,Any adverse event,Any adverse event,True,any_ae,Retatrutide,True,True,8.0,SC,QW
NCT04881760,Any adverse event during treatment,Adverse events during treatment,True,False,False,False,False,"8 mg (ID, 4 mg)",treatment,35,33.0,94.0,Any adverse event during treatment,Any adverse event,Any adverse event,True,any_ae,Retatrutide,True,True,8.0,SC,QW
NCT04881760,Any adverse event during treatment,Adverse events during treatment,True,False,False,False,False,"12 mg (ID, 2 mg)",treatment,62,57.0,92.0,Any adverse event during treatment,Any adverse event,Any adverse event,True,any_ae,Retatrutide,True,True,12.0,SC,QW
NCT04881760,Serious adverse event,Serious adverse events,False,True,False,False,False,Placebo Group,control,70,3.0,4.0,Serious adverse event,Serious adverse events,Serious adverse events,True,serious_ae,Retatrutide,False,False,,,
NCT04881760,Serious adverse event,Serious adverse events,False,True,False,False,False,1 mg,treatment,69,3.0,4.0,Serious adverse event,Serious adverse events,Serious adverse events,True,serious_ae,Retatrutide,False,False,1.0,SC,QW
NCT04881760,Serious adverse event,Serious adverse events,False,True,False,False,False,"4 mg (ID, 2 mg)",treatment,33,0.0,0.0,Serious adverse event,Serious adverse events,Serious adverse events,True,serious_ae,Retatrutide,True,True,4.0,SC,QW
NCT04881760,Serious adverse event,Serious adverse events,False,True,False,False,False,"4 mg (ID, 4 mg)",treatment,33,2.0,6.0,Serious adverse event,Serious adverse events,Serious adverse events,True,serious_ae,Retatrutide,True,True,4.0,SC,QW
NCT04881760,Serious adverse event,Serious adverse events,False,True,False,False,False,"8 mg (ID, 2 mg)",treatment,35,1.0,3.0,Serious adverse event,Serious adverse events,Serious adverse events,True,serious_ae,Retatrutide,True,True,8.0,SC,QW
NCT04881760,Serious adverse event,Serious adverse events,False,True,False,False,False,"8 mg (ID, 4 mg)",treatment,35,2.0,6.0,Serious adverse event,Serious adverse events,Serious adverse events,True,serious_ae,Retatrutide,True,True,8.0,SC,QW
NCT04881760,Serious adverse event,Serious adverse events,False,True,False,False,False,"12 mg (ID, 2 mg)",treatment,62,2.0,3.0,Serious adverse event,Serious adverse events,Serious adverse events,True,serious_ae,Retatrutide,True,True,12.0,SC,QW
NCT04881760,Death,Fatal adverse events,False,False,True,False,False,Placebo Group,control,70,0.0,0.0,Death,Death,Fatal adverse events,True,fatal_ae,Retatrutide,False,False,,,
NCT04881760,Death,Fatal adverse events,False,False,True,False,False,1 mg,treatment,69,0.0,0.0,Death,Death,Fatal adverse events,True,fatal_ae,Retatrutide,False,False,1.0,SC,QW
NCT04881760,Death,Fatal adverse events,False,False,True,False,False,"4 mg (ID, 2 mg)",treatment,33,0.0,0.0,Death,Death,Fatal adverse events,True,fatal_ae,Retatrutide,True,True,4.0,SC,QW
NCT04881760,Death,Fatal adverse events,False,False,True,False,False,"4 mg (ID, 4 mg)",treatment,33,1.0,3.0,Death,Death,Fatal adverse events,True,fatal_ae,Retatrutide,True,True,4.0,SC,QW
NCT04881760,Death,Fatal adverse events,False,False,True,False,False,"8 mg (ID, 2 mg)",treatment,35,0.0,0.0,Death,Death,Fatal adverse events,True,fatal_ae,Retatrutide,True,True,8.0,SC,QW
NCT04881760,Death,Fatal adverse events,False,False,True,False,False,"8 mg (ID, 4 mg)",treatment,35,0.0,0.0,Death,Death,Fatal adverse events,True,fatal_ae,Retatrutide,True,True,8.0,SC,QW
NCT04881760,Death,Fatal adverse events,False,False,True,False,False,"12 mg (ID, 2 mg)",treatment,62,0.0,0.0,Death,Death,Fatal adverse events,True,fatal_ae,Retatrutide,True,True,12.0,SC,QW
NCT04881760,Adverse events leading to discontinuation of retatrutide or placebo,Adverse events leading to discontinuation,False,False,False,True,False,Placebo Group,control,70,0.0,0.0,Adverse events leading to discontinuation of retatrutide or placebo,Adverse events leading to discontinuation,Adverse event leading to discontinuation,True,ae_leading_to_discontinuation,Retatrutide,False,False,,,
NCT04881760,Adverse events leading to discontinuation of retatrutide or placebo,Adverse events leading to discontinuation,False,False,False,True,False,1 mg,treatment,69,5.0,7.0,Adverse events leading to discontinuation of retatrutide or placebo,Adverse events leading to discontinuation,Adverse event leading to discontinuation,True,ae_leading_to_discontinuation,Retatrutide,False,False,1.0,SC,QW
NCT04881760,Adverse events leading to discontinuation of retatrutide or placebo,Adverse events leading to discontinuation,False,False,False,True,False,"4 mg (ID, 2 mg)",treatment,33,2.0,6.0,Adverse events leading to discontinuation of retatrutide or placebo,Adverse events leading to discontinuation,Adverse event leading to discontinuation,True,ae_leading_to_discontinuation,Retatrutide,True,True,4.0,SC,QW
NCT04881760,Adverse events leading to discontinuation of retatrutide or placebo,Adverse events leading to discontinuation,False,False,False,True,False,"4 mg (ID, 4 mg)",treatment,33,3.0,9.0,Adverse events leading to discontinuation of retatrutide or placebo,Adverse events leading to discontinuation,Adverse event leading to discontinuation,True,ae_leading_to_discontinuation,Retatrutide,True,True,4.0,SC,QW
NCT04881760,Adverse events leading to discontinuation of retatrutide or placebo,Adverse events leading to discontinuation,False,False,False,True,False,"8 mg (ID, 2 mg)",treatment,35,5.0,14.0,Adverse events leading to discontinuation of retatrutide or placebo,Adverse events leading to discontinuation,Adverse event leading to discontinuation,True,ae_leading_to_discontinuation,Retatrutide,True,True,8.0,SC,QW
NCT04881760,Adverse events leading to discontinuation of retatrutide or placebo,Adverse events leading to discontinuation,False,False,False,True,False,"8 mg (ID, 4 mg)",treatment,35,2.0,6.0,Adverse events leading to discontinuation of retatrutide or placebo,Adverse events leading to discontinuation,Adverse event leading to discontinuation,True,ae_leading_to_discontinuation,Retatrutide,True,True,8.0,SC,QW
NCT04881760,Adverse events leading to discontinuation of retatrutide or placebo,Adverse events leading to discontinuation,False,False,False,True,False,"12 mg (ID, 2 mg)",treatment,62,10.0,16.0,Adverse events leading to discontinuation of retatrutide or placebo,Adverse events leading to discontinuation,Adverse event leading to discontinuation,True,ae_leading_to_discontinuation,Retatrutide,True,True,12.0,SC,QW
NCT04881760,Nausea,Adverse events during treatment that occurred in ≥5% of total participants,True,False,False,False,False,Placebo Group,control,70,8.0,11.0,Nausea,Nausea,Nausea,False,,Retatrutide,False,False,,,
NCT04881760,Nausea,Adverse events during treatment that occurred in ≥5% of total participants,True,False,False,False,False,1 mg,treatment,69,10.0,14.0,Nausea,Nausea,Nausea,False,,Retatrutide,False,False,1.0,SC,QW
NCT04881760,Nausea,Adverse events during treatment that occurred in ≥5% of total participants,True,False,False,False,False,"4 mg (ID, 2 mg)",treatment,33,6.0,18.0,Nausea,Nausea,Nausea,False,,Retatrutide,True,True,4.0,SC,QW
NCT04881760,Nausea,Adverse events during treatment that occurred in ≥5% of total participants,True,False,False,False,False,"4 mg (ID, 4 mg)",treatment,33,12.0,36.0,Nausea,Nausea,Nausea,False,,Retatrutide,True,True,4.0,SC,QW
NCT04881760,Nausea,Adverse events during treatment that occurred in ≥5% of total participants,True,False,False,False,False,"8 mg (ID, 2 mg)",treatment,35,6.0,17.0,Nausea,Nausea,Nausea,False,,Retatrutide,True,True,8.0,SC,QW
NCT04881760,Nausea,Adverse events during treatment that occurred in ≥5% of total participants,True,False,False,False,False,"8 mg (ID, 4 mg)",treatment,35,21.0,60.0,Nausea,Nausea,Nausea,False,,Retatrutide,True,True,8.0,SC,QW
NCT04881760,Nausea,Adverse events during treatment that occurred in ≥5% of total participants,True,False,False,False,False,"12 mg (ID, 2 mg)",treatment,62,28.0,45.0,Nausea,Nausea,Nausea,False,,Retatrutide,True,True,12.0,SC,QW
NCT04881760,Covid-19,Adverse events during treatment that occurred in ≥5% of total participants,True,False,False,False,False,Placebo Group,control,70,14.0,20.0,Covid-19,COVID-19,COVID-19,False,,Retatrutide,False,False,,,
NCT04881760,Covid-19,Adverse events during treatment that occurred in ≥5% of total participants,True,False,False,False,False,1 mg,treatment,69,13.0,19.0,Covid-19,COVID-19,COVID-19,False,,Retatrutide,False,False,1.0,SC,QW
NCT04881760,Covid-19,Adverse events during treatment that occurred in ≥5% of total participants,True,False,False,False,False,"4 mg (ID, 2 mg)",treatment,33,4.0,12.0,Covid-19,COVID-19,COVID-19,False,,Retatrutide,True,True,4.0,SC,QW
NCT04881760,Covid-19,Adverse events during treatment that occurred in ≥5% of total participants,True,False,False,False,False,"4 mg (ID, 4 mg)",treatment,33,6.0,18.0,Covid-19,COVID-19,COVID-19,False,,Retatrutide,True,True,4.0,SC,QW
NCT04881760,Covid-19,Adverse events during treatment that occurred in ≥5% of total participants,True,False,False,False,False,"8 mg (ID, 2 mg)",treatment,35,6.0,17.0,Covid-19,COVID-19,COVID-19,False,,Retatrutide,True,True,8.0,SC,QW
NCT04881760,Covid-19,Adverse events during treatment that occurred in ≥5% of total participants,True,False,False,False,False,"8 mg (ID, 4 mg)",treatment,35,12.0,34.0,Covid-19,COVID-19,COVID-19,False,,Retatrutide,True,True,8.0,SC,QW
NCT04881760,Covid-19,Adverse events during treatment that occurred in ≥5% of total participants,True,False,False,False,False,"12 mg (ID, 2 mg)",treatment,62,15.0,24.0,Covid-19,COVID-19,COVID-19,False,,Retatrutide,True,True,12.0,SC,QW
NCT04881760,Decreased appetite,Adverse events during treatment that occurred in ≥5% of total participants,True,False,False,False,False,Placebo Group,control,70,6.0,9.0,Decreased appetite,Decreased appetite,Decreased appetite,False,,Retatrutide,False,False,,,
NCT04881760,Decreased appetite,Adverse events during treatment that occurred in ≥5% of total participants,True,False,False,False,False,1 mg,treatment,69,9.0,13.0,Decreased appetite,Decreased appetite,Decreased appetite,False,,Retatrutide,False,False,1.0,SC,QW
NCT04881760,Decreased appetite,Adverse events during treatment that occurred in ≥5% of total participants,True,False,False,False,False,"4 mg (ID, 2 mg)",treatment,33,6.0,18.0,Decreased appetite,Decreased appetite,Decreased appetite,False,,Retatrutide,True,True,4.0,SC,QW
NCT04881760,Decreased appetite,Adverse events during treatment that occurred in ≥5% of total participants,True,False,False,False,False,"4 mg (ID, 4 mg)",treatment,33,8.0,24.0,Decreased appetite,Decreased appetite,Decreased appetite,False,,Retatrutide,True,True,4.0,SC,QW
NCT04881760,Decreased appetite,Adverse events during treatment that occurred in ≥5% of total participants,True,False,False,False,False,"8 mg (ID, 2 mg)",treatment,35,4.0,11.0,Decreased appetite,Decreased appetite,Decreased appetite,False,,Retatrutide,True,True,8.0,SC,QW
NCT04881760,Decreased appetite,Adverse events during treatment that occurred in ≥5% of total participants,True,False,False,False,False,"8 mg (ID, 4 mg)",treatment,35,11.0,31.0,Decreased appetite,Decreased appetite,Decreased appetite,False,,Retatrutide,True,True,8.0,SC,QW
NCT04881760,Decreased appetite,Adverse events during treatment that occurred in ≥5% of total participants,True,False,False,False,False,"12 mg (ID, 2 mg)",treatment,62,18.0,29.0,Decreased appetite,Decreased appetite,Decreased appetite,False,,Retatrutide,True,True,12.0,SC,QW
NCT04881760,Diarrhea,Adverse events during treatment that occurred in ≥5% of total participants,True,False,False,False,False,Placebo Group,control,70,8.0,11.0,Diarrhea,Diarrhea,Diarrhea,False,,Retatrutide,False,False,,,
NCT04881760,Diarrhea,Adverse events during treatment that occurred in ≥5% of total participants,True,False,False,False,False,1 mg,treatment,69,6.0,9.0,Diarrhea,Diarrhea,Diarrhea,False,,Retatrutide,False,False,1.0,SC,QW
NCT04881760,Diarrhea,Adverse events during treatment that occurred in ≥5% of total participants,True,False,False,False,False,"4 mg (ID, 2 mg)",treatment,33,4.0,12.0,Diarrhea,Diarrhea,Diarrhea,False,,Retatrutide,True,True,4.0,SC,QW
NCT04881760,Diarrhea,Adverse events during treatment that occurred in ≥5% of total participants,True,False,False,False,False,"4 mg (ID, 4 mg)",treatment,33,4.0,12.0,Diarrhea,Diarrhea,Diarrhea,False,,Retatrutide,True,True,4.0,SC,QW
NCT04881760,Diarrhea,Adverse events during treatment that occurred in ≥5% of total participants,True,False,False,False,False,"8 mg (ID, 2 mg)",treatment,35,7.0,20.0,Diarrhea,Diarrhea,Diarrhea,False,,Retatrutide,True,True,8.0,SC,QW
NCT04881760,Diarrhea,Adverse events during treatment that occurred in ≥5% of total participants,True,False,False,False,False,"8 mg (ID, 4 mg)",treatment,35,7.0,20.0,Diarrhea,Diarrhea,Diarrhea,False,,Retatrutide,True,True,8.0,SC,QW
NCT04881760,Diarrhea,Adverse events during treatment that occurred in ≥5% of total participants,True,False,False,False,False,"12 mg (ID, 2 mg)",treatment,62,9.0,15.0,Diarrhea,Diarrhea,Diarrhea,False,,Retatrutide,True,True,12.0,SC,QW
NCT04881760,Vomiting,Adverse events during treatment that occurred in ≥5% of total participants,True,False,False,False,False,Placebo Group,control,70,1.0,1.0,Vomiting,Vomiting,Vomiting,False,,Retatrutide,False,False,,,
NCT04881760,Vomiting,Adverse events during treatment that occurred in ≥5% of total participants,True,False,False,False,False,1 mg,treatment,69,2.0,3.0,Vomiting,Vomiting,Vomiting,False,,Retatrutide,False,False,1.0,SC,QW
NCT04881760,Vomiting,Adverse events during treatment that occurred in ≥5% of total participants,True,False,False,False,False,"4 mg (ID, 2 mg)",treatment,33,4.0,12.0,Vomiting,Vomiting,Vomiting,False,,Retatrutide,True,True,4.0,SC,QW
NCT04881760,Vomiting,Adverse events during treatment that occurred in ≥5% of total participants,True,False,False,False,False,"4 mg (ID, 4 mg)",treatment,33,4.0,12.0,Vomiting,Vomiting,Vomiting,False,,Retatrutide,True,True,4.0,SC,QW
NCT04881760,Vomiting,Adverse events during treatment that occurred in ≥5% of total participants,True,False,False,False,False,"8 mg (ID, 2 mg)",treatment,35,2.0,6.0,Vomiting,Vomiting,Vomiting,False,,Retatrutide,True,True,8.0,SC,QW
NCT04881760,Vomiting,Adverse events during treatment that occurred in ≥5% of total participants,True,False,False,False,False,"8 mg (ID, 4 mg)",treatment,35,9.0,26.0,Vomiting,Vomiting,Vomiting,False,,Retatrutide,True,True,8.0,SC,QW
NCT04881760,Vomiting,Adverse events during treatment that occurred in ≥5% of total participants,True,False,False,False,False,"12 mg (ID, 2 mg)",treatment,62,12.0,19.0,Vomiting,Vomiting,Vomiting,False,,Retatrutide,True,True,12.0,SC,QW
NCT04881760,Constipation,Adverse events during treatment that occurred in ≥5% of total participants,True,False,False,False,False,Placebo Group,control,70,2.0,3.0,Constipation,Constipation,Constipation,False,,Retatrutide,False,False,,,
NCT04881760,Constipation,Adverse events during treatment that occurred in ≥5% of total participants,True,False,False,False,False,1 mg,treatment,69,5.0,7.0,Constipation,Constipation,Constipation,False,,Retatrutide,False,False,1.0,SC,QW
NCT04881760,Constipation,Adverse events during treatment that occurred in ≥5% of total participants,True,False,False,False,False,"4 mg (ID, 2 mg)",treatment,33,5.0,15.0,Constipation,Constipation,Constipation,False,,Retatrutide,True,True,4.0,SC,QW
NCT04881760,Constipation,Adverse events during treatment that occurred in ≥5% of total participants,True,False,False,False,False,"4 mg (ID, 4 mg)",treatment,33,2.0,6.0,Constipation,Constipation,Constipation,False,,Retatrutide,True,True,4.0,SC,QW
NCT04881760,Constipation,Adverse events during treatment that occurred in ≥5% of total participants,True,False,False,False,False,"8 mg (ID, 2 mg)",treatment,35,4.0,11.0,Constipation,Constipation,Constipation,False,,Retatrutide,True,True,8.0,SC,QW
NCT04881760,Constipation,Adverse events during treatment that occurred in ≥5% of total participants,True,False,False,False,False,"8 mg (ID, 4 mg)",treatment,35,4.0,11.0,Constipation,Constipation,Constipation,False,,Retatrutide,True,True,8.0,SC,QW
NCT04881760,Constipation,Adverse events during treatment that occurred in ≥5% of total participants,True,False,False,False,False,"12 mg (ID, 2 mg)",treatment,62,10.0,16.0,Constipation,Constipation,Constipation,False,,Retatrutide,True,True,12.0,SC,QW
NCT04881760,Fatigue,Adverse events during treatment that occurred in ≥5% of total participants,True,False,False,False,False,Placebo Group,control,70,3.0,4.0,Fatigue,Fatigue,Fatigue,False,,Retatrutide,False,False,,,
NCT04881760,Fatigue,Adverse events during treatment that occurred in ≥5% of total participants,True,False,False,False,False,1 mg,treatment,69,3.0,4.0,Fatigue,Fatigue,Fatigue,False,,Retatrutide,False,False,1.0,SC,QW
NCT04881760,Fatigue,Adverse events during treatment that occurred in ≥5% of total participants,True,False,False,False,False,"4 mg (ID, 2 mg)",treatment,33,4.0,12.0,Fatigue,Fatigue,Fatigue,False,,Retatrutide,True,True,4.0,SC,QW
NCT04881760,Fatigue,Adverse events during treatment that occurred in ≥5% of total participants,True,False,False,False,False,"4 mg (ID, 4 mg)",treatment,33,2.0,6.0,Fatigue,Fatigue,Fatigue,False,,Retatrutide,True,True,4.0,SC,QW
NCT04881760,Fatigue,Adverse events during treatment that occurred in ≥5% of total participants,True,False,False,False,False,"8 mg (ID, 2 mg)",treatment,35,1.0,3.0,Fatigue,Fatigue,Fatigue,False,,Retatrutide,True,True,8.0,SC,QW
NCT04881760,Fatigue,Adverse events during treatment that occurred in ≥5% of total participants,True,False,False,False,False,"8 mg (ID, 4 mg)",treatment,35,3.0,9.0,Fatigue,Fatigue,Fatigue,False,,Retatrutide,True,True,8.0,SC,QW
NCT04881760,Fatigue,Adverse events during treatment that occurred in ≥5% of total participants,True,False,False,False,False,"12 mg (ID, 2 mg)",treatment,62,6.0,10.0,Fatigue,Fatigue,Fatigue,False,,Retatrutide,True,True,12.0,SC,QW
NCT04881760,Early satiety,Adverse events during treatment that occurred in ≥5% of total participants,True,False,False,False,False,Placebo Group,control,70,4.0,6.0,Early satiety,Early satiety,Early satiety,False,,Retatrutide,False,False,,,
NCT04881760,Early satiety,Adverse events during treatment that occurred in ≥5% of total participants,True,False,False,False,False,1 mg,treatment,69,3.0,4.0,Early satiety,Early satiety,Early satiety,False,,Retatrutide,False,False,1.0,SC,QW
NCT04881760,Early satiety,Adverse events during treatment that occurred in ≥5% of total participants,True,False,False,False,False,"4 mg (ID, 2 mg)",treatment,33,1.0,3.0,Early satiety,Early satiety,Early satiety,False,,Retatrutide,True,True,4.0,SC,QW
NCT04881760,Early satiety,Adverse events during treatment that occurred in ≥5% of total participants,True,False,False,False,False,"4 mg (ID, 4 mg)",treatment,33,1.0,3.0,Early satiety,Early satiety,Early satiety,False,,Retatrutide,True,True,4.0,SC,QW
NCT04881760,Early satiety,Adverse events during treatment that occurred in ≥5% of total participants,True,False,False,False,False,"8 mg (ID, 2 mg)",treatment,35,0.0,0.0,Early satiety,Early satiety,Early satiety,False,,Retatrutide,True,True,8.0,SC,QW
NCT04881760,Early satiety,Adverse events during treatment that occurred in ≥5% of total participants,True,False,False,False,False,"8 mg (ID, 4 mg)",treatment,35,2.0,6.0,Early satiety,Early satiety,Early satiety,False,,Retatrutide,True,True,8.0,SC,QW
NCT04881760,Early satiety,Adverse events during treatment that occurred in ≥5% of total participants,True,False,False,False,False,"12 mg (ID, 2 mg)",treatment,62,6.0,10.0,Early satiety,Early satiety,Early satiety,False,,Retatrutide,True,True,12.0,SC,QW
NCT04881760,Increase in lipase level,Adverse events during treatment that occurred in ≥5% of total participants,True,False,False,False,False,Placebo Group,control,70,2.0,3.0,Increase in lipase level,Lipase increased,Pancreatic enzyme increased,False,,Retatrutide,False,False,,,
NCT04881760,Increase in lipase level,Adverse events during treatment that occurred in ≥5% of total participants,True,False,False,False,False,1 mg,treatment,69,2.0,3.0,Increase in lipase level,Lipase increased,Pancreatic enzyme increased,False,,Retatrutide,False,False,1.0,SC,QW
NCT04881760,Increase in lipase level,Adverse events during treatment that occurred in ≥5% of total participants,True,False,False,False,False,"4 mg (ID, 2 mg)",treatment,33,3.0,9.0,Increase in lipase level,Lipase increased,Pancreatic enzyme increased,False,,Retatrutide,True,True,4.0,SC,QW
NCT04881760,Increase in lipase level,Adverse events during treatment that occurred in ≥5% of total participants,True,False,False,False,False,"4 mg (ID, 4 mg)",treatment,33,2.0,6.0,Increase in lipase level,Lipase increased,Pancreatic enzyme increased,False,,Retatrutide,True,True,4.0,SC,QW
NCT04881760,Increase in lipase level,Adverse events during treatment that occurred in ≥5% of total participants,True,False,False,False,False,"8 mg (ID, 2 mg)",treatment,35,1.0,3.0,Increase in lipase level,Lipase increased,Pancreatic enzyme increased,False,,Retatrutide,True,True,8.0,SC,QW
NCT04881760,Increase in lipase level,Adverse events during treatment that occurred in ≥5% of total participants,True,False,False,False,False,"8 mg (ID, 4 mg)",treatment,35,2.0,6.0,Increase in lipase level,Lipase increased,Pancreatic enzyme increased,False,,Retatrutide,True,True,8.0,SC,QW
NCT04881760,Increase in lipase level,Adverse events during treatment that occurred in ≥5% of total participants,True,False,False,False,False,"12 mg (ID, 2 mg)",treatment,62,5.0,8.0,Increase in lipase level,Lipase increased,Pancreatic enzyme increased,False,,Retatrutide,True,True,12.0,SC,QW
NCT04881760,Hypersensitivity,Adverse events of special interest,False,False,False,False,True,Placebo Group,control,70,2.0,3.0,Hypersensitivity,Hypersensitivity,Hypersensitivity,False,,Retatrutide,False,False,,,
NCT04881760,Hypersensitivity,Adverse events of special interest,False,False,False,False,True,1 mg,treatment,69,7.0,10.0,Hypersensitivity,Hypersensitivity,Hypersensitivity,False,,Retatrutide,False,False,1.0,SC,QW
NCT04881760,Hypersensitivity,Adverse events of special interest,False,False,False,False,True,"4 mg (ID, 2 mg)",treatment,33,1.0,3.0,Hypersensitivity,Hypersensitivity,Hypersensitivity,False,,Retatrutide,True,True,4.0,SC,QW
NCT04881760,Hypersensitivity,Adverse events of special interest,False,False,False,False,True,"4 mg (ID, 4 mg)",treatment,33,2.0,6.0,Hypersensitivity,Hypersensitivity,Hypersensitivity,False,,Retatrutide,True,True,4.0,SC,QW
NCT04881760,Hypersensitivity,Adverse events of special interest,False,False,False,False,True,"8 mg (ID, 2 mg)",treatment,35,3.0,9.0,Hypersensitivity,Hypersensitivity,Hypersensitivity,False,,Retatrutide,True,True,8.0,SC,QW
NCT04881760,Hypersensitivity,Adverse events of special interest,False,False,False,False,True,"8 mg (ID, 4 mg)",treatment,35,7.0,20.0,Hypersensitivity,Hypersensitivity,Hypersensitivity,False,,Retatrutide,True,True,8.0,SC,QW
NCT04881760,Hypersensitivity,Adverse events of special interest,False,False,False,False,True,"12 mg (ID, 2 mg)",treatment,62,8.0,13.0,Hypersensitivity,Hypersensitivity,Hypersensitivity,False,,Retatrutide,True,True,12.0,SC,QW
NCT04881760,Antidrug antibodies during treatment,Adverse events of special interest,False,False,False,False,True,Placebo Group,control,70,1.0,1.0,Antidrug antibodies during treatment,Antidrug antibodies,Immunogenicity,False,,Retatrutide,False,False,,,
NCT04881760,Antidrug antibodies during treatment,Adverse events of special interest,False,False,False,False,True,1 mg,treatment,69,3.0,4.0,Antidrug antibodies during treatment,Antidrug antibodies,Immunogenicity,False,,Retatrutide,False,False,1.0,SC,QW
NCT04881760,Antidrug antibodies during treatment,Adverse events of special interest,False,False,False,False,True,"4 mg (ID, 2 mg)",treatment,33,4.0,12.0,Antidrug antibodies during treatment,Antidrug antibodies,Immunogenicity,False,,Retatrutide,True,True,4.0,SC,QW
NCT04881760,Antidrug antibodies during treatment,Adverse events of special interest,False,False,False,False,True,"4 mg (ID, 4 mg)",treatment,33,5.0,16.0,Antidrug antibodies during treatment,Antidrug antibodies,Immunogenicity,False,,Retatrutide,True,True,4.0,SC,QW
NCT04881760,Antidrug antibodies during treatment,Adverse events of special interest,False,False,False,False,True,"8 mg (ID, 2 mg)",treatment,35,5.0,16.0,Antidrug antibodies during treatment,Antidrug antibodies,Immunogenicity,False,,Retatrutide,True,True,8.0,SC,QW
NCT04881760,Antidrug antibodies during treatment,Adverse events of special interest,False,False,False,False,True,"8 mg (ID, 4 mg)",treatment,35,2.0,6.0,Antidrug antibodies during treatment,Antidrug antibodies,Immunogenicity,False,,Retatrutide,True,True,8.0,SC,QW
NCT04881760,Antidrug antibodies during treatment,Adverse events of special interest,False,False,False,False,True,"12 mg (ID, 2 mg)",treatment,62,11.0,18.0,Antidrug antibodies during treatment,Antidrug antibodies,Immunogenicity,False,,Retatrutide,True,True,12.0,SC,QW
NCT04881760,Hyperesthesia or related adverse event,Adverse events of special interest,False,False,False,False,True,Placebo Group,control,70,1.0,1.0,Hyperesthesia or related adverse event,Hyperesthesia,Neurologic sensory disturbance,False,,Retatrutide,False,False,,,
NCT04881760,Hyperesthesia or related adverse event,Adverse events of special interest,False,False,False,False,True,1 mg,treatment,69,1.0,1.0,Hyperesthesia or related adverse event,Hyperesthesia,Neurologic sensory disturbance,False,,Retatrutide,False,False,1.0,SC,QW
NCT04881760,Hyperesthesia or related adverse event,Adverse events of special interest,False,False,False,False,True,"4 mg (ID, 2 mg)",treatment,33,2.0,6.0,Hyperesthesia or related adverse event,Hyperesthesia,Neurologic sensory disturbance,False,,Retatrutide,True,True,4.0,SC,QW
NCT04881760,Hyperesthesia or related adverse event,Adverse events of special interest,False,False,False,False,True,"4 mg (ID, 4 mg)",treatment,33,2.0,6.0,Hyperesthesia or related adverse event,Hyperesthesia,Neurologic sensory disturbance,False,,Retatrutide,True,True,4.0,SC,QW
NCT04881760,Hyperesthesia or related adverse event,Adverse events of special interest,False,False,False,False,True,"8 mg (ID, 2 mg)",treatment,35,1.0,3.0,Hyperesthesia or related adverse event,Hyperesthesia,Neurologic sensory disturbance,False,,Retatrutide,True,True,8.0,SC,QW
NCT04881760,Hyperesthesia or related adverse event,Adverse events of special interest,False,False,False,False,True,"8 mg (ID, 4 mg)",treatment,35,5.0,14.0,Hyperesthesia or related adverse event,Hyperesthesia,Neurologic sensory disturbance,False,,Retatrutide,True,True,8.0,SC,QW
NCT04881760,Hyperesthesia or related adverse event,Adverse events of special interest,False,False,False,False,True,"12 mg (ID, 2 mg)",treatment,62,8.0,13.0,Hyperesthesia or related adverse event,Hyperesthesia,Neurologic sensory disturbance,False,,Retatrutide,True,True,12.0,SC,QW
NCT04881760,Cardiac arrhythmia,Adverse events of special interest,False,False,False,False,True,Placebo Group,control,70,2.0,3.0,Cardiac arrhythmia,Cardiac arrhythmia,Cardiac arrhythmia,False,,Retatrutide,False,False,,,
NCT04881760,Cardiac arrhythmia,Adverse events of special interest,False,False,False,False,True,1 mg,treatment,69,3.0,4.0,Cardiac arrhythmia,Cardiac arrhythmia,Cardiac arrhythmia,False,,Retatrutide,False,False,1.0,SC,QW
NCT04881760,Cardiac arrhythmia,Adverse events of special interest,False,False,False,False,True,"4 mg (ID, 2 mg)",treatment,33,0.0,0.0,Cardiac arrhythmia,Cardiac arrhythmia,Cardiac arrhythmia,False,,Retatrutide,True,True,4.0,SC,QW
NCT04881760,Cardiac arrhythmia,Adverse events of special interest,False,False,False,False,True,"4 mg (ID, 4 mg)",treatment,33,2.0,6.0,Cardiac arrhythmia,Cardiac arrhythmia,Cardiac arrhythmia,False,,Retatrutide,True,True,4.0,SC,QW
NCT04881760,Cardiac arrhythmia,Adverse events of special interest,False,False,False,False,True,"8 mg (ID, 2 mg)",treatment,35,0.0,0.0,Cardiac arrhythmia,Cardiac arrhythmia,Cardiac arrhythmia,False,,Retatrutide,True,True,8.0,SC,QW
NCT04881760,Cardiac arrhythmia,Adverse events of special interest,False,False,False,False,True,"8 mg (ID, 4 mg)",treatment,35,5.0,14.0,Cardiac arrhythmia,Cardiac arrhythmia,Cardiac arrhythmia,False,,Retatrutide,True,True,8.0,SC,QW
NCT04881760,Cardiac arrhythmia,Adverse events of special interest,False,False,False,False,True,"12 mg (ID, 2 mg)",treatment,62,7.0,11.0,Cardiac arrhythmia,Cardiac arrhythmia,Cardiac arrhythmia,False,,Retatrutide,True,True,12.0,SC,QW
NCT04881760,Hepatic disorder,Adverse events of special interest,False,False,False,False,True,Placebo Group,control,70,2.0,3.0,Hepatic disorder,Hepatic disorder,Hepatic disorders,False,,Retatrutide,False,False,,,
NCT04881760,Hepatic disorder,Adverse events of special interest,False,False,False,False,True,1 mg,treatment,69,5.0,7.0,Hepatic disorder,Hepatic disorder,Hepatic disorders,False,,Retatrutide,False,False,1.0,SC,QW
NCT04881760,Hepatic disorder,Adverse events of special interest,False,False,False,False,True,"4 mg (ID, 2 mg)",treatment,33,1.0,3.0,Hepatic disorder,Hepatic disorder,Hepatic disorders,False,,Retatrutide,True,True,4.0,SC,QW
NCT04881760,Hepatic disorder,Adverse events of special interest,False,False,False,False,True,"4 mg (ID, 4 mg)",treatment,33,0.0,0.0,Hepatic disorder,Hepatic disorder,Hepatic disorders,False,,Retatrutide,True,True,4.0,SC,QW
NCT04881760,Hepatic disorder,Adverse events of special interest,False,False,False,False,True,"8 mg (ID, 2 mg)",treatment,35,1.0,3.0,Hepatic disorder,Hepatic disorder,Hepatic disorders,False,,Retatrutide,True,True,8.0,SC,QW
NCT04881760,Hepatic disorder,Adverse events of special interest,False,False,False,False,True,"8 mg (ID, 4 mg)",treatment,35,2.0,6.0,Hepatic disorder,Hepatic disorder,Hepatic disorders,False,,Retatrutide,True,True,8.0,SC,QW
NCT04881760,Hepatic disorder,Adverse events of special interest,False,False,False,False,True,"12 mg (ID, 2 mg)",treatment,62,2.0,3.0,Hepatic disorder,Hepatic disorder,Hepatic disorders,False,,Retatrutide,True,True,12.0,SC,QW
NCT04881760,Biliary disorder,Adverse events of special interest,False,False,False,False,True,Placebo Group,control,70,0.0,0.0,Biliary disorder,Biliary disorder,Hepatobiliary disorders,False,,Retatrutide,False,False,,,
NCT04881760,Biliary disorder,Adverse events of special interest,False,False,False,False,True,1 mg,treatment,69,0.0,0.0,Biliary disorder,Biliary disorder,Hepatobiliary disorders,False,,Retatrutide,False,False,1.0,SC,QW
NCT04881760,Biliary disorder,Adverse events of special interest,False,False,False,False,True,"4 mg (ID, 2 mg)",treatment,33,0.0,0.0,Biliary disorder,Biliary disorder,Hepatobiliary disorders,False,,Retatrutide,True,True,4.0,SC,QW
NCT04881760,Biliary disorder,Adverse events of special interest,False,False,False,False,True,"4 mg (ID, 4 mg)",treatment,33,0.0,0.0,Biliary disorder,Biliary disorder,Hepatobiliary disorders,False,,Retatrutide,True,True,4.0,SC,QW
NCT04881760,Biliary disorder,Adverse events of special interest,False,False,False,False,True,"8 mg (ID, 2 mg)",treatment,35,1.0,3.0,Biliary disorder,Biliary disorder,Hepatobiliary disorders,False,,Retatrutide,True,True,8.0,SC,QW
NCT04881760,Biliary disorder,Adverse events of special interest,False,False,False,False,True,"8 mg (ID, 4 mg)",treatment,35,2.0,6.0,Biliary disorder,Biliary disorder,Hepatobiliary disorders,False,,Retatrutide,True,True,8.0,SC,QW
NCT04881760,Biliary disorder,Adverse events of special interest,False,False,False,False,True,"12 mg (ID, 2 mg)",treatment,62,0.0,0.0,Biliary disorder,Biliary disorder,Hepatobiliary disorders,False,,Retatrutide,True,True,12.0,SC,QW
NCT04881760,Severe gastrointestinal adverse event,Adverse events of special interest,False,True,False,False,True,Placebo Group,control,70,0.0,0.0,Severe gastrointestinal adverse event,Severe gastrointestinal adverse events,Severe gastrointestinal adverse events,True,other_summary,Retatrutide,False,False,,,
NCT04881760,Severe gastrointestinal adverse event,Adverse events of special interest,False,True,False,False,True,1 mg,treatment,69,0.0,0.0,Severe gastrointestinal adverse event,Severe gastrointestinal adverse events,Severe gastrointestinal adverse events,True,other_summary,Retatrutide,False,False,1.0,SC,QW
NCT04881760,Severe gastrointestinal adverse event,Adverse events of special interest,False,True,False,False,True,"4 mg (ID, 2 mg)",treatment,33,0.0,0.0,Severe gastrointestinal adverse event,Severe gastrointestinal adverse events,Severe gastrointestinal adverse events,True,other_summary,Retatrutide,True,True,4.0,SC,QW
NCT04881760,Severe gastrointestinal adverse event,Adverse events of special interest,False,True,False,False,True,"4 mg (ID, 4 mg)",treatment,33,1.0,3.0,Severe gastrointestinal adverse event,Severe gastrointestinal adverse events,Severe gastrointestinal adverse events,True,other_summary,Retatrutide,True,True,4.0,SC,QW
NCT04881760,Severe gastrointestinal adverse event,Adverse events of special interest,False,True,False,False,True,"8 mg (ID, 2 mg)",treatment,35,1.0,3.0,Severe gastrointestinal adverse event,Severe gastrointestinal adverse events,Severe gastrointestinal adverse events,True,other_summary,Retatrutide,True,True,8.0,SC,QW
NCT04881760,Severe gastrointestinal adverse event,Adverse events of special interest,False,True,False,False,True,"8 mg (ID, 4 mg)",treatment,35,1.0,3.0,Severe gastrointestinal adverse event,Severe gastrointestinal adverse events,Severe gastrointestinal adverse events,True,other_summary,Retatrutide,True,True,8.0,SC,QW
NCT04881760,Severe gastrointestinal adverse event,Adverse events of special interest,False,True,False,False,True,"12 mg (ID, 2 mg)",treatment,62,4.0,6.0,Severe gastrointestinal adverse event,Severe gastrointestinal adverse events,Severe gastrointestinal adverse events,True,other_summary,Retatrutide,True,True,12.0,SC,QW
NCT04881760,Injection-site reaction,Adverse events of special interest,False,False,False,False,True,Placebo Group,control,70,0.0,0.0,Injection-site reaction,Injection-site reaction,Injection-site reactions,False,,Retatrutide,False,False,,,
NCT04881760,Injection-site reaction,Adverse events of special interest,False,False,False,False,True,1 mg,treatment,69,1.0,1.0,Injection-site reaction,Injection-site reaction,Injection-site reactions,False,,Retatrutide,False,False,1.0,SC,QW
NCT04881760,Injection-site reaction,Adverse events of special interest,False,False,False,False,True,"4 mg (ID, 2 mg)",treatment,33,0.0,0.0,Injection-site reaction,Injection-site reaction,Injection-site reactions,False,,Retatrutide,True,True,4.0,SC,QW
NCT04881760,Injection-site reaction,Adverse events of special interest,False,False,False,False,True,"4 mg (ID, 4 mg)",treatment,33,1.0,3.0,Injection-site reaction,Injection-site reaction,Injection-site reactions,False,,Retatrutide,True,True,4.0,SC,QW
NCT04881760,Injection-site reaction,Adverse events of special interest,False,False,False,False,True,"8 mg (ID, 2 mg)",treatment,35,0.0,0.0,Injection-site reaction,Injection-site reaction,Injection-site reactions,False,,Retatrutide,True,True,8.0,SC,QW
NCT04881760,Injection-site reaction,Adverse events of special interest,False,False,False,False,True,"8 mg (ID, 4 mg)",treatment,35,1.0,3.0,Injection-site reaction,Injection-site reaction,Injection-site reactions,False,,Retatrutide,True,True,8.0,SC,QW
NCT04881760,Injection-site reaction,Adverse events of special interest,False,False,False,False,True,"12 mg (ID, 2 mg)",treatment,62,5.0,8.0,Injection-site reaction,Injection-site reaction,Injection-site reactions,False,,Retatrutide,True,True,12.0,SC,QW
NCT04881760,Major depressive disorder or suicidal ideation,Adverse events of special interest,False,True,False,False,True,Placebo Group,control,70,1.0,1.0,Major depressive disorder or suicidal ideation,Major depressive disorder or suicidal ideation,Depression and suicidality,False,,Retatrutide,False,False,,,
NCT04881760,Major depressive disorder or suicidal ideation,Adverse events of special interest,False,True,False,False,True,1 mg,treatment,69,0.0,0.0,Major depressive disorder or suicidal ideation,Major depressive disorder or suicidal ideation,Depression and suicidality,False,,Retatrutide,False,False,1.0,SC,QW
NCT04881760,Major depressive disorder or suicidal ideation,Adverse events of special interest,False,True,False,False,True,"4 mg (ID, 2 mg)",treatment,33,0.0,0.0,Major depressive disorder or suicidal ideation,Major depressive disorder or suicidal ideation,Depression and suicidality,False,,Retatrutide,True,True,4.0,SC,QW
NCT04881760,Major depressive disorder or suicidal ideation,Adverse events of special interest,False,True,False,False,True,"4 mg (ID, 4 mg)",treatment,33,0.0,0.0,Major depressive disorder or suicidal ideation,Major depressive disorder or suicidal ideation,Depression and suicidality,False,,Retatrutide,True,True,4.0,SC,QW
NCT04881760,Major depressive disorder or suicidal ideation,Adverse events of special interest,False,True,False,False,True,"8 mg (ID, 2 mg)",treatment,35,0.0,0.0,Major depressive disorder or suicidal ideation,Major depressive disorder or suicidal ideation,Depression and suicidality,False,,Retatrutide,True,True,8.0,SC,QW
NCT04881760,Major depressive disorder or suicidal ideation,Adverse events of special interest,False,True,False,False,True,"8 mg (ID, 4 mg)",treatment,35,0.0,0.0,Major depressive disorder or suicidal ideation,Major depressive disorder or suicidal ideation,Depression and suicidality,False,,Retatrutide,True,True,8.0,SC,QW
NCT04881760,Major depressive disorder or suicidal ideation,Adverse events of special interest,False,True,False,False,True,"12 mg (ID, 2 mg)",treatment,62,0.0,0.0,Major depressive disorder or suicidal ideation,Major depressive disorder or suicidal ideation,Depression and suicidality,False,,Retatrutide,True,True,12.0,SC,QW
NCT04881760,Renal event,Adverse events of special interest,False,True,False,False,True,Placebo Group,control,70,1.0,1.0,Renal event,Renal impairment,Renal impairment,False,,Retatrutide,False,False,,,
NCT04881760,Renal event,Adverse events of special interest,False,True,False,False,True,1 mg,treatment,69,1.0,1.0,Renal event,Renal impairment,Renal impairment,False,,Retatrutide,False,False,1.0,SC,QW
NCT04881760,Renal event,Adverse events of special interest,False,True,False,False,True,"4 mg (ID, 2 mg)",treatment,33,1.0,3.0,Renal event,Renal impairment,Renal impairment,False,,Retatrutide,True,True,4.0,SC,QW
NCT04881760,Renal event,Adverse events of special interest,False,True,False,False,True,"4 mg (ID, 4 mg)",treatment,33,0.0,0.0,Renal event,Renal impairment,Renal impairment,False,,Retatrutide,True,True,4.0,SC,QW
NCT04881760,Renal event,Adverse events of special interest,False,True,False,False,True,"8 mg (ID, 2 mg)",treatment,35,0.0,0.0,Renal event,Renal impairment,Renal impairment,False,,Retatrutide,True,True,8.0,SC,QW
NCT04881760,Renal event,Adverse events of special interest,False,True,False,False,True,"8 mg (ID, 4 mg)",treatment,35,1.0,3.0,Renal event,Renal impairment,Renal impairment,False,,Retatrutide,True,True,8.0,SC,QW
NCT04881760,Renal event,Adverse events of special interest,False,True,False,False,True,"12 mg (ID, 2 mg)",treatment,62,0.0,0.0,Renal event,Renal impairment,Renal impairment,False,,Retatrutide,True,True,12.0,SC,QW
NCT04881760,Major adverse cardiovascular event,Adverse events of special interest,False,True,False,False,True,Placebo Group,control,70,0.0,0.0,Major adverse cardiovascular event,Major adverse cardiovascular events,Major adverse cardiovascular events,True,other_summary,Retatrutide,False,False,,,
NCT04881760,Major adverse cardiovascular event,Adverse events of special interest,False,True,False,False,True,1 mg,treatment,69,2.0,3.0,Major adverse cardiovascular event,Major adverse cardiovascular events,Major adverse cardiovascular events,True,other_summary,Retatrutide,False,False,1.0,SC,QW
NCT04881760,Major adverse cardiovascular event,Adverse events of special interest,False,True,False,False,True,"4 mg (ID, 2 mg)",treatment,33,0.0,0.0,Major adverse cardiovascular event,Major adverse cardiovascular events,Major adverse cardiovascular events,True,other_summary,Retatrutide,True,True,4.0,SC,QW
NCT04881760,Major adverse cardiovascular event,Adverse events of special interest,False,True,False,False,True,"4 mg (ID, 4 mg)",treatment,33,0.0,0.0,Major adverse cardiovascular event,Major adverse cardiovascular events,Major adverse cardiovascular events,True,other_summary,Retatrutide,True,True,4.0,SC,QW
NCT04881760,Major adverse cardiovascular event,Adverse events of special interest,False,True,False,False,True,"8 mg (ID, 2 mg)",treatment,35,0.0,0.0,Major adverse cardiovascular event,Major adverse cardiovascular events,Major adverse cardiovascular events,True,other_summary,Retatrutide,True,True,8.0,SC,QW
NCT04881760,Major adverse cardiovascular event,Adverse events of special interest,False,True,False,False,True,"8 mg (ID, 4 mg)",treatment,35,0.0,0.0,Major adverse cardiovascular event,Major adverse cardiovascular events,Major adverse cardiovascular events,True,other_summary,Retatrutide,True,True,8.0,SC,QW
NCT04881760,Major adverse cardiovascular event,Adverse events of special interest,False,True,False,False,True,"12 mg (ID, 2 mg)",treatment,62,0.0,0.0,Major adverse cardiovascular event,Major adverse cardiovascular events,Major adverse cardiovascular events,True,other_summary,Retatrutide,True,True,12.0,SC,QW
NCT04881760,Pancreatitis,Adverse events of special interest,False,True,False,False,True,Placebo Group,control,70,0.0,0.0,Pancreatitis,Pancreatitis,Pancreatitis,False,,Retatrutide,False,False,,,
NCT04881760,Pancreatitis,Adverse events of special interest,False,True,False,False,True,1 mg,treatment,69,0.0,0.0,Pancreatitis,Pancreatitis,Pancreatitis,False,,Retatrutide,False,False,1.0,SC,QW
NCT04881760,Pancreatitis,Adverse events of special interest,False,True,False,False,True,"4 mg (ID, 2 mg)",treatment,33,0.0,0.0,Pancreatitis,Pancreatitis,Pancreatitis,False,,Retatrutide,True,True,4.0,SC,QW
NCT04881760,Pancreatitis,Adverse events of special interest,False,True,False,False,True,"4 mg (ID, 4 mg)",treatment,33,0.0,0.0,Pancreatitis,Pancreatitis,Pancreatitis,False,,Retatrutide,True,True,4.0,SC,QW
NCT04881760,Pancreatitis,Adverse events of special interest,False,True,False,False,True,"8 mg (ID, 2 mg)",treatment,35,0.0,0.0,Pancreatitis,Pancreatitis,Pancreatitis,False,,Retatrutide,True,True,8.0,SC,QW
NCT04881760,Pancreatitis,Adverse events of special interest,False,True,False,False,True,"8 mg (ID, 4 mg)",treatment,35,0.0,0.0,Pancreatitis,Pancreatitis,Pancreatitis,False,,Retatrutide,True,True,8.0,SC,QW
NCT04881760,Pancreatitis,Adverse events of special interest,False,True,False,False,True,"12 mg (ID, 2 mg)",treatment,62,1.0,2.0,Pancreatitis,Pancreatitis,Pancreatitis,False,,Retatrutide,True,True,12.0,SC,QW
